The role of Xenopus BRG1, a conserved subunit of SWI/SNF class of remodeling complexes, during early frog development by Singhal, Nishant
    
Dissertation der Fakultät für Biologie 
der Ludwig-Maximilians-Universität München 
 
 
 
 
 
The role of Xenopus BRG1, a conserved 
subunit of SWI/SNF class of remodeling 
complexes, during early frog development. 
 
 
 
 
Vorgelegt von 
Nishant Singhal 
Aus Kalagarh, India. 
2005 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissertation eingereicht:  08. März 2005 
 
Erster Berichterstatter:  Prof. Dr. Peter Becker 
 
Zweiter Berichterstatter:  Prof. Dr. Thomas Cremer 
 
Sonderberichterstatter:  Prof. Ralph Rupp 
 
Tag der mündlichen Prüfung:  07. Juni 2005 
     
 
 
 
 
 
 
 
 
To my parents…………… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Acknowledgements 
 
I am very grateful to Prof. Ralph A.W. Rupp for giving me an opportunity to 
work on this project. His valuable guidance in this project from the day when I 
just started to pick up developmental biology makes me immensely indebted to 
him. 
I am very much thankful to Prof. Peter Becker for his guidance and for the 
excellent scientific atmosphere in the department. I am also very much indebted 
to his painstaking advises, which helped me immensely to correct this 
dissertation.  
I would also like to extend my acknowledgments to Prof. Klobeck for 
providing equipments required during this work and as well as being a source of 
all time available scientific advises.  
I take this opportunity to extend my acknowledgments to Neil Armstrong 
and Dr. Xaio Lei for helping me to learn frog techniques and discussions in late 
hours of lab work. I wish to express gratitude to Drs. Ryan Cabot, Maria Kuppner 
and Gregor Gilfillan for critically reading parts of my thesis and helping me to 
correct the language. I extend my sincere thanks to Prof. Anthony Imbalzano, Dr. 
Alex Brehm and Dr. Paul Wade for providing me with initial reagents required in 
this project. The acknowledgement will remain incomplete without acknowledging 
the support of Prof Elisabeth Kremmer, who helped me to generate monoclonal 
antibodies.  
Hereby, I would also like to acknowledge all my colleagues who helped 
me in this project directly or indirectly.  
At last, I would like to extend my thanks to my wife for all those delicious 
lunches and for moral support during this project. Indeed, credit goes to my 
daughter who made me fresh every evening with her great smile.  
      
  I 
 
TABLE OF CONTENTS 
1   SUMMARY                1 
2   INTRODUCTION                          4  
2.1   Advantage of Xenopus as a model system           4 
2.2   Early development of Xenopus             6 
2.2.1   Fertilization and cleavage                      6 
2.2.2   Gastrulation                7 
2.2.3   Neurulation and organogenesis             9 
2.3   Role of signaling events in establishment of early pattern  
formation                    10 
2.3.1   Organizer formation                       10  
2.3.2   Morphogens and signaling thresholds                    14 
2.4   Evidence for regulation of embryonic patterning by chromatin      
        environment                                                                                    15 
2.5   Chromatin structure and chromatin remodeling complexes       16 
2.5.1   Chromatin structure                       16 
2.5.2   Chromatin remodeling                      19 
2.5.2.1  Histone modifications                                19 
2.5.2.1.1  Acetylation                                            20 
2.5.2.1.2  Deacetylation                                            20 
2.5.2.1.3  Methylation                                            21 
2.5.2.1.4  Phosphorylation                                           21 
2.5.2.1.5  Ubiquitination                                           21 
2.5.2.1.6  ADP-ribosylation and other modification                                        22 
2.5.2.2  ATP dependent chromatin remodeling                              22 
2.5.2.2.1  ISWI, a SANT-like domain-containing member of the  
SNF2 family                  24 
2.5.2.2.2 The CHD class of remodelers are characterized by  
                      chromodomain                                                       24 
2.5.2.2.3       The SWI/SNF complexes                                          25 
      
  II 
 
2.5.2.2.3.1 SWI/SNF complexes                                          25 
2.5.2.2.3.2 Interaction motifs in SWI/SNF class of remodelers                  28 
2.5.2.2.3.3 Differential targeting of SWI/SNF remodelers         30 
2.5.2.2.3.4 Nucleosomal remodeling by SWI/SNF complexes        30 
2.5.2.2.3.5 Function of RSC class of remodelers                                             32 
2.5.2.2.3.6 Function of mammalian SWI/SNF complexes         32 
2.5.2.2.3.7 SWI/SNF complexes in disease                                                  33 
2.6  Objective of this work             35 
3   MATERIALS AND METHODS           36 
3.1   Reagents               36 
3.2   Devices                     36 
3.3   Nucleic acids              37 
3.3.1   Size standards                        37 
3.3.2   Oligonucleotides                        37 
3.3.3   Plasmids               39 
3.3.3.1  Plasmids for in-vitro transcription                      39 
3.3.3.2  Plasmids for dig-labeled RNA in-situ hybridization probes             39 
3.4   Bacterial manipulation             40 
3.5   Embryological methods             40 
3.5.1   Solutions                     40 
3.5.2   Experimental animals                  41 
3.5.3   Superovulation of the female Xenopus laevis                41 
3.5.4   Preparation of testis                       41 
3.5.5   In-vitro fertilization of eggs and culture of the embryos                  41 
3.5.6   Jelly coat removal                                      41 
3.5.7   Injection of embryos                       42 
3.5.8   Preparation of explants                       42 
3.6   Histological methods             42 
3.6.1   Solution                         42 
3.6.2   Fixation of embryos                       43 
      
  III 
 
3.6.3   Immunocytochemistry                       43 
3.7   Protein methods              44 
3.7.1   SDS page and western blotting           44 
3.7.2   Immunoprecipitation            44 
3.8   Molecular biological methods            46 
3.8.1   Isolation of nucleic acids                       46 
3.8.1.1  Mini-preparation with Qiagen kit                                46 
3.8.1.2  Isolation of RNA                                  46 
3.8.2   Analysis and manipulation of nucleic acids                    47 
3.8.2.1  Gel electrophoresis of nucleic acids                               47  
3.8.2.2  Isolation of DNA fragments from agarose gel                              47 
3.8.2.3  Cloning methods                                  47 
3.8.3   Polymerase chain reaction (PCR)                     47 
3.8.3.1  PCR amplification of xbrg1 cDNA fragments for cloning                47 
3.8.3.2  RT-PCR                                        48 
3.8.3.3  Northern blotting             49 
3.8.4   In-vitro transcription                       49 
3.8.4.1  In-vitro reverse transcription                                49 
3.8.4.2  In-vitro transcription for microinjection                               49 
3.8.4.3  In-vitro transcription of dig-labeled RNA probes                             50 
3.8.5   Site-directed mutagenesis                       51 
3.8.6   Design and synthesis of antisense morpholino oligonucleotides   52 
3.8.7   Expression and purification of GST-xBRG1 fusion protein  
for the generation of monoclonal antibody                                     53 
3.8.8   RNA in-situ hybridization                       54 
4   RESULTS              58 
4.1   Dominant negative human BRG1 causes head and eye  
defects in Xenopus embryos               58 
4.2   Phenotypes produced by dn hBRG1 are specific                   61 
4.3   Cloning of Xenopus brg1             62 
      
  IV 
 
4.4   Xbrg1 is maternally expressed and has a tissue specific  
expression pattern                              74 
4.5   Generation and characterization of monoclonal  
antibodies for xBRG1                   76 
4.6   Optimization of in-vitro transcription for xbrg1          78 
4.7   Xenopus BRG1 is required for anterior-posterior axis  
formation                    80 
4.8   Ventral overexpression of wild type xBRG1 produces  
partial secondary axis                              81 
4.9   Reduction of endogenous xBRG1 causes severe head and  
axial abnormalities                                                                          83 
4.10   Phenotypes produced by xBrg1 antisense morpholino 
oligonucleotides are rescuable           86 
4.11   BRG1 knock-down affects expression of various differentiation  
          markers              88 
4.12   BRG1 knock-down causes down regulation of genes required  
for early patterning of the dorsal mesoderm          91 
4.13   BRG1 knock-down affect the expression levels of Myod and  
Myf-5                      94 
4.14   Functional interdependence of xBRG1 and ?-CATENIN       94 
4.15   Gene - and signal specific roles of xBRG1          97 
4.16   Modulation of WNT-dependent gene-activation by xBRG1       101 
4.17   Cloning of Xenopus ini1           104 
4.18   Expression pattern of Xini1                    107 
5   DISCUSSION            108 
5.1   Cloning and expression pattern                                 108 
5.2   Role of BRG1 in dorso-ventral patterning        110 
5.2.1   Methodological considerations                   110 
5.2.2   Specific role of BRG1 in anterio-posterior axis formation             112 
5.3   BRG1 is required for normal expression of WNT target genes    114 
      
  V 
 
5.4   BRG1 containing complexes have gene and signal specific  
                      functions                 116 
5.5   Effect of BRG1 knock-down on organogenesis        117 
5.6   Signaling thresholds at the nucleosomal level        119 
5.7   Specific recruitment of BRG1 on its target genes      120 
5.8   Conclusions and outlook           121  
6   LITERATURE            123 
ABBREVIATIONS            149 
CURRICULUM VITAE           151
                                                                                                               1 Summary   
  1 
  
1 SUMMARY 
BRG1 is a conserved subunit of the SWI/SNF family of ATP dependent 
chromatin remodeling complexes. These complexes play an important role in the 
transcription of various genes by making promoters accessible to the 
transcription machinery. Mutations in BRG1 have been connected to various 
cancers. In addition, a BRG1 knock-out in mice is lethal at the periimplantation 
stage, while BRG1 heterozygote mice are predisposed to exencephaly and 
tumors of epithelial origin, showing the importance of BRG1 in normal 
development and disease.  
In this study, I used Xenopus laevis to study the role of BRG1 because 
this system allows manipulation of endogenous protein levels by the use of 
antisense oligonucleotide mediated knock-down as well as interference analysis 
at early stages of development by overexpression of wild type and dominant 
negative protein variants. Since BRG1 is conserved among all vertebrates, I 
initially studied the role of BRG1 in Xenopus development by overexpression of 
wild type and dominant negative human BRG1. Overexpression of dominant 
negative human BRG1 gave a ventralized phenotype suggesting a role of BRG1 
in dorsal-ventral patterning. The specificity of phenotypes was confirmed by 
using wild type human BRG1. On the other hand, overexpression of wild type 
and dominant negative variants of human BRM showed no developmental 
phenotypes. 
Prompted by these results, a frog brg1 cDNA was cloned by searching the 
Xenopus laevis EST database, using human BRG1 as a query. In addition, 
monoclonal antibodies specific to xBRG1 were raised and characterized. The 
expression pattern of Xbrg1 was found to be ubiquitous until gastrula stage and 
is tissue specific from neurula stage onwards. A Xenopus homologue of INI1, a 
subunit of SWI/SNF chromatin-remodeling complex, was cloned using database 
search. The expression pattern of Xini1 was found to be similar to Xbrg1. 
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Using site directed mutagenesis, a dominant negative construct of xBRG1 
was made by mutating the conserved lysine into arginine (K770R). Loss and gain 
of function studies showed that BRG1 is involved in AP axis formation during 
Xenopus development. The gain of function studies were done by overex-
pressing wild type and dominant negative xBRG1, while loss of function studies 
were done using highly specific antisense morpholino oligos. Specificity of 
morpholino treatment was further proven by the rescue of ventralized phenotypes 
of morphant embryos by overexpression of human BRG1. It was found that 
BRG1 knock-down affects several tissues as assessed by in-situ hybridization 
using tissue specific markers.  
To determine the molecular explanation for these pleiotropic effects, 
several genes involved in early patterning of Xenopus embryo during organizer 
formation were analyzed. The analysis was done using whole mount in-situ 
hybridization, revealing the spatial gene expression pattern. This analysis 
revealed that BRG1 mostly affects WNT signaling dependent genes required for 
dorsal mesoderm formation while leaving pan-mesodermal genes unaffected. 
Furthermore the genetic interaction of BRG1 with the WNT pathway was 
confirmed by epistasis experiments showing that overexpression of ?-CATENIN 
can rescue the xBrg1 antisense morpholino oligos dependent ventralized 
phenotypes as well as formation of secondary axis by overexpression of ?-
CATENIN could be prevented by BRG1 knock-down.  
Since the whole embryo represents a complex situation whereby many 
signaling pathways interact with each other and influence the outcome, the 
animal cap system was used to analyze the effect of BRG1 on various signaling 
pathways by analyzing corresponding direct target genes. Animal cap assays 
showed that the effect of BRG1 is signal specific. Moreover, among the affected 
signaling pathways, BRG1 knock-down affected only specific genes. These 
results showed that the BRG1 effect is gene and signal specific.  
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The importance of WNT signaling has also been shown in cancer as well 
as in haematopoietic and embryonic stem cell self renewal. Given the importance 
of the WNT signaling, the role of BRG1 on the WNT signaling pathway was 
further investigated. Treatment of animal cap cells with various doses of Wnt8 
mRNA showed the differential requirement of the WNT signal for maximal 
stimulation of direct target genes. The direct target genes of the WNT pathway 
showed various degrees of reduction in their maximal stimulation upon BRG1 
protein knock-down. The requirement of BRG1 for proper stimulation of the WNT 
target genes was further confirmed by overexpression of xBRG1 under sub-
optimal conditions of WNT stimulation.  
A major conclusion from these experiments is that BRG1 protein defines 
signaling thresholds for WNT-mediated activation of target genes. This implies 
that chromatin remodeling complexes are part of the machinery, which translates 
inductive signals into spatial gene expression domains.   
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2 INTRODUCTION 
An animal starts its life as a single cell, i.e. a fertilized egg. Repeated 
division of this cell gives rise to a multicellular organism in a complex but precise 
manner. The development of a multicellular organism involves complex series of 
genetic, cellular and physiological events. These events occur in a correct order 
in specific cells, and at the appropriate times to orchestrate the proper 
development of an organism. Selective gene expression controls the four 
essential processes to develop an embryo; a) cell proliferation, producing many 
cells from one, b) cell differentiation, creating cells with different characteristics at 
different positions, c) cell interaction, coordinating the behavior of one cell with 
that of its neighbors, and d) cell movement, rearranging the cell to form 
structured tissues and organs toward establishing the body plan. 
 Transient and stable gene expression patterns are governed by various 
external stimuli, causing epigenetic changes in the genome via direct or indirect 
mechanisms. The external stimuli are relayed to the genome of the cells via 
various signaling pathways. The major signaling pathways, which control 
embryonic patterning and cell specification, are conserved throughout evolution. 
Thus, the study of these pathways using one model system would allow making 
predictions in other systems.  
2.1 Advantage of Xenopus as a model system 
 Over several years, the African clawed frog, Xenopus laevis has been one 
of the most successful vertebrate model systems to study the various signaling 
pathways involved in the patterning and cell specification that give rise to a 
normal embryo.  
 The advantages of the Xenopus model system have been well 
appreciated over time. It has been used extensively to study events in early 
embryogenesis. The embryonic development of Xenopus is rapid. From 
fertilization to feeding stage tadpole, it takes only about 48 hours. The eggs of 
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Xenopus are about 1.5 mm in diameter and so are easy to handle. Moreover, a 
single female lays up to 1500 eggs per day, thus providing sufficient material for 
study. Other then these features, eggs can be laid at the desire by hormone 
induction. The eggs are easy to culture in semi-sterile conditions and do not 
require external nutrients aside from the yolk present in the embryo.  
 In Xenopus, fate maps were created, showing the statistical contribution of 
each blastomeres of the 32-cell stage embryo, which can be used to trace the 
origin of the cells in various tissues (Dale and Slack, 1987).  
Maternal mRNAs deposited in the egg control the early developmental 
events of all embryos, which include the patterning of the basic body plan, the 
determination of cell fate, and the early patterning of the major organs and body 
musculature. These maternal mRNAs are the source of early patterning events 
occurring prior to the start of transcription. These events can be studied easily in 
Xenopus embryos because of the long duration taken to complete these events 
and in addition, the embryos are easily accessible due to external development. 
These features allow to study and learn about the cellular and molecular 
mechanisms of early patterning including the role of specific extracellular growth 
factors, cell surface receptors and intracellular signaling pathway components. 
Many of the factors originally identified in Xenopus were later shown to be 
involved in other critical biological processes and oncogenesis. Other then these 
features, Xenopus has given an excellent contribution to our understanding of 
cell biological and biochemical processes, including chromosome replication, 
chromatin, cytoskeleton, and nuclear assembly and cell cycle progression. 
 Another experimentally important aspect of the Xenopus model system is 
the availability of the animal cap assay system. The animal cap is derived from 
the roof of the blastocoel, which is made up of prospective ectodermal cells. The 
animal cap system allows the study of various signaling pathways in an isolated, 
but still endogenous tissue. Animal caps have been used mostly for induction 
assays. Animal cap cells consist of multipotential embryonic stem cells, which 
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can be differentiated into various organs upon differential treatments (Ariizumi 
and Asashima, 2001; Fukui et al., 2003). This property of animal cap cells 
provides an ideal system to study the complex mechanisms involved in organ 
differentiation outside the embryo.  
2.2 Early development of Xenopus 
2.2.1 Fertilization and cleavage 
 The mature Xenopus egg has a dark, pigmented animal region and a pale, 
yolk-rich vegetal region. The egg is enclosed in a protective vitelline membrane, 
which is embedded in a gelatinous coat. The unfertilized egg of Xenopus is 
radially symmetrical about the animal-vegetal axis and this symmetry is broken 
with the fertilization. At fertilization, one sperm enters the egg in the animal 
region. The egg and sperm nuclei fuse to form the diploid zygote nucleus. The 
vitelline membrane lifts off the egg surface and in about 15 minute the egg has 
rotated within it under the influence of gravity so that the heavier yolky, vegetal 
region is now downward. Within 90 minute of fertilization, changes in the egg 
become distinguishable opposite to the site of sperm entry. The plasma 
membrane and the cortex-, a gel-like layer of actin filaments and associated 
material about 5 μm thick beneath the membrane, rotate about 30o relative to the 
rest of the cytoplasm, which remains stationary. This cortical rotation is towards 
the site of sperm entry, the opposite vegetal cortex move towards the animal pole 
(Gerhart et al., 1989).  
The first cleavage occurs along the animal-vegetal axis in 90 minute of 
fertilization, and divides the embryo into equal left and right halves. The second 
cleavage is also along the animal vegetal axis but at right angle to the first and 
divides the embryo in the 4-cells at which stage dorsal and ventral sides could be 
easily distinguished by the pigmentation and the size of the blastomeres. The 
third cleavage is equatorial, at right angle to the first two, and divides the embryo 
into four animal cells and four vegetal cells. After about 12 cell divisions a 
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spherical mass of cells with a fluid filled cavity, known as the blastocoel, is 
formed, although it can first be seen at the 4-8-cell stage of the embryo.  This 
spherical mass of the cells is called as blastula (Gerhart and Keller, 1986; Keller, 
1991).  
2.2.2 Gastrulation 
Gastrulation in Xenopus is initiated on the future dorsal side of the 
embryo, just below the equator. Gastrulation converts the blastula into a three-
layered structure with clearly recognizable anterio-posterior and dorso-ventral 
axis and bilateral symmetry. At the blastula stage, the mesodermal and 
endodermal germ layers are located in the equatorial and vegetal region and are 
essentially on the outside of the embryo, while the ectoderm is confined to the 
animal region. Gastrulation involves extensive cell movements and 
rearrangement of the tissues of the blastula.  
Gastrulation is initiated by the invagination on the surface of the blastula 
on the dorsal side, forming a small slit like infolding-the blastopore. The dorsal 
blastopore lip is initially composed of cells called the bottle cells (Jonas and 
Spannhof, 1971; Keller, 1981; Spannhof and Dittrich, 1967). The layer of the 
future endoderm and mesoderm in the marginal zone involutes through the 
dorsal lip of the blastopore and converge and extend along the anterio-posterior 
axis beneath the ectoderm while the ectoderm spreads downward to cover the 
whole embryo by a process known as epiboly (Keller and Danilchik, 1988). The 
number of deep cell layers increases during gastrulation through three rounds of 
successive cell divisions in the animal hemisphere as well as numerous deep 
layer cells integrates into one layer. The most superficial layer expands by cell 
division and flattening. The result of these expansions is the epiboly of the 
superficial and deep cells of the animal cap and the non-involuting marginal zone 
over the surface of the embryo (Keller, 1980; Keller et al., 1985). The layer of 
dorsal endoderm is closely applied to the mesoderm; the space between it and 
the yolky vegetal cells is known as the archenteron and is the precursor of the 
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gut cavity. The inward movement of the endoderm and mesoderm eventually 
spreads to form a complete circle around the blastopore. By the end of 
gastrulation, the blastopore has closed. The dorsal mesoderm lies beneath the 
dorsal ectoderm, and the lateral mesoderm begins to spread in a ventral direction 
on either side. The inner surface of the archenteron becomes completely covered 
by a layer of endoderm, forming the gut.  At the same time, the ectoderm spread 
to cover the whole embryo. During gastrulation, dorsal mesoderm develops into 
two main structures, the notochord and the somites. The notochord is a stiff, rod 
like structure that forms along the dorsal midline and eventually becomes 
incorporated into the vertebrae. The somites form by segmentation of the 
paraxial mesoderm lying immediately at either side of the notochord. Somites are 
formed in pairs, and segmentation proceeds in an anterio-posterior direction.  
 
Figure 2.1 Schematic representation of early development of Xenopus laevis (adapted from De 
Robertis et al., 2000).  
 
                                                                                                            2 Introduction                            
  9 
  
2.2.3 Neurulation and organogenesis 
Gastrulation is succeeded by neurulation, the formation of the neural tube, 
and the early embryonic precursor of the central nervous system. While 
notochord and somites are developing, the neural plate ectoderm above them 
begins to develop into the neural tube. At this stage, the embryo is called a 
Neurula. The early signs of neural development are the formation of the neural 
folds, which form on the edges of the neural plate. These rise up fold towards the 
midline and fuse together to form the neural tube, which sinks beneath the 
epidermis (Keller et al., 1992a; Keller et al., 1992b; Keller, 1980; Keller et al., 
1985). The anterior neural tube gives rise to the brain; further back, the neural 
tube overlying the notochord will develop into the spinal cord. The main 
structures that can be recognized at this stage are the neural tube, the 
notochord, the somites, the lateral plate mesoderm, and the endoderm lining the 
gut. The unsegmented lateral plate mesoderm, lying lateral and ventral to the 
somites, gives rise to tissues of the heart and kidney, as well as to the gonads 
and gut muscle, while the most ventral mesoderm gives rise to the blood islands. 
The endoderm lining the gut will bud off organs such as the liver and lungs. At 
the tail bud stage, the brain is already divided up into a number of regions while 
the eye and ear have begun to develop at the anterior end. There are three 
branchial arches, of which the anterior most will form the lower jaw. More 
posteriorly, the somites and notochord are well developed. The post-anal tail of 
the tadpole is formed last. It develops from the tail bud, which, at the dorsal lip of 
the blastopore, gives rise to the continuation of notochord, somites and neural 
tube. Nieuwkoop and Faber have divided the early development of Xenopus into 
various stages (Nieuwkoop and Faber, 1967). 
After organogenesis is completed, the mature tadpole hatches out of its 
jelly covering and begins to swim and feed. Later, the tadpole larva undergoes 
metamorphosis to give rise to the adult frog. 
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2.3 Role of signaling events in establishment of early pattern 
formation 
2.3.1 Organizer formation 
 At the gastrula stage, the dorsal side of the embryo can be recognized by 
the presence of the dorsal blastopore lip. The importance of this dorsal lip was 
shown in a transplantation experiment carried out by Spemann and Mangold in 
1924, using salamander gastrulae. They isolated dorsal lips from the embryos 
and transplanted it in the host gastrula stage embryo on the ventral side opposite 
to dorsal lip of the host embryo. This transplantation of dorsal lip resulted in an 
embryo with a complete secondary axis (Spemann, H., and Mangold. 1924). 
These experiments were also later repeated in Xenopus and were found to have 
the same effect. These experiments revealed the importance of dorsal lip cells in 
axis formation. In another complementary experiment, embryos were dissected 
into dorsal and vegetal halves at gastrula stage. The dorsal half of the gastrula 
gave rise to all dorsal structures while the ventral half of the gastrula embryo 
remained undifferentiated tissue showing that the differentiation of the embryo is 
determined by the dorsal side of the gastrula embryo (De Robertis et al., 2000). 
 The group of Nieuwkoop in 1969 carried out another important set of 
experiments. These experiments utilized the property of Xenopus embryo 
explants to be cultured in isolation in normal buffered saline. They showed that 
animal caps develop into epidermis, while vegetal explants neither develop into 
recognizable tissues nor develop posterior endodermal character (Nieuwkoop, 
1963). When animal caps were grafted onto vegetal explants, mesoderm and 
pharyngeal endoderm developed. Using pigmentation and 
3
H-thymidine labeled 
cells as markers, it was concluded that mesoderm and head endoderm develop 
exclusively from the animal cap tissue and were therefore induced by vegetal 
cells. Explants of dorsal vegetal cells induce dorsal mesoderm, giving rise to 
notochord and muscles, as well as head endoderm. Explants from the ventral 
vegetal cells induce ventral mesoderm and gives rise to blood and mesenchyme 
                                                                                                            2 Introduction                            
  11 
  
(Nieuwkoop, P.D. 1973). These experiments gave rise to the three signal model 
(Heasman, 1997) for mesoderm patterning, consisting of an early pair of signals 
differing qualitatively between dorsal and ventral vegetal blastomeres, that acted 
in the blastula stage to divide the early marginal zone of mesoderm into two 
distinct territories: the dorsal and ventral mesoderm. The third signal, a 
dorsalizing inductive signal from the dorsal mesoderm, would then impose dorsal 
(paraxial) and intermediate fates on neighboring ventral mesoderm in the 
gastrula stage (Heasman, 1997). In subsequent experiments it was shown that 
vegetal cells start inducing signals as soon as 16-32 cell stage, arguing for 
maternal proteins for meso-endoderm induction since zygotic transcription starts 
only after mid blastula transition. Later it was shown that induction of both dorsal 
and ventral mesoderm is induced by gradients of several nodal related signals 
released by endoderm at the blastula stage and thus modifying the three-signal 
model into a two-signal model (Agius et al., 2000). These experiments also 
showed a gradient of Xnrs from the dorsal to the ventral side of the embryo.  
Xenopus nodal related genes (xnrs) are potent mesoderm inducers (Jones 
et al., 1995) and the events leading to the generation of the gradient of Xnrs can 
be traced back to the fertilization stage. Fertilization of an egg with sperm starts a 
rotation in the cortex of the egg with respect to the yolky cytoplasm leading to the 
asymmetry in the egg. This event of cortical rotation brings about stabilization of 
?-CATENIN on the dorsal side of the embryo (Rowning et al., 1997). Increased 
stabilization of ?-CATENIN leads to activation of the canonical WNT signaling 
pathway on the dorsal side of the embryo (Schneider et al., 1996). When the 
embryos were UV irradiated, dorsal structures of the embryo were abolished 
giving rise to a ventralized embryo. UV treatment of the embryo causes 
disruption of microtubules and thus prevents the accumulation of ?-CATENIN, 
which mediates WNT signaling on the dorsal side of the embryo (Moon and 
Kimelman, 1998). 
Vg1, a TGF-? factor was the first known asymmetrically localized RNA in 
the egg. Vg1 is localized to the vegetal pole of the embryo (Melton, 1987; Weaks 
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and Melton, 1987). VG1 precursor protein is abundant in vegetal cells, but the 
processed mature form has not been readily detected and no activity has been 
demonstrated for the putative VG1 mature protein. By using an engineered VG1 
fusion (Bvg1) that promotes formation of mature VG1 protein in vivo, it was 
shown that VG1 could be involved in mesoderm induction (Dale et al., 1993; 
Thomsen and Melton, 1993). VegT, a T-box transcription factor is localized to the 
vegetal pole of the Xenopus oocytes (Zhang and King, 1996). VG1 and VegT are 
both potent inducers of endoderm. It was shown that depletion of maternal VegT 
leads to the absence of endoderm (Cui et al., 1996; Joseph and Melton, 1998; 
Zhang et al., 1998). Besides Vg1, endoderm expresses Xnrs. It was found that in 
wild type embryos, microinjection of VegT and Vg1 induces only low levels of 
xnrs transcription. However, when ?-CATENIN is also provided, a high level of 
Xnr expression is achieved (Agius et al., 2000). It has been shown that the 
expression of Xnrs in the endoderm occurs in a gradient, having higher 
expressions in dorsal endoderm and lower levels of expression in ventral 
endoderm. This gradient is probably established due to higher levels of Wnt 
signaling on the dorsal side of the embryo. The dorsal endoderm thus 
establishes a signaling center called “Nieuwkoop center” (De Robertis et al., 
2000).  In the dorsal-animal cap marginal region, the ?-CATENIN signal induces 
the expression of Chordin and Noggin. Chordin and Noggin are BMP 
antagonists. This region of embryo has been named as the “BCNE center” for 
Blastula Chordin and Noggin Expression center (Kuroda et al., 2004). The 
Nieuwkoop center and BCNE center show only a limited overlap. Both blastula 
centers are formed simultaneously, as soon as zygotic transcription starts and 
require the beta-catenin signal on the dorsal side of the embryo, but the 
Nieuwkoop center also requires Vg1 and VegT mRNAs localized in the vegetal 
pole of the fertilized egg.  
A high level of Xnr expression in the Nieuwkoop center induces the 
formation of dorsal mesoderm and low level of Xnrs induces the formation of 
ventral mesoderm at the gastrula stage of the embryo (Agius et al., 2000). The 
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dorsal mesoderm is known as “Organizer” (De Robertis et al., 2000). BMP-2, a 
maternal component, is expressed in the ventral mesoderm of the embryo and 
has been shown to induce ventral mesoderm in animal cap explants. It has also 
been shown that dorsal injections of BMP-2 could ventralize the embryo 
(Clement et al., 1995; Nishimatsu and Thomsen, 1998; Plessow et al., 1991), 
showing it to be a potential inducer of ventral mesoderm. 
 
Figure 2.2 Signaling events during the formation of Organizer (adapted from the De 
Robertis et al., 2004). 
Nieuwkoop center cells form anterior endoderm at gastrula and BCNE 
center cells give rise to prospective brain and floor plate, as well as the 
notochord region of the Spemann organizer at gastrula. Both signaling centers 
are required for brain formation as Nieuwkoop center cells involute to come into 
intimate contact with the future brain to provide a “double assurance” mechanism 
for brain formation (De Robertis and Kuroda, 2004).  
The organizer acts as an inhibitory center for early maternal signals. 
Molecules secreted by the organizer can be divided based on their inhibitory 
properties. Among the molecules secreted by the organizer, frzb-1 (Leyns et al., 
1997; Wang et al., 1997), dickkopf-1 (Glinka et al., 1998) and crescent (Pera and 
De Robertis, 2000) act as zygotic WNT signaling inhibitors. cerberus (Piccolo et 
al., 1999) acts to inhibit WNT, NODAL as well as BMP signaling, while chordin 
(Sasai et al., 1994) and noggin (Smith and Harland, 1992) that are first 
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expressed in the BCNE center and later in the organizer, inhibit BMP signaling. 
follistatin also inhibits BMP signaling (Fainsod et al., 1997), while lefty/antivin are 
antagonists to the TGF-?/NODAL receptor (Cheng et al., 2000; Meno et al., 
1999; Meno et al., 1996; Thisse and Thisse, 1999). The inhibition of BMP 
signaling by chordin and noggin sets up a gradient of BMP signaling in 
mesodermal tissue that is required for the differentiation of head and tail 
structures. Similar to WNT signaling inhibition, inhibition of NODAL signaling by 
organizer-secreted molecules is also required for head formation. Thus, the 
organizer plays a central role in the patterning of the embryo.  
On one hand maternal WNT signaling is required for early patterning as 
described above, zygotic WNT signaling is involved in ventral mesoderm 
formation in combination with BMP signaling (Hoppler and Moon, 1998).  
2.3.2 Morphogens and signaling thresholds 
The dynamic gradients of NODAL and WNT/?-CATENIN activity revealed 
detailed steps in early patterning. The idea of morphogen gradients and 
thresholds has long been an important one in developmental biology (Green, 
2002). Morphogens are defined as substances, whose nonuniform distribution in 
a field of cells differentially determines the fate and phenotype of those cells. A 
graded morphogen provides polarity and a scalar value that can be interpreted 
by cells according to threshold values to provide a coordinate system. The 
morphogen gradients for Activin (Green and Smith, 1990) and FGF (Green et al., 
1992; Slack, 1987; Slack et al., 1987) have been investigated in the animal cap 
assay system. To produce distinct cell types, morphogen interpretation relies on 
the sharpening of threshold responses to cellular stimuli. This suggests some 
kind of cooperation leading to a steep sigmoid response in the interpreting cell 
(Lewis et al., 1977; Slack, 1993). In Xenopus, the detailed analysis of xbra 
regulation has shown that the initial dose window of xbra induction by increasing 
the dose of ACTIVIN is bounded by an initially relatively “fuzzy” dose threshold, 
but it progressively sharpened with time over a few hours (Green et al., 1994; 
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Gurdon et al., 1999). One of the mechanisms of sharpening of a threshold is cell 
contact dependent and consists of a positive feed back loop as manifested by 
“community effect” (Gurdon et al., 1993; Standley et al., 2001). The other 
mechanism involves inhibition as in the case of xbra by Goosecoid, which is 
induced at higher concentrations of ACTIVIN (Artinger et al., 1997). However 
other than these mechanisms, chromatin environment may also play an 
important role in setting up fine activation thresholds as pointed out by some in-
vitro studies (Laybourn and Kadonaga, 1992).  
 
2.4. Evidence for regulation of embryonic patterning in Xenopus 
by chromatin environment 
The animal cap cells are able to form the mesodermal tissue from the 
morula through to the blastula stage (Woodland and Jones, 1987). At early 
gastrula, animal cap cells loose the ability to form mesodermal tissue (Green et 
al., 1990). The mechanism of mesodermal competence has been studied in 
detail using ACTIVIN to induce the mesoderm in the animal cap cells. It has been 
shown that loss of mesodermal competence is programmed cell autonomously 
and occurs even in the single cell (Grainger and Gurdon, 1989). One of the 
factors required for loss of mesodermal competence of animal cells was shown 
to be somatic linker histones (Steinbach et al., 1997). In this report it was shown 
that accumulation of somatic linker histone H1, which is required for forming 
higher order chromatin structures and acts as a general repressor of transcription 
(Paranjape et al., 1994), causes the loss of mesoderm forming capacity of animal 
cells. In other words, the repressive chromatin environment blocks the 
conversion of ectodermal cells into mesodermal cells. In a recently published 
report, the authors showed that BRG1 overexpression could induce xbra 
induction even in the gastrula stage animal caps after bFGF induction (Hansis et 
al., 2004). It has been also shown that treatment of embryos with TSA, an 
inhibitor of HDAC, before gastrulation, results in the loss of muscles in the 
embryos (Rupp et al., 2002; Steinbach et al., 2000). These experiments showed 
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the role of chromatin environment in the correct expression of various genes 
required for normal development of the embryo. Below is a brief overview of 
chromatin structure and chromatin remodeling mechanisms required for 
regulation of gene transcription. 
2.5 Chromatin structure and chromatin remodeling complexes 
Based on his light microscopic observation of nuclear material the German 
anatomist Walter Flemming in 1882 (Fleming et al., 1882) first established the 
term chromatin, which is derived from the Greek word “Khorma” which means 
color. The details of chromatin were studied using biochemical and electron 
microscopic techniques. When chromatin structures were digested with 
micrococal nuclease that breaks down unprotected DNA, about 200 bp DNA 
fragments were obtained (Clark and Felsenfeld, 1971). When interphase nuclei 
are broken open very gently and their contents were examined under the 
electron microscope, most of the chromatin is in the form of a fiber with a 
diameter of about 30 nm. When this chromatin is subjected to treatments that 
cause it to unfold partially, it can be seen under the electron microscope as a 
beaded structure termed “beads on a string” (Olins and Olins, 1974). In this, the 
string is DNA, and each bead is a nucleosome core particle. The term 
“nucleosome” was given by the group of Chambon (Oudet et al., 1975), while a 
proposal was made about 31 years ago by Roger Kornberg that the structure of 
chromatin is based on a repeating unit of eight histone molecules and about 200 
bp, laid the basis for subsequent chromatin research (Kornberg, 1974).  
2.5.1 Chromatin structure 
The nucleosome represents the basic building block of chromatin. A 
nucleosome is composed of DNA and histone proteins. The histone proteins are 
present as core histones and as linker histones. In each nucleosome, 147 base 
pairs of DNA are wrapped around a core of histone proteins. 
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Albert Kossel first isolated histones, the basic proteins from nuclei and 
termed them “histon” in 1884. Histones represent the major class of DNA binding 
proteins. As a universal component of the chromosomes, histones were thought 
to be roughly equal to that of DNA; In fact, they were long viewed as the genetic 
material itself. Upon extraction in acid, which prevents proteolysis, five types of 
histones, designated as H1, H2A, H2B, H3 and H4 were found (Phillips and 
Johns, 1965). Among them H2A, H2B, H3 and H4 form the core of the 
nucleosome and H1 serves as the linker histone. 
 
 
Figure 2.3 Diagrammatic representation of DNA Packaging into chromatin (adapted from Hansen, 
2002).  
The histone core consists of a (H3)2(H4)2 tetramer flanked by two H2A-
H2B dimer thus forming an octamer. Each core histone contains two functional 
domains: a signature “ histone fold” motif sufficient for both histone-histone 
interaction as well as DNA-histone interaction within the nucleosome and second 
an amino terminal and carboxy terminal “tail domain” containing sites for post-
translational modifications (Arents et al., 1991). Linker histone H1 is unrelated in 
sequence to core histones. H1 consists of a globular domain flanked by amino 
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and carboxyl terminal tail domains while globular domain interacts with the 
nucleosome, the H1 tail domains are believed to be required for chromatin 
folding (Parseghian and Hamkalo, 2001; Ramakrishnan, 1997). 
The low-resolution (7-Å) structure of the nucleosome was determined in 
1984, and it revealed that the histone octamer forms a helical ramp around which 
1.7 turns of a left handed DNA super helix is wrapped. The high-resolution 
structure at 2.8 Å was resolved in the year 1997 (Luger et al., 1997). It shows 
that where the DNA enters and leaves the nucleosome, it is bound by N-terminal 
extensions of the H3 histone fold. Each of the heterodimers binds about 30 bp of 
DNA. The DNA is contacted at 10 bp intervals as the minor groove faces protein. 
The average number of base pairs per helical turn of DNA–the helical periodicity 
of DNA, was found to be 10.2 bp.  
 
Figure 2.4 High-resolution Nucleosome structure at 2.8 Å (adapted from Luger et al., 1997).  
A value of 10.2 bp allows the minor and major grooves from neighboring turns of 
the DNA super helix to line up, forming channels through which the histone tail 
can pass. This also leaves the major grooves accessible, enabling them to 
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participate in cellular processes, acting, for example, as DNA integration-
hotspots. In conjunction with the linker histone, H1, which is present in 
stoichiometric amounts with histone octamer, nucleosomal arrays fold into 
higher-order structures. 
2.5.2 Chromatin remodeling  
This packaging of the DNA provides on one hand a means to prevent the 
DNA from becoming an unmanageable tangle; it also serves as a means to 
regulate various processes like DNA replication, repair, recombination and 
transcription. The regulation of these processes are mainly governed either by 
covalent modifications of histone tails or by energy dependent nucleosomal 
structural alterations that may change the nucleosome position with respect to 
the DNA sequence, or may displace histone subunits. Regulation of nucleosomal 
structure requires enzymatic proteins.  
There are two classes of nucleosome remodeling enzymes, also referred 
to as chromatin remodeling enzymes. The first class of enzyme is responsible for 
covalent modification of histone tails such as histone acetyltransferase and 
deacetylases. It was proposed that distinct histone modifications on one or more 
tails act sequentially or in combination to form a ‘histone code’ that is read by 
other proteins to bring about distinct downstream events (Jenuwein and Allis, 
2001; Strahl and Allis, 2000). The second class of enzymes utilize the energy of 
ATP hydrolysis to alter or disrupt the nucleosomal structure by affecting DNA-
histone interactions (Becker and Horz, 2002; Kadam and Emerson, 2002; 
Katsani et al., 2003; Narlikar et al., 2002; Tsukiyama, 2002). 
2.5.2.1 Histone modifications 
The known post-synthetic modifications of histones that cause a change in 
the state of chromatin are phosphorylation, methylation, ubiquitination, ADP-
ribosylation along with acetylation and deacetylation.  
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2.5.2.1.1 Acetylation 
The discovery of HAT provided a link between histone acetylation and 
gene activation (Brownell and Allis, 1995; Brownell and Allis, 1996; Brownell et 
al., 1996). Based on their protein sequence and functional conservation, HATs 
can be grouped into three main families: The GNATs, the MYST and the 
hormone receptor co activator p160 (SRC) family. (Gregory et al., 2001; Vaquero 
et al., 2003). Other HATs such as CBP/p300, TAFII250, TAFIIC and NUT1 do not 
belong to any family. Even though most of them have been shown to be involved 
in transcriptional activation, SAS (some thing about silencing) has been 
implicated in transcriptional repression (Reifsnyder et al., 1996) and has been 
proposed to be in the MYST family of HATs.  
The effect of acetylation is partly explained by a decrease in the positive 
charge of the histone while other hypothesis propose that the acetylated lysine’s 
are recognized by bromodomain containing proteins, which then affect local 
chromatin structure.  Many biological processes such as chromatin assembly, 
DNA repair and apoptosis, dosage compensation or cell cycle progression are 
affected by histone acetylation (Carrozza et al., 2003; Hassan et al., 2001; 
Kristeleit et al., 2004; Neely and Workman, 2002).  
2.5.2.1.2 Deacetylation 
The connection between acetylation and transcription is further shown by 
the fact that deacetylation can cause repression. The isolation of a human 
histone deacetylase, HDAC1, which was homologous to RPD3 (Furukawa et al., 
1996) demonstrated the connection of deacetylation and repression. The HDACs 
have been divided into three groups. Class I enzymes includes HDACs 1-3 and 8 
whereas class II includes HDAC 4-7, 9 and 10. The class III enzymes are related 
to the silencing regulator SIR2 (Imai et al., 2000). 
All of the known deacetylases occur in multi-protein complexes with 
important functions. The complexes are able to deacetylate histones in 
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nucleosomes, whereas the isolated deacetylase subunits cannot deacetylate 
histones. Other members of the deacetylase complex include chromodomain 
proteins, retinoblastoma protein-associated proteins, and SIN3 (Wang et al., 
2004a).  
2.5.2.1.3 Methylation 
Histone methylation was first described by Murray in 1964 (Murray,1964). 
Arginine residues can be mono- or dimethylated by PRMTs and lysine residues 
can be mono- di- or tri-methylated by SET-domain containing histone 
methyltransferases (HMTs). While tri-methylation of histone is associated with 
silencing of gene transcription, di-methylation of histone has been shown to be 
associated with transcriptionally active gene transcription. The group of Thomas 
Jenuwein discovered SUV39H1, a homologue of Drosophila Su (var) 3-9 
(Aagaard et al., 2000; Zhang and Reinberg, 2001), which supported a direct 
connection between heterochromatin formation, gene silencing and specific 
histone lysine methylation. The histone methylation is generally related to gene 
silencing with some exceptions (Lachner and Jenuwein, 2002; Lachner et al., 
2003).   
2.5.2.1.4 Phosphorylation 
This modification occurs on serine or threonine residues. Labile forms of 
phosphorylation involving P-N linkage of lysines or arginine have also been 
described (Smith et al., 1978). Histone phosphorylation has also been observed 
on metaphase chromosomes during condensation. (Green, 2001; Mahadevan et 
al., 2004; Nowak and Corces, 2004). 
2.5.2.1.5 Ubiquitination 
This modification of protein is primarily a signal required for protein 
turnover and has also been involved in various physiological processes such as 
spermiogenesis, DNA repair, and transcription. Ubiquitinated H2A and H2B were 
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preferentially found in transcriptionally active chromatin, supporting a positive 
role of this modification in gene expression (Zhang, Y., 2003).  
2.5.2.1.6 ADP-ribosylation and other modification 
Nishizuka and colleagues first described Poly-ADP ribosylation (Nishizuka 
et al., 1968). It can be catalyzed on arginine or glutamine residues by the poly 
(ADP-ribose) polymerase. All four core histones and linker histone H1 can be 
used as a substrate for this reaction (Rouleau et al., 2004). Other than this, 
biotinylation (Camporeale et al., 2004) as well as SUMOlation (Shiio and 
Eisenman, 2003) of histones has also been reported. 
 
Figure 2.5 The known histone post translational modifications (adapted from Khorasanizadeh, 
2004). 
 2.5.2.2 ATP dependent chromatin remodeling 
The complexes involved in energy dependent chromatin remodeling are 
multi-protein complexes, containing 2-12 subunits (Becker and Horz, 2002). Each 
complex has a catalytic subunit, carrying the ATPase activity. These ATPases 
are highly conserved throughout evolution. In addition to the ATPase motif, 
proteins in the SNF2 family also contain sequence motifs similar to those found 
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in DNA and RNA helicase protein families. Proteins with these helicase motifs 
have been divided into multiple superfamilies based upon amino acid sequences 
found within the motifs. By this method, the SNF2 family has been assigned to 
the helicase superfamily 2, which also includes the ERCC3, RAD3, PRIA, 
ELF4A, and PRP16 protein families (Eisen et al., 1995).  
Our lab has established a family of SNF2-like nuclear ATPases by 
browsing the annotated human genome database. Furthermore, the homologues 
of these ATPases have also been established in Xenopus showing that 
vertebrates share a common family of ATPase chromatin remodeling complexes 
(Linder et al., 2004).  The enzymes in the SNF2 family can be subdivided into 
several subfamilies according to the sequence motifs outside of their ATPase 
domain.  
 
Figure 2.6 Sequence similarity tree of the human SNF2-domain containing proteins (adapted from 
Linder et al., 2004). 
Based on this analysis, seven subfamilies have been assigned, out of 
which nucleosome-remodeling activity has been shown only for SWI2/SNF2-
related enzymes (Sudarsanam and Winston, 2000), ISWI type enzymes (Langst 
and Becker, 2004), and for CHD family members (Brehm et al., 2000). In addition 
the recently identified INO80 also shows nucleosome remodeling activity (Shen 
et al., 2000). Other members are known to be involved in DNA repair, 
recombination, as well as in transcription (Becker and Horz, 2002). 
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2.5.2.2.1 ISWI, a SANT-like domain-containing member of the 
SNF2 family 
The ATPase ISWI was first discovered in Drosophila melanogaster 
because of the similarity of its ATPase domain to that of BRM (Elfring et al., 
1994). NURF (Gdula et al., 1998; Martinez-Balbas et al., 1998; Xiao et al., 2001), 
CHRAC (Varga-Weisz et al., 1997) and ACF (Ito et al., 1999) are various 
chromatin-remodeling complexes, which contain the ISWI ATPase. Later ISWI 
containing complexes were identified in human (Barak et al., 2003; Poot et al., 
2000), mouse (Lazzaro and Picketts, 2001) and Xenopus (Guschin et al., 2000). 
Two SANT-like domains in the C-terminus of the protein distinguish them from 
the other members of SNF2 family (Aasland et al., 1996).  Homozygous null 
mutation of ISWI is lethal in Drosophila (Deuring et al., 2000). The homozygous 
deletion of SNF2H, a murine homologue of ISWI, is lethal, but mice with 
heterozygous deletion of SNF2H were normal (Stopka and Skoultchi, 2003). 
2.5.2.2.2 The CHD class of remodelers are characterized by the 
presence of a chromodomain 
Among this class of remodelers, CHD3 (MI-2?) and CHD4 (MI-2?) are 
mostly studied members of this family. The members of this class contain two 
PHD fingers in addition to the characteristic chromodomain. MI-2 was identified 
as a dermatomyositis-specific autoantigen. It has been shown to reside in the 
NURD complex (for nucleosome remodeling and deacetylation)(Knoepfler and 
Eisenman, 1999). 
 Like ISWI, the MI-2 ATPase is an active enzyme for nucleosome 
remodeling, able to disrupt histone-DNA interactions and to induce nucleosome 
sliding on DNA fragments (Brehm et al., 2000). Interestingly, MI-2? has also 
been shown to combine deacetylation and ATP dependent remodeling (Wade et 
al., 1999).  
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2.5.2.2.3 The SWI/SNF complexes 
2.5.2.2.3.1 SWI/SNF complexes 
 The yeast SWI/SNF complex was the first chromatin- remodeling complex 
to be described (Stern et al., 1984). The genes encoding its various subunits 
were originally identified in two independent screens for mutants affecting either 
mating type switching or growth on sucrose (Sudarsanam and Winston, 2000; 
Workman and Kingston, 1998) and hence were named  “switching defective” and 
“Sucrose non-fermenting”. The biochemical evidence for a direct connection 
between chromatin and SWI/SNF function was provided by the findings that the 
SWI/SNF complex could alter nucleosome structure in an ATP dependent 
manner (Vignali et al., 2000; Workman and Kingston, 1998). 
 A closely related yeast chromatin-remodeling complex is called RSC for 
“Remodel the Structure of Chromatin” (Cairns et al., 1994; Cairns et al., 1999). 
This complex contains about 15 subunits, sharing two identical and at least four 
homologous subunits with the ySWI/SNF complex (Cairns et al., 1998; Wang, 
2003). STH1 is the paralogue of the SWI2/SNF2 ATPase subunit in the RSC 
complex. Furthermore, RSC8, RSC6 and SFH1 in RSC correspond to SWI3, 
SWP73 and SNF5 in ySWI/SNF, respectively. RSC complexes are about 10 
times more abundant than SWI/SNF complexes. 
 Despite these structural similarities, there are several important functional 
differences between ySWI/SNF and RSC. In contrast to ySWI/SNF, RSC 
functions are required for yeast viability. A Genome wide gene expression 
analysis revealed that ySWI/SNF and RSC regulate different, largely non-
overlapping sets of target genes. RSC complexes have also been shown to be 
involved in sister chromatid cohesion and chromosome segregation, which 
indicates the broader role of these complexes in chromatin dynamics (Baetz et 
al., 2004; Hsu et al., 2003; Huang et al., 2004; Wong et al., 2002). 
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Homologous ATPase complexes have also been isolated in Drosophila 
and mammals. Human cells contain two distinct SWI2/SNF2 like ATPase 
subunits, named hBRM and BRG1, which are equally similar to yeast 
SWI2/SNF2 and STH1. In contrast, Drosophila contains only a single protein 
corresponding to yeast SWI2/SNF2 or STH1, called BRM (Papoulas et al., 1998; 
Tamkun et al., 1992). In higher eukaryotes, the remodeling complexes of 
SWI/SNF class are referred to as BAP (BRM associated proteins) in Drosophila 
and hSWI/SNF-BAF (BRG1/hBRM- Associated factors) in mammals, whereas 
the RSC orthologue are referred to as PBAP or hSWI/SNF-PBAF in Drosophila 
or mammals, respectively. BRM was originally discovered as a suppressor of 
polycomb and therefore was classified as a trithorax-group protein. Two BRM 
associated proteins, the common subunit Moira (MOR) and the BAP selective 
subunit OSA, are also encoded by trxG genes (Brizuela and Kennison, 1997; 
Collins et al., 1999; Collins and Treisman, 2000; Crosby et al., 1999; Kennison 
and Tamkun, 1988; Vazquez et al., 1999). 
 Most of the Drosophila and mammalian subunits are equally similar to 
their counterparts in ySWI/SNF and RSC. The two exceptions are OSA/BAF250 
and Polybromo/BAF180, which are the signature subunits of the ySWI/SNF or 
RSC type subfamilies respectively. OSA/BAF250 is related to the ySWI/SNF 
subunit Swi1, whereas there is no homologue in RSC (Collins et al., 1999; 
Collins and Treisman, 2000; Dallas et al., 2000). Conversely, Polybromo/BAF180 
is structurally related to the RSC1, RSC2 and RSC4 proteins, but lacks a 
counterpart in ySWI/SNF. In addition, BAF can contain either BRG1 or BRM as 
the core motor subunit, whereas PBAF contains only BRG1 (Mohrmann et al., 
2004; Xue et al., 2000). In mammals there appear to be additional tissue specific 
subunits of SWI/SNF remodelers. A number of studies have reported additional 
sub-complexes in which the SWI/SNF type remodelers are associated with other 
factors such as BRCA1 (Bochar et al., 2000) or components of the histone 
deacetylating SIN3 complex (Sif et al., 2001). It has been shown that BAF53b is  
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Table 1 (Roberts and Orkin, 2004; Wang, 2003) 
Yeast Drosophila Human 
SWI/ 
SNF 
RSC BAP PBAP BAF PBAF EBAFa EBAFb BRG1-I BRM BRG1-
II 
SWI2/ 
SNF2 
STH1 BRM BRM BRG1 
or BRM 
BRG1 BRG1 BRG1 BRG1 BRM 
(BRM) 
BRG1 
SNF5 SFH1 SNR1 SNR1 SNF5/ 
INI1 
SNF5/ 
INI1 
SNF5/ 
INI1 
SNF5/ 
INI1 
SNF5/ 
INI1 
SNF5/ 
INI1 
SNF5/ 
INI1 
SWI3 RSC8 Moira Moira BAF155 BAF155 BAF155 BAF155 BAF155 BAF155 BAF155 
    BAF170 BAF170 BAF170 BAF170 BAF170 BAF170 BAF170 
 RSC1 
RSC2 
RSC4 
 Polybromo  BAF180      
SWI1  OSA  BAF250  BAF250a BAF250b BAF250 BAF250 BAF250 
ARP7 
AND 
ARP9 
ARP7 
AND 
ARP9 
BAP55 BAP55 BAF53 BAF53 BAF53 BAF53 BAF53 BAF53 BAF53 
  Actin Actin Actin Actin Actin Actin    
SWP73
/ 
SNF12 
RSC6 BAP60 BAP60 BAF60 BAF60 BAF60 BAF60 BAF60 BAF60  
SWP82           
  BAP111 BAP111 BAF57 BAF57      
 RSC3, 30          
 RSC5,7,1
0, 13-15 
         
SNF11           
SNF6           
TFG3           
 RSC9          
      ENL ENL    
      EBAF70 EBAF70    
      EBAF100 EBAF100    
      EBAF140 EBAF140    
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part of a brain specific complex (Olave et al., 2002a), while BAF60c could be a 
part of heart specific complex since it shows a heart specific expression pattern 
in early embryonic stage; later it is also expressed in somites (Lickert et al., 
2004). Various SWI/SNF complexes have been summarized in table 1.  
2.5.2.2.3.2 Interaction motifs in the SWI/SNF class of remodelers 
 The distinguishing feature of the SWI/SNF class of chromatin remodelers 
is the presence of a bromodomain in the ATPase subunit, which is absent in 
ISWI, CHD/MI-2 and INO80 type remodelers (Eberharter and Becker, 2004).  
Bromodomains are 90 amino acid long modules. Bromodomains 
recognize acetylated lysines in histone tails (Dhalluin et al., 1999; Hassan et al., 
2002; Hudson et al., 2000; Jacobson et al., 2000; Marmorstein and Berger, 2001; 
Owen et al., 2000; Zeng and Zhou, 2002). PBAP and PBAF contain another 
bromodomain protein called polybromo or BAF180. Polybromo contains six  
 
Figure 2.7 BAF 180 contains six bromodomains while BRG1 contains one bromodomain. 
bromodomains, which are required for targeting of remodelers to hyperacetylated 
yeast chromatin domains (Mohrmann et al., 2004), however, in Drosophila it was 
found that the deletion of the bromodomain of BRM neither affects BRM function 
nor chromatin binding (Elfring et al., 1998). 
SWI/SNF remodeling complexes harbor a number of distinct DNA binding 
domains. Polybromo and BAP111 each contain a high mobility group (HMG) 
domain. HMG domains are highly conserved protein folds, which contact the 
DNA in the minor groove and induce a sharp bend (Thomas and Travers, 2001). 
BAP111 and its human orthologue BAF57 are common subunits of SWI/SNF 
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remodelers in higher eukaryotes, but are absent in yeast. Studies on Drosophila 
established that BAP111 is required for normal BRM complex function in vivo 
(Papoulas et al., 2001). 
 In addition to its highly conserved HMG domain, Polybromo harbors two, 
less well conserved, C2H2-type zinc fingers. The putative double C2H2 zinc 
finger motif is present in Drosophila and C.elegans polybromo, but absent in 
chicken and human. The C-terminus of BAP170 also contains a highly 
conserved, double zinc finger motif comprising a canonical C2H2 zinc finger, and 
a second one in which the spacing between the two cysteine residue is 
somewhat larger. The strict conservation of the zinc finger motifs in BAP170 
suggests that they might be functionally important (Mohrmann et al., 2004). 
 BAP 170 contains a second DNA binding motif in its N-terminus, an AT 
rich interaction domain (ARID). ARID domain proteins are also present in yeast 
Swi1, Drosophila OSA and mammalian BAF250, which define the ySWI/SNF, 
BAP and BAF subclass, respectively (Collins et al., 1999). ARID domains are 
sometimes referred to as BRIGHT domains and have also been implicated in 
sequence-specific as well as sequence-independent DNA binding (Gregory et al., 
1996; Herrscher et al., 1995; Wilsker et al., 2002). The ARID harbors a helix-turn-
helix region and, as reflected by its name, preferentially binds AT-rich 
sequences. ARID domain in OSA binds DNA without sequence specificity while 
dead ringer is an example of a sequence-specific DNA binding ARID containing 
protein.  The ARID of BAF 250 has been implicated in transcriptional co-
activation of hormone receptors (Inoue et al., 2002), suggesting that it acquires 
specificity through interactions with other cofactors. 
Actin is known for many cellular functions in the cytoplasm of eukaryotic 
cells, including processes like muscle contraction, cell motility, or cytokinesis. 
Actin is highly expressed and is in fact the most abundant protein in many cell 
types. The purification of actin by biochemical means led to the striking finding 
that it was a tightly bound subunit of SWI/SNF family of remodeling complexes 
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(Olave et al., 2002b; Papoulas et al., 1998; Zhao et al., 1998), which was for a 
long time considered as a contaminant. Actin Related Proteins (ARPS), consist 
of a large and diverse group of proteins that share between 10% to 80% 
sequence similarities with actin (Schafer and Schroer, 1999). The actin fold is 
conserved in the Arps, but there is much less conservation in flanking regions 
(Robinson et al., 2001). The presence of stoichiometric amounts of actin and 
Arps in diverse chromatin remodeling complexes has been firmly established 
(Olave et al., 2002b). Yeast SWI/SNF and RSC contain ARP7 and ARP9, 
whereas Drosophila BAP and PBAP and human BAF and PBAF contain one 
ARP, BAP55 and BAF53 respectively and actin (Cairns et al., 1998; Peterson et 
al., 1998; Wang et al., 1996a; Wang et al., 1996b). It has been proposed that 
Actin and ARPs can modulate binding of the remodeling complex to chromatin or 
to the nuclear matrix, stimulate the DNA-dependent ATPase activity, promote 
complex assembly and stability, histone binding, or remodeling and translocation 
(Boyer and Peterson, 2000; Rando et al., 2002; Shen et al., 2003; Szerlong et 
al., 2003). 
2.5.2.2.3.3 Differential targeting of SWI/SNF remodelers 
 Results in Drosophila suggest that BRM is involved in transcription of most 
genes (Armstrong et al., 2002), however, one way in which variation in subunit 
composition can direct functional differentiation is through unique gene targeting. 
Immunolocalization on larval salivary gland polytene chromosomes revealed that 
OSA and Polybromo, the defining subunits of BAP and PBAP, each display 
distinct, albeit overlapping genome-wide distributions (Mohrmann et al., 2004). 
Genome wide expression studies in yeast revealed that ySWI/SNF and RSC 
each regulate different sets of target genes (Angus-Hill et al., 2001; Holstege et 
al., 1998; Sudarsanam et al., 2000).  
2.5.2.2.3.4 Nucleosomal remodeling by SWI/SNF complexes 
 Nucleosomal remodeling by SWI/SNF complexes is either by 
displacement of histone octamers, sliding of histone octamers or by stable 
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alteration of nucleosomes as shown in figure 2.7.  (Boeger et al., 2004; Bruno et 
al., 2003; Fan et al., 2003; Haushalter and Kadonaga, 2003; Langst and Becker, 
2004). It has also been shown that BRG1 opens centrally located sites more then 
an order of magnitude better then SNF2H, an ISWI homologue. This capability of 
BRG1 is caused by its ability to create DNA loops on the surface of a 
nucleosome, even when that nucleosome is constrained by adjacent 
nucleosomes (Fan et al., 2003). It has been also shown that SWI/SNF-
complexes move nucleosomes to the DNA ends in the absence of histone H1. In 
the presence of histone H1, SWI/SNF slides octamer to more central positions 
and does not promote nucleosome movements off the ends of the DNA 
(Ramachandran et al., 2003). These observations shed light on the roles of H1 
and SWI/SNF in modulating chromatin structure. 
 
 
Figure 2.8 Nucleosomal remodeling by SWI/SNF complexes (modified after Vignali et. al., 2000). 
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2.5.2.2.3.5 Function of RSC class of remodelers 
 RSC complexes have been shown to be involved in sister chromatid 
cohesion and segregation (Baetz et al., 2004; Hsu et al., 2003; Huang et al., 
2004; Wong et al., 2002). The accurate transmission of the genome during cell 
division requires chromatin restructuring. Various studies revealed that several 
RSC subunits, namely STH1, SFH1, RSC3 and RSC9 are essential for cell cycle 
progression through G2 and mitosis (Angus-Hill et al., 2001; Damelin et al., 
2002). Current evidence suggests that cell cycle failure in RSC mutant is not due 
to defective transcription of cell cycle control genes (Ng et al., 2002) rather it 
appears that the spindle checkpoints might play a critical role in the G2/M arrest 
caused by RSC mutants (Tsuchiya et al., 1992). An independent genetic screen 
for haploinsufficient modifiers of chromosome segregation fidelity further 
supported this notion (Baetz et al., 2004). Thus, RSC mediates chromatin 
restructuring, independent of transcription regulation and appears to be directly 
required for chromosome segregation.  
Although the molecular mechanisms remain unclear, recent studies 
suggest that RSC is required for the loading of cohesin on chromosome arms, 
and for kinetochore function (Baetz et al., 2004; Hsu et al., 2003; Huang et al., 
2004). The cohesin complex is the molecular machine responsible for the 
controlled pairing of sister chromatids prior to their segregation (Nasmyth et al., 
2000; Yokomori, 2003). PBAF complexes have been shown to be localized at the 
kinetochore (Xue et al., 2000). 
2.5.2.2.3.6 Function of mammalian SWI/SNF complexes 
Biochemical studies revealed important functional differences between 
BRM and BRG1. BRG1 binds to Zn-finger proteins through a unique N-terminal 
domain, which is not present in BRM. Conversely, BRM interacts with two 
ankyrin repeat proteins that are critical components of notch signal transduction 
(Kadam and Emerson, 2003). Thus, BRG1 and BRM complexes may direct 
distinct cellular processes through recruitment to specific promoters mediated by 
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protein-protein interaction that is unique to each ATPase. Moreover, PBAF, but 
not BAF, is necessary for ligand-dependent transactivation by several nuclear 
hormone receptors, such as VDR and PPAR (Lemon et al., 2001). However, 
other researchers reported that the BAF complex, but not PBAF complex, is 
required for glucocorticoid receptor dependent transcription (Trotter and Archer, 
2004). 
Studies on mammalian SWI/SNF remodelers also uncovered functional 
differences. Gene inactivation experiments in mice revealed that the in-vivo 
importance of the very similar mammalian paralogs, BRM and BRG1, is quite 
different. BRM knock-out mice are viable and display only a subtly altered control 
of cell proliferation (Reyes et al., 1998), while in contrast, BRG1 knock-out mice 
die already during early embryogenesis and animals with mono-allelic BRG1 
expression are predisposed to tumors, suggesting a role in neoplasias (Bultman 
et al., 2000). These differences might be the results of distinct timing of 
expression of BRM and BRG1 (LeGouy et al., 1998) or perhaps BRG1 may 
compensate for loss within the BAF complex, but conversely, BRM cannot 
replace BRG1 in the PBAF complex. Such a scenario would implicate that 
inactivation of BRM will only lead to a partial loss of BAF function, whereas loss 
of BRG1 will completely abrogate PBAF. Alternatively, the difference between 
inactivation of either BRM or BRG1 might reflect the functional difference 
between BAF and PBAF. 
2.5.2.2.3.7 SWI/SNF complexes in disease 
A very important development has been the realization that inactivation of 
SWI/SNF complexes plays a critical causal role in the development of human 
cancers. Mice with mono-allelic BRG1 expression are also predisposed to 
tumors, albeit at a low incidence (Bultman et al., 2000). Tumors are of epithelial 
origin, localize in subcutaneous tissues and display glandular structures. Loss of 
BRG1 or mutations in BRG1 have been identified in human tumor cell lines and 
in some primary tumors (Wong et al., 2000). In non-small cell lung cancers, the 
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loss of BRG1 expression correlates with a poorer prognosis (Reisman et al., 
2003). BRG1 has been implicated further in tumorogenesis by its association 
with proteins with an established role in lung cancers, including pRb, BRCA1, 
MLL (Klochendler-Yeivin et al., 2002; Roberts and Orkin, 2004). BRG1 is not only 
an anti-proliferation factor but some cells also require its function for cell growth 
or differentiation. Thus, the BRG1 containing SWI/SNF complexes act in a cell 
type specific manner. Whereas, some cells cannot survive without its activity, in 
others it activates the senescence program. 
The human snf5 gene, a universal component of SWI/SNF complexes, 
was deleted or mutated in atypical teratoid and malignant rhabdoid tumors 
(ATRTs and MRTs), very aggressive cancers of early childhood. ATRTs and 
MRTs typically occur in the kidneys and the brain. hSNF5/INI1 mutations were 
also found associated with chronic myeloid leukemia, chronoid plexus carcinoma, 
medulloblastoma and central primitive neuroectodermal tumors (Biegel et al., 
2002; Versteege et al., 2002; Versteege et al., 1998). In addition to somatic 
mutations, germ line mutations have been reported, which predispose carriers to 
various cancers, including MRTs. Typically, the wild type allele is either lost or 
mutated in the resulting tumor, consistent with a typical tumor suppressor 
phenotype. Indeed, gene inactivation studies in mice revealed that heterozygous 
mice survive but are prone to soft tissue tumors, resembling MRTs (Roberts et 
al., 2000; Roberts et al., 2002). These results pointed out the role of SNF5 in 
tumor inhibition. Re-expression of hSNF5 in MRT cells causes an accumulation 
of cells in G0/G1, cellular senescence and apoptosis through direct 
transcriptional activation of the tumor suppressor p16
INK4a.
(Ae et al., 2002; Baetz 
et al., 2004; Versteege et al., 2002; Zhang et al., 2002). It was also shown that 
hSNF5 is critical for the recruitment of BRG1 to the p16
INK4a 
promoter and 
transcriptional activation (Oruetxebarria et al., 2004). Authors also showed that 
the induction of cellular senescence by hSNF5 was strictly dependent upon the 
p16
INK4a
pRb tumor suppressor pathway by using siRNA knock-down 
experiments. 
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 To circumvent the periimplantation lethality seen in case of INI1 knock-out 
mice (Guidi et al., 2001), a reversibly inactivating conditional allele was used in 
mice to study hSNF5 function (Roberts et al., 2000). This experiment 
demonstrated that most normal, nonmalignant cells require SNF5 for their 
survival. They also showed that loss of SNF5 function resulted in a highly 
penetrant and extremely short latency development of lymphomas and rhabdoid 
tumors. These results indicate that oncogenic transformation due to a loss of 
SNF5 functions might be limited to certain cell types or to cells that contain 
additional mutations. 
2.6 Objectives of this work 
BRG1 is essential in normal development of mice as shown by 
homozygous deletion of brg1. BRG1 has also been found to be associated with 
various human cancers. Furthermore, BRG1 heterozygous mice display tumors 
of epithelial origin. These observations indicate important roles of BRG1 in 
normal development and disease.  
The periimplantation lethality of mice by homozygous deletion of brg1 
precludes the investigation of the role of BRG1 in early development of mice. 
Thus, the function of BRG1 will be studied during early development of Xenopus.  
Furthermore the role of BRG1 will be addressed to ascertain its role in 
global versus selective transcriptional regulation. The role of BRG1 will also be 
addressed in embryonic induction and patterning. 
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3 MATERIALS AND METHODS 
3.1 Reagents 
Fine chemicals: Fluka, Merck, Sigma, USB. 
Bio-chemicals 
Agar (Difco); Agarose (Gibco/BRL); Ampicillin, Streptomycin, Bacto trypton, 
Yeast extract (Difco); Chicken serum, lamb serum (Gibco/BRL); Human 
choriongonadotrophin  (Sigma); Levamisol (Vector Laboratories). 
Enzymes and proteins 
Alkaline phosphatase (Roche), BSA fraction V, Chymostatin, Leupeptin, 
Pepstatin (Sigma); DNase1 (Stratagene); Klenow enzyme (Roche); MMTV 
reverse transcriptase (Gibco/BRL); Restriction endonuclease with 10x restriction 
buffer system (New England Bio Labs, Roche, Fermentas); RNaseA (Sigma); 
RNAsin (Promega); T3, T7 and SP6 RNA polymerase with 5x incubation buffer 
(Promega); Taq DNA polymerase with 10x PCR buffer (Perkin Elmer); Pfu 
polymerase with 10x PCR buffer (Stratagene); Proteinase K (Sigma);RNase free 
DNase I (Promega);Pre-standard protein molecular weight standard low and high 
range (Gibco/BRL). 
Immunochemical 
Sheep anti-mouse IgG coupled with alkaline peroxidase (1:5000,Roche); Sheep 
anti-Digoxygenin Fab fragment coupled with alkaline phosphatase (Roche); BM 
Purple solution (Roche). 
3.2 Devices 
Branso Digital Sonifier; 250-D 
FRENCH Pressure Cell Press 
Gel filtration columns QuickSpin G-50 (Roche). 
Glass injection needles: Glass 1BBL W/FIL 1.0 mm (World Precision Instrument). 
Injector Pli-100 (Digitimer Ltd.). 
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Incubator: Driblock DB1 and DB20 (Teche). 
Micro needle Puller P-87 (Sutter Instrument). 
Micromanipulator: Mm-33 (Science Products). 
Microscopes: Stereomicroscopes Stemi SV6 and Stemi SV11 (Zeiss). 
Microsurgery: Gastromaster (Xenotek Engineering). 
Nylon membrane: Hybond TM N (Amersham). 
PVDF membrane: Millipore 
Software: Adobe Photoshop 6.0;Illustrator 9.0 (Adobe); McVector 6.0 (Oxford 
Molecular Group): Microsoft Office 98 (Microsoft). 
Spectrophotometer: GeneQuant II (Pharmacia Biotech). 
Thermocycler: Primus 96 plus (MWG). 
Centrifuges: Eppendorf centrifuge 5417C (Eppendorf); centrifuge 2.0 RS 
(Haereus);Sorvall RC-5B (Dupont). 
3.3 Nucleic acids 
3.3.1 Size standard 
DNA standard: Gene Ruler™ 1kb DNA ladder (Fermentas). The DNA ladder 
yields the following 14 discrete fragments (in base pairs): 10000, 8000, 6000, 
5000, 4000, 3500,3000, 2500, 2000, 1500, 1000, 750, 500, 250. 
DNA standard: Gene Ruler™ 100bp DNA ladder plus (Fermentas). The DNA 
ladder yields the following 14 discrete fragments (in base pairs): 3000, 2000, 
1500, 1200, 1031, 900, 800, 700, 600, 500, 400, 300, 200, 100. 
3.3.2 Oligonucleotides 
All oligonucleotides were synthesized from MWG Biotech or by Biomer. 
Random Hexamer 
RR13: 5’- NNNNNC -3’ (N =G, A, T or C) 
Primers used in RT-PCR analyses 
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Xenopus nodal related 3: (Armstrong et al., 1998) 
Forward: 5’- TGAATCCACTTGTGCAGTTCC -3’ 
Reverse: 5’- GACAGTCTGTGTTACATGTCC -3’ 
Xenopus siamois: (Armstrong et al., 1998) 
Forward: 5’- CCATGATATTCATCCAACTGTGG -3’ 
Reverse: 5’- GTTCTGTTCCTAGATCTGGTAC -3’ 
Xenopus brachyury: (Sun et al., 1999) 
Forward:  5’- TTCTGAAGGTGAGCATGTCG -3’ 
Reverse:  5’- GTTTGACTTTGCTAAAAGAGACAGG -3’ 
Xenopus fd-1’: (Friedle et al., 1998) 
Forward: 5’- AGGAGATGAAACTGGAGGGAGCTTAA -3’ 
Reverse: 5’- GCCAAGGTAGCCATCATTAGAGAGAC -3’ 
Xenopus goosecoid: (Prothmann et al., 2000) 
Forward: 5’- ACAACTGGAAGCACTGGA -3’ 
Reverse: 5’- TCTTATTCCAGAGGAACC -3’ 
Xenopus nodal related 6: (Yang et al., 2002) 
Forward: 5’- TCCAGTATGATCCATCTGTTGC -3’  
Reverse: 5’- TTCTCGTTCCTCTTGTGCCTT -3’ 
Xenopus myf-5: (Shi et al., 2002) 
Forward: 5’- CTATTCAGAATGGAGATGGT -3’ 
Reverse: 5’- GTCTTGGAGACTCTCAATA -3’ 
Xenopus myodb: (Steinbach et al., 1998) 
Forward: 5’- TGACAGCCCAAATGACTCGAGACTT -3’ 
Reverse: 5’- AGCAACCAGCAGGAGGCAGGCTGAA -3’ 
Xenopus histone h4: (Niehrs et al., 1994) 
Forward: 5’- CGGGATAACATTCAGGGTATCACT -3’ 
Reverse: 5’- ATCCATGGCGGTAACTGTCTTCCT -3’ 
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3.3.3 Plasmids 
3.3.3.1 Plasmids for in-vitro transcription 
Plasmid Linearized by Polymerase 
pCS2+ wt hbrg1 Nar1 Sp6 
pCS2+ dn hbrg1 Nar1 Sp6 
pCS2+ wt hbrm Asp718I Sp6 
pCS2+ dn hbrm Asp718I Sp6 
pCS2+ wt xiswi Not1 Sp6 
pCS2+ dn xiswi Not1 Sp6 
pCS2+ wt xbrg1 Not1 Sp6 
pCS2+ wt xbrg1 Not1 Sp6 
 
3.3.3.2 Plasmids for dig-labeled RNA in-situ hybridization probes 
RNA antisense Probe Plasmids linearized by Polymerase 
Xnr3 EcoR1 T7 
Chordin EcoR1 T7 
Goosecoid EcoR1 T7 
Xbra EcoR1 T7 
Xvent2 Rupp lab  
Xpo HindIII T7 
XmyoDb (pRR3) HindIII T7 
Xmyf-5    (pRR65) Rupp lab 
N-?-tubulin BamHI T3 
Nkx2.5 HindIII T7 
Pax8 EcoRI T7 
Troponin  Not1 T7 
Mlc35 BamHI T3 
HoxB9 BamHI T7 
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Globin PstI T7 
Msr Bgl2 T7 
Shh KpnI T3 
Xbrg1 Spe1 T7 
Xini1 EcoR1 T3 
 
3.4 Bacterial manipulation 
Preparation of competent cells and transformation was performed according to 
standard methods (Sambrook et al.,1989). 
3.5 Embryological Methods 
3.5.1 Solutions 
Cystein: 2% L-Cystein in 0.1 x MBS or 0.1 x MMR (pH 7.8 at 23
o
C, adjusted with 
5 M NaOH). 
Human Chorionicgonadotropin (HCG): 1000 I.U/ml HCG in ddH2O. 
MEMFA: 0.1 M MOPS, 2mM EGTA, 1 mM MgSO4, 3.7% formaldehyde (pH 7.4 
at 23
 o
C).  
1 x Modified Barth ’s Saline (MBS): 5 mM HEPES, 88 mM of NaCl, 1 mM of KCl, 
0.7 mM CaCl2, 1 mM MgSO4, 2.5 mM NaHCO3 (pH 7.6 at 23
o
C). Add the CaCl2 
before use. 
0.1 x MBS/Gentamycin: 0.1 x MBS +10 μg/ml Gentamycin in cell culture water. 
0.5 x MBS/BSA: 0.5 x MBS, 1 mg/ml BSA, 10 μg/ml Gentamycin in cell culture 
water. 
0.5 x MBS/CS: 0.5 x MBS with 20% chicken serum and stored at -20
o
C. 
1 x Marc’s Modified Ringer’s Solution (MMR): 0.1 M NaCl, 2 mM of KCl, 1 mM 
MgCl2, 2 mM CaCl2, 5 mM HEPES (pH 7.5 at 23
 o
C) 
0.1 x MMR: 0.1 x MMR +10 μg/ml Gentamycin. 
0.1 x MMR/Ficoll: 0.1 x MMR, 6%(w/v) Ficoll, 10 μg/ml Gentamycin. 
0.4 x MMR/Ficoll: 0.4 x MMR, 6%(w/v) Ficoll, 10 μg/ml Gentamycin. 
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3.5.2 Experimental animals 
Adult wild type (Nasco) Xenopus laevis frogs were used. The frogs were 
kept in water at 16-19
o
C and at a population density of 5 L water per frog. Frogs 
were fed three times weakly. 
3.5.3 Superovulation of the female Xenopus laevis 
Xenopus laevis females were stimulated for laying eggs by injecting 500 
units of human chorionic gonadotropin into the dorsal lymph sac and incubated at 
15-23
 o
C overnight. Frogs layed eggs about 12 hours after injection.  
3.5.4 Preparation of testis 
The male frog was anaesthetized by 0.1 g 3-Aminobenzoesaeure-
ethylester per 100 ml ddH2O for 20 min, cooled down in ice and killed by 
decapitation. The two testes were taken from the abdominal cavity by opening 
and pulling out the yellow fat body, to which they are connected by connective 
tissue. The testis were either used immediately or stored in MBS/CS plus 
antibiotics for maximum of 7 days. 
3.5.5 In-vitro fertilization of eggs and culture of the embryos 
Freshly laid eggs were in-vitro fertilized either by piercing testis with a 
forceps or by mincing a portion of testis to release sperms. Afterwards they were 
cultured in 0.1 x MBS or 0.1 x MMR at 15-23
o
C in 110 mm petriplates. 
3.5.6 Jelly coat removal 
In order to prepare embryos for injection with mRNA (A) or morpholino 
oligos, after approx.1 hpf, the jelly coat was removed in a 2% cystein solution for 
5 min under agitation. Embryos were then washed three times with 0.1 x MBS 
and were cultured in 0.1 x MBS or 0.1 x MMR at 15-23
o
C. 
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3.5.7 Injection of embryos 
The glass injection needles were pulled with Microneedle Puller (Sutter 
Instrument, model P-87). They were filled with 1-2 μl nucleotide acid containing 
solution just before the injection. The needles were placed into the holder of the 
injection equipment (Medical System, model Pi-100). The injection volume was 
adjusted by manual breaking of the needle tip and choice of the injection 
pressure and/or the injection duration. Totally, 2.5-10 nanoliter solution was 
injected per embryo. Embryos were usually injected at 2-4-cell stage. After 
injection, embryos were incubated in 0.1 x MMR at 15-23
o
C until the desired 
developmental stages. The medium was changed every day to increase survival. 
 
3.5.8 Preparation of explants 
For the preparation of explants, injected embryos were transferred in 3 cm 
cell culture dishes covered with 1% agarose. The culture medium for explants 
was 0.5 x MMR. The animal caps were removed with Gastromaster (Xenotek 
Engineering) after seven hrs post fertilization. The caps were transferred 
individually into a 96-well plate covered with 50 μl 1% agarose and filled with 0.5 
x MMR. 
3.6 Histological methods 
3.6.1 Solution 
AP buffer: 100 mM Tris HCl (pH 9.5), 50 mM MgCl2, 100 mM NaCl, 0.1%Tween 
20, 5mM Levamisol. 
AP staining solution: 4.5 μl NBT, 3.5 μl BCIP in 1 ml AP buffer or BM purple from 
Roche. 
MEMFA: 0.1 M MOPS, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde (pH 7.4 
at 23
 o
C). 
PBS: 137 mM of NaCl, 2.7 mM of KCl, 8 mM Na2HPO4, 1.7 mM KH2PO4 (pH 7.2 
at 23
 o
C). 
PBT: PBS plus 2 mg/ml BSA plus 0.1%(v/v) triton-X-100. 
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3.6.2 Fixation of embryos 
Embryos were fixed in MEMFA for 2 h under rotation on a vertical wheel. 
The embryos were washed thrice with PBS. The vitelline membrane was 
manually removed with a pair of sharp forceps from the embryos used for 
immunohistochemistry. These embryos were finally washed once with methanol 
and then stored in methanol at -20
o
C
 
until use. Embryos for in-situ hybridization 
were incubated for several hours in 100% ethanol. Rinsed once more with 100 % 
ethanol and then stored in 100% ethanol at -20
o
C
 
until use. 
3.6.3 Immunocytochemistry 
1. Fix embryos in MEMFA for two hours at room temperature with rotation. Rinse 
in PBS, remove vitelline membrane manually, and store the embryos in 100 % 
methanol. 
2. Rehydrate by 75%, 50%, 25% methanol in PBS with each wash of 5 minutes. 
3. Incubate in PBT for 15 min. 
4. Block protein-binding sites by incubating embryos in PBT plus 10% heat 
inactivated goat serum at room temperature for one hour. 
5. Remove blocking solution and add primary antibody; incubate overnight at 
4
o
C. 
6. Wash vials by filling them for at least 5 times with each wash for one hour by 
PBT. 
7. Blocked as above (step 4) for one hour. 
8. Add secondary antibody coupled with AP in blocking solution and incubate at 
4
o
C
 
overnight. 
9. Washing was done with at least five changes, 4 ml of PBT per wash for one 
hour each. 
10. Wash twice in AP buffer for 5-20 minutes. 
11. Staining was performed in 1 ml staining solution in dark. 
12. After staining, embryos were washed in PBS and fixed overnight. The      
      embryos were stored in PBS at 4
o
C. 
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3.7 Protein Methods 
3.7.1 SDS-PAGE and Western blotting 
SDS-PAGE (SDS-polyacrylamide gel electrophoresis) and Western 
blotting were carried out according to standard protocols (Sambrook et al., 1989). 
The signals were detected by ECL kit (Amersham) as per manufacturer’s 
instruction. In short, 7.5% gels were used to resolve the proteins with a constant 
voltage of 120V and 400mA for one and a half hour. The protein was transferred 
on to the PVDF membrane by the wet transfer system from BioRad for 90 
minutes at 120V and at 4
o
C. The membrane was soaked into 5% milk in TBST to 
block nonspecific binding sites. The membrane was washed once with TBST for 
15 minutes and twice in TBST for 5 minutes each. The membrane was incubated 
with primary antibody against xBRG1 antibody XB3F1 at a dilution of 1:20 for 
overnight at 4
o
C. The membrane was washed as described above and then 
incubated with anti-Rat IgG and IgM Peroxidase conjugated antibody at a dilution 
of 1:5000 for one hour at room temperature. The membrane was washed once in 
TBST for 15 minutes and then for four times in TBST each for 5 minutes. The 
signal was detected by ECL solution. To detect ?-CATENIN signal, membrane 
was stripped in stripping buffer for 30 minutes at 60
o
C, blocked and proceeded 
as described above with antibody p14L (Schneider et al., 1993), specific for X ?-
CATENIN. 
3.7.2 Immunoprecipitation 
Xenopus embryos extracts was prepared in RIPA lysis buffer containing 
protease inhibitors by incubating them for 1hour on ice. Protein G beads were 
blocked in equal volume of 20% BSA for two hours at 4
o
C. Blocked beads were 
incubated with anti-BRG1 antibody XB3F1 rat monoclonal antibody supernatant 
for another two hrs at 4
o
C. Antibody coated beads were used for 
Immunoprecipitation of endogenous or in-vitro translated xBRG1 by incubating 
them with whole embryo lysate or in-vitro translated protein for overnight at 4oC.  
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Next day beads were washed three times with 150 mM RIPA lysis buffer 
containing protease inhibitors and two times with 500 mM RIPA lysis buffer. The 
immunoprecipitated proteins were detected by western blotting using the 
antibody as indicated in figures.  
Immunoprecipitation of the protein after formaldehyde cross-linking was 
done as described above with some modifications. The beads coating was done 
with 20% BSA along with 2.5 μg/μl sonicated herring sperm DNA. After 
immunoprecipitation, beads were given two additional washings with LiCl 
solution. For crosslinking, 100 embryos were incubated in 1 ml of 1% 
formaldehyde under various conditions as shown in figures. The cross-linked 
embryos were washed twice with ice cold PBS. Four mililiters of RIPA lysis buffer 
with protease inhibitors was added to the embryos and embryos were sheared 
with 200 μl pipette tips. These sheared embryos were applied to French press at 
1100 psi twice.  
Composition of RIPA buffer 
10% NP40 10ml 
5% Sodium deoxycholate 10 ml 
10% SDS 1 ml 
5M NaCl 3 ml 
0.5M EDTA 1 ml 
1M Tris pH8.0  5 ml 
Double distilled H2O 70 ml 
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Phosphatase inhibitors Protease inhibitors 
10 mM Sodium pyrophosphate 
50 mM Sodium fluoride 
0.2 mM Sodium vanadate 
 
1 mM PMSF 
10 μg/ml Pepstain A 
10 μg /ml Leupeptin A 
10 μg /ml Aprotinin 
10 μg /ml Antipain 
10 μg /ml Chymostatin 
3.8 Molecular biological methods 
3.8.1 Isolation of nucleic acids 
3.8.1.1 Mini-preparation with Qiagen kit 
Plasmid DNA mini-preparations were carried out using Qiagen mini-
preparation kit’s standard protocol. 
3.8.1.2 Isolation of RNA 
The embryos or explants were collected at the desired developmental 
stage in 1.5 ml eppendorf tubes. Pipette off the buffer as much as possible and 
add Trizol (GibcoBRL), 60 μl per explant and 200 μl per embryo, vortex for 5-10 
min at room temperature. If not used immediately, trizol samples were stored at 
70
o
C. Two micro liter of chloroform was added per 10 μl of trizol amount and then 
shaken vigorously for 15 seconds and incubated for 3 minutes. The samples 
were then centrifuged for 20 minutes at 11900 RCF at 4
o
C. The upper phase was 
collected and incubated with 0.5 volume of Isopropanol at room temperature for 
10 minutes and then centrifuged at 4
o
C for 10 minutes at 11900 RCF. The pellet 
was washed with 70% ethanol. The ethanol was removed and dried. The RNA 
was dissolved in RNase free water in a volume of 2 μl per explant or 25 μl per 
embryo. 
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3.8.2 Analysis and manipulation of nucleic acids 
3.8.2.1 Gel electrophoresis of nucleic acids 
DNA or in-vitro synthesized RNA was isolated in horizontal agarose gel. 
Depending upon fragment size, 1% or 1.7% agarose gel was used. After 
electrophoresis, the gels were photographed. 100bp or 1kb DNA ladder was 
used as size standard. 
3.8.2.2 Isolation of DNA fragments from agarose gel 
In order to isolate DNA fragments after electrophoresis from agarose gel, 
the appropriate band was cut out under long-wave UV light. The DNA was 
extracted from the gel with Qiagen gel-extraction kit. 
3.8.2.3 Cloning methods 
The cloning of DNA has been performed according to standard methods 
(Sambrook et al., 1989). 
3.8.3 Polymerase chain reaction (PCR) 
3.8.3.1 PCR amplification of xbrg1 c-DNA fragment for cloning 
The reaction was accomplished in a total volume of 50 ?l. The reaction 
mixture contained 1 μl of the cDNA template, 25 pmol each primer, 0.5 mm 
dNTPs, 1 U advantage taq polymerase and 1x buffer.  
Following Primers were used:  
Primers for xbrg1 
Forward Primer 
5’ TGTCGGTGATAGTTGGTGGAAAAC 3’ 
Reverse Primer  
5’ AGGGGGTAAAGGAATGTGATG 3’ 
Since normal PCR gave a smear in case of xbrg1, Touch down PCR was 
carried out to obtain full-length c-DNA for xbrg1 as following:  
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Step 1.  95
o
C                                 1 Min. 
Step 2.  95
o
C                                 15 Seconds 
             60
o
C                                  30 Seconds 
             68
o
C                                   6 Min 
for 5 cycles 
Step3.  95
o
C                                15 Seconds 
             60
o
C                                30 Seconds (temp decrease @ 0.5
o
C per cycle) 
             68
o
C                                  6 Min 
for 20 cycles  
Step 4. 95
o
C                                 15 Seconds 
             50
o
C                                  30 Seconds 
             68
o
C                                   6 Min  
for 10 cycles 
Step 5. 72
o
C                                   10 Min 
The PCR obtained a band of about 5Kb. The band was excised from the 
gel and cloned into PCRII TOPO vector. The clones were checked by EcoR1 
restriction digestion. The ORF only of xbrg1 was further sub cloned into pCS2+ 
vector with a flag tag at the C-terminus. The primers used were having EcorV 
and Xho1 restriction sites, which were used to clone xbrg1 into Stu1 and Xho1 
restriction sites of pCS2+ vector. The primers were following:  
Forward primer: 
5’ GAGATATCCACGATGTCCACCCCAGACCCT 3’ 
Reverse Primer: 
5’ CCGCTCGAGTTATTTATCGTCATCGTCTTTGTAGTCGTCTTCTTCACTTCC 
ACTTCC 3’ 
The pCS2+ vector containing full-length xbrg1 was sequenced by MWG. 
3.8.3.2 RT-PCR 
In RT-PCR assay, RNA was initially reverse-transcribed to yield cDNA. 
The cDNA samples were normalized by PCR amplification of H4 (histone4) in the 
linear range. The desired target cDNA species were amplified using specific 
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primers. PCR was carried out in the exponential phase of amplification and PCR 
samples were loaded side by side in the agarose gel to compare their intensity. 
3.8.3.3 Northern blotting 
Northern blotting was carried out using standard protocol (Sambrook et al, 
1989). For the detection of Xbrg1 transcripts, Northern hybridization was done 
using a RNA probe made from N-terminal sequence of xbrg1. The probe was 
about 2 kb long. The blots were exposed for three days.  
3.8.4 In-vitro transcription 
3.8.4.1 In-vitro reverse transcription 
A cDNA pool was generated from total cellular RNA by using random 
oligonucleotides and reverse transcriptase (RTase) (Steinbach and Rupp, 
1999).The reaction was accomplished in a total volume of 20 μl. The reaction 
contains 2μl of total RNA, 4μl RT buffer, 1μl RTase, 2μl dNTPs, 1μl RNAsin and 
100 pmol random hexamer primers as well as 200 U reverse transcriptase. The 
reaction was as following: total RNA was mixed with random hexamers and 
RNase free water and incubated for 5 minutes at 70
o
C. The reaction was cooled 
down in ice and rest of the components were mixed. The samples were 
incubated at 25
o
C for 10 min and then transferred to 42
o
C for 60 minutes. The 
samples were incubated at 70
o
C for 10 min to inactivate reverse transcriptase. 
The sample was cooled down to 4
o
C. The synthesized cDNA were stored at -
20
o
C. 
3.8.4.2 In-vitro transcription for microinjection 
Capped mRNA used for microinjection was in-vitro transcribed with RNA 
polymerase. The reaction was setup in a total volume of 50 μl containing 2.5 μg 
linearized plasmid DNA, 1 x transcription buffer, 0.5 mM dNTPs, 2.5 mM RNA 
cap structure analogue, 10mM DTT, 20U RNAsin and 40U Sp6 or 60U T3 or T7 
RNA Polymerase and incubated for at least 2.5 hours at 37
o
C except xbrg1, 
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which were incubated at 20
o
C. The template was digested with 10 U of RNase 
free DNase I by incubating the samples for 30 min at 37
o
C. The volume was filled 
up with RNase free water to 90 μl, extracted and centrifuged with one volume of 
PCI (13500 x g, eppendorf centrifuge 5415C, 14000 rpm, 23
o
C, 5 min). About 80 
μl of the supernatant was applied on the Quick Spin column and eluted by 
centrifugation (1100 x g, 23
o
C, 4 min). It was again centrifuged (13500 x g, 23
o
C, 
5 min), and supernatant was transferred into a new 1.5 ml reaction tube. The 
RNA was precipitated with 0.1 volume of 3 M sodium acetate and 2.5 volume of 
ice-cold 100% ethanol for 30 min at -20
o
C. After centrifugation (13500 x g, 4
o
C, 
20 min), the pellet was washed with 0.5 ml of 70% ethanol, air-dried and 
dissolved in 10 μl RNase free water. The concentration was determined by 
GeneQuant II (Pharmacia Biotech). 
3.8.4.3 In-vitro transcription of dig labeled RNA probes 
Plasmid was linearized and used to generate antisense RNA by using 
RNA polymerases. The reactions were set up as following: in a total volume of 20 
μl; 1 μg linearized plasmid DNA, 1 x transcription buffer, 0.1 mM Dig NTPs, 20 U 
RNAsin and 20 U SP6 or T3 or T7 RNA Polymerase, incubated at 37
o
C for 2 h. 
To obtain the antisense probe for xbrg1, -36 to+ 618 fragment of xbrg1 was 
cloned into the pCRII-TOPO (Invitrogen Life Technologies) vector. It was 
linearized with Spe1 and transcribed using T7 promoter to obtain antisense 
probe.    
PCR primers for the xbrg1 (-36 to +618 fragment) 
Forward Primer 
5’ TGTCGGTGATAGTTGGTGGAAAAC 3’ 
Reverse Primer 
5’ TGGTTCTGGTTGAAGGGAGTAGGG 3’ 
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3.8.5 Site-directed mutagenesis 
The dominant negative BRG1 was produced by doing a point mutation at 
position 770 and dominant negative ISWI was obtained by doing a point mutation 
at position 204, converting lysine into arginine. 
Mutagenesis Primers for xBRG1 (K770-R) 
Forward Primer  
5’ GAGATGGGCCTGGGAAGGACTATTCAGACCATT 3’ 
Reverse Primer  
5’ AATGGTCTGAATAGTCCTTCCCAGGCCCATCTC 3’  
Mutagenesis Primers for xISWI (K204 - R) 
Forward Primer  
5’ GAAATGGGTCTAGGAAGGACTTTGCAGACCATC 3’ 
Reverse Primer 
5’ GATGGTCTGCAAAGTCCTTCCTAGACCCATTTC 3’ 
For BRG1, mutagenesis was done on EST 234591 cDNA clone, which 
spans the location of aa 770. Successful mutation was confirmed by sequencing. 
This mutated fragment was replaced with the wild type fragment in the wild type 
xbrg1 clone into the XmaC1 sites and orientation was checked by restriction 
enzyme analysis and by sequencing.  
Site-directed mutagenesis was done with the Quick Change site-directed 
mutagenesis kit (Stratagene, Cat.200518) according to the instruction manual. In 
brief, the Quick Change site-directed mutagenesis method was performed using 
Pfu DNA polymerase and a temperature cycler. The basic procedure utilizes a 
super coiled double-stranded DNA (dsDNA) template (50 ng each). The 
oligonucleotide primers, each complementary to opposite strands of the vector, 
are extended during temperature cycling by Pfu DNA polymerase. Incorporation 
of the oligonucleotide primers generates a mutated plasmid containing staggered 
nicks. Following temperature cycling (96
o
C 1 min, 55
o
C, 1 min, 72
o
C 2 min/kb, 20 
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cycles), the product was treated with DpnI. The DpnI endonuclease (target 
sequence: 5’-GmATC-3’) is specific for methylated and hemimethylated DNA and 
is used to digest the parental DNA template and to select for mutation-containing 
synthesized DNA. DNA isolated from almost all E.coli strains is dam methylated 
and therefore susceptible to DpnI digestion. The nicked vector DNA containing 
the desired mutations was then transformed into XL1-Blue super competent 
cells. After the transformation, the competent cells repair the nicks in the mutated 
plasmid. The small amount of starting DNA template required to perform this 
method, the high fidelity of the Pfu turbo DNA polymerase, and the low number of 
thermal cycles all contribute to the high mutation efficiency and decreased 
potential for generating random mutations during the reaction. The mutated 
plasmids were confirmed by sequencing. 
3.8.6. Designing and synthesis of antisense morpholino 
oligonucleotides 
Following Morpholino antisense oligo was designed against xBrg1 
5’ CCATTGGAGGGTCTGGGGTGGACAT 3’ 
The antisense morpholino oligo were designed against Xbrg1 on the basis of 
following guidelines: 
1) An optimal target sequence chosen was 25-base pair long to obtain maximum 
efficiency. 
2) were within in the region from the 5´cap through the first 25 bases of coding 
sequence.  
3) had approximately 50% GC content. 
4) had little or no self-complementarity. 
5) having less then seven total guanine and  less then three contiguous guanines 
in a 25- mer oligo.  
Based on above criteria following oligo was synthesized from Gene-Tool, LLC. 
Following is the sequence of standard control morpholino oligos supplied by 
company:   
5' CCTCTTACCTCAGTTACAATTTATA 3' 
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3.8.7. Expression and Purification of GST-xBRG1 fusion protein 
for the generation of monoclonal antibody 
For the generation of monoclonal antibodies against xBRG1 a fragment 
covering aa 202 to aa 282 was sub-cloned into pGEX4T3 vector to generate a 
GST fusion protein. The primers used were following:  
Primers for GST- xBRG1 fusion protein construction in PGEX: aa202-282 
Forward Primers:  
5’ CGGGATCCCCCATGCCTGGGATGCAACAA 3’ 
Reverse Primers: 
5’ GGAATTCGGTCAAGTGGCAGGAGCAGCCGCATT 3’  
The gst-xbrg1 construct was transformed in to BL21 E.Coli host strain. 
Five clones were tested for optimization of the fusion protein production. The 
clones were grown until the cell density reached at O.D. 0.7. The cells were 
induced by 1mM IPTG for 2hrs. This initial screening yielded two clones, giving 
good yield of fusion protein as determined by SDS page analysis. These two 
clones were further tested. The clone yielding better amount of fusion protein 
was chosen for large-scale production of fusion protein.  
 This clone was grown in 2.5 liter of culture volume until the cell density of 
equivalent to O.D; 0.7 was reached. The bacterial cells were induced as 
described. After induction, bacterial pellet was collected by centrifugation at 6000 
x g for 10 minutes in aliquots of 500 ml culture volume. The pellet was frozen at   
-20
o
C. Afterwards, pellet from 1 liter culture was resuspended in ice cold PBS. 
This 50ml culture pellet was divided into two parts and then each aliquot was 
sonicated at 60% amplitude on Branso Digital Sonifier 250-D of 1’ cycle for 3’ on 
ice to keep sample cool. Sonicated samples were then incubated with 20% 
Triton-X at final concentration of 1% for 30’ at 4
o
C. The samples were centrifuged 
at 12000 x g for 15’ and supernatant was collected. The supernatant was 
incubated with 50% glutathione sepharose 4b beads for overnight at 4
o
C. On 
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next day, the slurry was centrifuged at 500 x g for 5’. The Glutathione sepharose 
beads were washed three times with ice cold PBS. The slurry was incubated with 
1mL of 8 M urea buffer for two hrs at 20
o
C. The beads were removed by 
centrifugation of the samples at 2000 x g for 10’. The protein amount was 
measured in supernatant by Bradford method as well as by running BSA 
standards on SDS-PAGE. The protein was about 8 mg/mL by comparing with 
BSA standards on gel as well as by Bradford method. 
 The GST-xBRG1 fusion protein was used to immunize rats for the 
production of xBRG1 specific antibodies, which was carried out in collaboration 
with Prof. Elisabeth Kremmer. 
3.8.8 RNA in-situ hybridization 
The RNA in-situ hybridization was performed as described previously 
(Harland, 1991) with slight modifications. The method used is described below: 
Day 1: 
1. The fixed embryos were rehydrated by serial changes of 75%, 50% and 25% 
ethanol series. 
2. Washed 3 times in PBSw. 
3. Treated with 10 μg/ml Proteinase K in PBSw (1 ml per vial) for 30 min at room 
temperature. 
4. Rinsed with PBSw. 
5. Washed 2 times in PBSw, 5 min each 
6. Fixed with 4% PFA in PBSw (0.5ml per vial). Stand for 5 min and then rock for 
15 min. 
7. Short rinsed with PBSw. 
8. Washed 5 times in PBSw. 
9. Incubation in 50% PBSw / 50% hybridization solution, followed by 100% 
hybridization solution for about 3 min each step without agitation at RT. 
10. Added 0.5 ml of fresh hybridization solution. 
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11. Embryos were incubated at 65
o
C for 1 hour to inactivate endogenous 
phophatases. 
12. Embryos were pre-hybridized at 60
o
C for 2-6 hours. 
13. Heated 30 ng of probe to 95
o
C for 2-5 min. Add to 100 μl of pre-warmed 
hybridization solution. 
14. Add the probe to the embryos in pre-hybridization solution. 
15. Incubate at 60
o
C overnight (hybridization). 
Day 2: 
16. Pre-warmed 2 x SSC / 0.1%CHAPS to 37
o
C, and 0.2 x SSC / 0.1% CHAPS 
to 60
o
C. 
17. Short sequential washes of embryos at 60
o
C with: 
a) Hybridization solution 
b) 50% hybridization solution / 50% 2 x SSC / 0.1% CHAPS 
c) 2 x SSC / 0.1% CHAPS 
18. Washed 2 times in two x SSC / 0.1%CHAPS for 30 min at 37
o
C. 
19. Short rinse with 0.2 x SSC / 0.1% CHAPS 
20. Washed 2 times in 0.2 x SSC / 0.1% CHAPS for 30 min at 60
o
C. 
21. Rinsed in 50% TBS / 50% 0.2 x SSC / 0.1% CHAPS. 
22. Washed once in TBS. 
23. Rinsed in TBS / 0.1%Triton-X (TBSX). 
24. Incubated in antibody buffer (0.5 ml per vial) for 2 hours at 4
o
C. 
25. In parallel, pre-absorb AP-conjugated anti-DIG antibodies (1/5000 diluted) 
against Xenopus proteins present in antibody solution. 
26. Added 0.5 ml of pre absorbed antibody solution to embryos (i.e. final dilution 
of antibodies was10
-4
). 
27. Incubate overnight at 4
o
C. 
Day 3: 
28. Rinsed with TBSX 
29. Washed 6 times in TBSX for 1 hour each. 
30. Rinsed with AP-buffer. 
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31. Equilibrated in AP-buffer for 15 minutes. 
32. Replaced AP-buffer with 0.5 ml BM-Purple staining solution. 
33. Incubate overnight at room temperature in dark with slight rocking (color 
reaction). 
Day 4: 
34. Stop reaction by washing twice in PBS for 10 min at room temperature with 
rocking. 
35. Refix embryos in MEMFA for 2 hours, short rinse with H2O or PBS, store in 
H2O or PBS at 4
o
C. 
Solutions: 
Antibody-buffer: 80% (v/v) TBSX, 15% (v/v) heat-inactivated lamb serum, 5% 
(v/v) Xenopus egg extract. 
DEPC-H2O: dd H2O with 0.1% (v/v) Diethylpyrocarbonate (DEPC) agitated at 
room temperature and incubated overnight and then autoclaved twice. 
10 mM DIG NTP mixture: 10 mM CTP, GTP, ATP, 6.5 mM UTP and 3.5 mM Dig-
11- UTP. 
Hybridizing solution: 5 x SSC, 50% (v/v) formamide, 1% (w/v) Boehringer block, 
0.1 % (w/v) Torula RNA, 0.01% Heparin, 0.1% Tween-20, 0.1 %CHAPS, 5 mM 
EDTA. 
Lamb Serum: Heat-inactivated lamb serum (30 min with 56
o
C), stored at -20
o
C. 
MEMFA: 0.1 M MOPS, 2 mM EGTA,1 mM MgSO4, 3.7% formaldehyde (pH 7.4 
at 23
o
C). 
PBS: 137 mM of NaCl, 2.7 mM of KCl, 8 mM Na2HPO4, 1.7 mM KH2PO4 (pH 7.2 
at 23
o
C). 
PBSw: 1 x PBS, 0.1 % Tween-20 (pH 7.5 at 23
o
C). 
PCI: 50% (v/v) phenol, 48% (v/v) chloroform, 2% (v/v) isoamyl alcohol. 
PCR buffer (Taq): 10 mM of trichloroethylene HCl, 50 mM of KCl, 15 mM MgCl2 
(pH 8.4 at 23
o
C). 
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PCR buffer (Pfu): 10 mM of trichloroethylene HCl, 10 mM of KCl, 2 mM MgCl2, 10 
mM (NH4)2SO4, 0.1% (v/v) triton X-100, 100 μg/ml nuclease free BSA in DEPC 
H2O (pH 8.4 at 23
o
C). 
5 x RNA polymerase transcriptions buffer: 200 mM of trichloroethylene HCl, 30 
mM MgCl2, 10 mM of spermidin, 50 mM of NaCl (pH 7.5 at 23
o
C). 
20 x SSC: 3 M NaCl, 0.3 M sodium citrate (pH 7.0 at 23
o
C). 
TBS: 50 mM of trichloroethylene HCl, 150 mM of NaCl (pH 7.5 at 23
o
C). 
TBSX:  1 x TBS, 0.1% triton-X (pH 7.5 at 23
o
C). 
TE: 1 mM EDTA, 10 mM of Tris HCl (pH 8.0 at 23oC). 
TBE: 100 mM of trichloroethylene HCl, 83 mM borate, 0.1 mM EDTA (pH 8.6 at 
23
o
C). 
Transcription buffer: 20 mM of Tris HCl, 10 mM of Spermidin, 3 mM MgCl2, 50 
mM of NaCl (pH 7.5 at 23
o
C) in DEPC H2O. 
AP-buffer: 100mM Tris HCl, 50mM MgCl2, 100mM NaCl. 
Xenopus egg extract for in-situ hybridization 
De-jelly unfertilized eggs with 2% Cystein, wash 3 times, add 1 volume of PBS 
then lysed by 10 strokes of a dounce homogenizations, and centrifuged (7500 x 
g, Sorvall RC-5b, rotors SS-34, 4
o
C, 10 min). The supernatant was transferred 
into a fresh centrifuge tube and centrifuged twice under the same conditions. The 
supernatant was aliquoted and stored at -20
o
C. 
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4 Results 
4.1 Dominant negative human BRG1 causes head and eye 
defects in Xenopus embryos  
 In order to study the role of BRG1 during normal development of the 
Xenopus embryo, I used wild type and dominant negative versions of human 
BRG1. The dominant negative version of human BRG1 was constructed by 
introducing a point mutation, which converts a conserved lysine at position 783 
into arginine (Khavari et al., 1993). The wild type and dominant negative versions 
of human brg1 (hbrg1) c-DNA (de la Serna et al., 2000) were cloned into the 
pCS2+ vector (Rupp et al., 1994). 
 
 
Figure 4.1. A schematic representation of experimental procedure carried out for microinjection in 
Xenopus laevis embryos. The embryos were fertilized and microinjected at 2-4-cell stage. The 
dorsal and ventral side of the embryo can be distinguished by pigmentation as shown in animal 
view of 4-cell stage embryo. The embryos were cultured for another two days until the embryos 
reached NF St. 35. The embryos were fixed in MEMFA and phenotypes were scored.   
These clones were used to synthesize mRNA by in-vitro transcription using the 
Promega in-vitro transcription system. The synthesized RNA was injected into 
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either dorsal or ventral marginal of Xenopus embryo at the four-cell stage. The 
injections were targeted to the equatorial zone at the boundary of pigmented 
animal half and un-pigmented vegetal half as represented in figure 4.1. The 
injected embryos were cultured for 50 hrs post-fertilization at 23
o
C until the 
embryos reached NF stage 35 (Nieuwkoop and Faber, 1967). 
Interestingly overexpression of dominant negative hBRG1 (dn hBRG1) 
into dorsal marginal zone produced embryos with a head and eye defect as well 
as a shorter anterio-posterior axis. As shown in figure 4.2, overexpression of dn 
hBRG1 gave a spread of phenotypes. The eye was always reduced, even in the 
least affected embryo, while more strongly affected embryos had severely 
reduced head as well as reduced anterio-posterior axes. Some embryos also 
displayed reduced pigmentation. Other than these defects, affected embryos 
were non-motile in response to mechanical as well as chemical stimuli. Finally, 
no heart beating was observed. The defects produced by overexpression of dn 
hBRG1 were dose dependent; about 63% embryos were affected with 250 pg of 
dominant negative Hbrg1 mRNA while about 81% embryos were affected by 500 
pg of dn Hbrg1 injections (Table 4.1.). The overexpression of wt hBRG1 and 
GFP alone did not produce any abnormalities. The embryos injected with wild 
type and dominant negative variants of Hbrg1 mRNA into the ventral marginal 
zone of four-cell stage embryos, also did not produce any phenotype and were 
normal when compared to Gfp alone-injected embryos or with un-manipulated 
embryos. These results showed that the overexpression of dn hBRG1 interferes 
with the dorsal program of the embryos while the ventral program remains 
unaffected. 
 BRM is a closely related ATPase to BRG1. In order to test if 
overexpression of human BRM also interferes with normal development of 
Xenopus embryos, the wild type human brm and dominant negative human brm 
(de la Serna et al., 2000) were cloned into pCS2+ vector and used to in-vitro 
synthesize mRNA. 
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Figure 4.2 Overexpression of dn hBRG1 on the dorsal side of the embryo produces embryo with 
head and eye defect. Severely affected embryos (A) show head and eye defects as well as 
shortened AP axes and reduced pigmentation while mildly affected embryos (C) shows only eye 
defect. In some cases, head and eye are defected but pigmentation remains normal (B). On the 
other hand, expression of wt hBRG1 does not produce phenotypes (D). All the injections were 
done with Gfp as a lineage tracer. The expression of GFP has been shown in adjoining figures. 
The expression of GFP shows that the expression of wt or dn hBRG1 does not affect cell viability.  
The in-vitro transcribed mRNA was again injected into the dorsal and 
ventral marginal zones of Xenopus embryo at four-cell stage at 500 pg/embryo. 
The phenotypes were compared with the embryos overexpressing GFP alone 
and with un-manipulated embryos. The injections of dominant negative (n=18) 
and wild type (n=20) variants of human BRM displayed no abnormalities.  
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These results demonstrate that while BRG1 is required for anterior-
posterior axis formation, BRM is either not involved or dispensable for AP axis 
formation. 
Table 4.1 Overexpression of human BRG1 in dorsal marginal 
zone affects anterior-posterior axes formation 
4.2 Phenotypes produced by dn human BRG1 are specific 
The gain of functions phenotypes produced by the mis-expression of dn 
hBRG1 was checked for specificity. To do so, wt Hbrg1 was co-injected along 
with dn Hbrg1. The dominant negative Hbrg1 at a dose of 250 pg of mRNA per 
embryo was injected either alone or in combination with wild type human brg1 in 
an increasing ratio. While the embryos injected with dominant negative Hbrg1 
alone showed the head defects as described above, co injection with wild type 
human brg1 showed recovery of eyes and a normal anterior-posterior axis in the 
best cases while in other cases they showed partial recovery of eyes. The 
percentage of rescued embryos increased with increasing amount of Hbrg1 
(Table 4.1). These results demonstrate that the phenotypes produced by 
dominant negative human BRG1 are due to the specific interference of BRG1 
function in the normal embryo. 
dn Hbrg1 
(pg/emb.) 
wt Hbrg1 
(pg/emb) 
Gfp 
(pg/emb) 
Total 
Number 
Normal Head 
and 
Eye 
defect 
(%) 
Gastrulation 
Defect 
- 250 100 61 56 - 2 
- 500 100 94 88 4(5) 2 
- 1000 100 22 22 - - 
250 - 100 160 37 101 (63) 22 
500 - 100 58 3 47 (81) 8 
250 250 100 55 13 27 (49) 15 
250 500 100 60 19 19 (32) 22 
250 1000 100 58 41 9 (15) 8 
0 0 100 21 20 - 1 
- - - 262 255 - 7 
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4.3 Cloning of Xenopus brg1 
 The results obtained with human BRG1 prompted us to search for a 
functional Xenopus homologue of BRG1 in order to further study the role of 
BRG1 in Xenopus development in detail. Since BRG1 is an evolutionarily 
conserved molecule from yeast to vertebrates, the Xenopus EST database was 
searched using hBRG1 as a query. 
 
Figure 4.3 Schematic representation of EST found by searching Xenopus EST database using 
hBRG1 as a query (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/x_tropicalis).  
AW766934 spans the N-terminus and BG234591 spans the C- terminus of the xBRG1 protein 
while a third EST shows a significant overlap with AW766934 and BG234591. Forward and 
reverse primers were designed using EST sequence to obtain the full-length xBRG1 protein. 
The searches obtained three overlapping ESTs, namely AW766934 
covering aa 1-566, BG234591 covering aa 603-1600 and the third one 
BQ728178. BQ728178 spans both the ESTs having 100% identity to AW766934 
in the region common to both the ESTs and about 95% identical with BG234591. 
Conceptual translation indicated that the three ESTs together covered the entire 
open reading frame of xbrg1 (Figure 4.3).  
The nucleotide sequence of EST clones corresponding to the N-terminus 
and the C-terminus portion of the protein was used to design forward and reverse 
primers for the cloning of xbrg1. The embryos at NF st.20 were used to obtain 
total cellular RNA. The cDNA was synthesized using oligo dT primers to obtain a 
full-length cDNA pool.  
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  1 ATG TCC ACC CCA GAC CCT CCA ATG GGG GGC ACT CCC CGG CCT GTT 
M   S   T   P   D   P   P   M   G   G   T   P   R   P   V 
 
 46 CCT TCT CCA GGG CCA GGG CCT TCT CCT GGA GCT ATG CTA GGC CCC 
P   S   P   G   P   G   P   S   P   G   A   M   L   G   P 
 
 91 AGT CCA GGC CCC TCC CCT GGC TCC GCA CAT AGC ATG ATG GGA CCA 
S   P   G   P   S   P   G   S   A   H   S   M   M   G   P 
 
136 AGC CCT GGG CCA CCT ATT CCA CCA CAG GGA CCT GCT GGC TAC CCA 
S   P   G   P   P   I   P   P   Q   G   P   A   G   Y   P 
 
181 CCC GAA AAT ATG CAA CAG ATG CAC AAG CCA ATG GAT TCC ATG CAT 
  P   E   N   M   Q   Q   M   H   K   P   M   D   S   M   H 
 
226 GAG AAA GCA ATG CCT GAA GAC CCC CGT TAC AAT CAG ATG AAG GGT 
E   K   A   M   P   E   D   P   R   Y   N   Q   M   K   G 
 
271 ATG GGC ATG AGA CCT GGA GCT CAC TCT GGG ATG GGG CCT CCA CCT 
M   G   M   R   P   G   A   H   S   G   M   G   P   P   P 
 
316 AGT CCT ATG GAC CAG CAC TCC CAA GGA TAC CCA TCA CCT CTG GGC 
S   P   M   D   Q   H   S   Q   G   Y   P   S   P   L   G 
 
361 AAC TCT GAG CAT GTG TCC AGC CCT GTA CCC TCT AAT GGC CCT CCC 
N   S   E   H   V   S   S   P   V   P   S   N   G   P   P 
 
406 TCT GGC CCT CCA ATG CCT TCA GGG CCA TCA GCT GGG ACA ATG GAG 
S   G   P   P   M   P   S   G   P   S   A   G   T   M   E 
 
451 AAC TCG GAC CCA CAA CAG CAG GCC AAC CGA AGC CCT ACT CCC TTC 
N   S   D   P   Q   Q   Q   A   N   R   S   P   T   P   F 
 
496 AAC CAG AAC CAG CTG CAC CAG TTG CGG GCT CAG ATA ATG GCT TAC 
N   Q   N   Q   L   H   Q   L   R   A   Q   I   M   A   Y 
 
541 AAA ATG CTG GCC AGG GGG CAA CCT TTA CCC GAC CAC CTT CAG ATG 
K   M   L   A   R   G   Q   P   L   P   D   H   L   Q   M 
 
586 GCG GTG CAA GGA AAA AGA CCC ATG CCT GGG ATG CAA CAA CAG ATG 
A   V   Q   G   K   R   P   M   P   G   M   Q   Q   Q   M 
 
631 CCA ACA CTA CCT CCA CCT GCT GCT TCA GGG ACA GGT CCC GGT CCT 
P   T   L   P   P   P   A   A   S   G   T   G   P   G   P 
 
676 GCT CCA GGT CCA GTG CCC CCT AAC TAC AAC AGA CCT CAT GGA ATG 
A   P   G   P   V   P   P   N   Y   N   R   P   H   G   M 
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721 GCT GGT CCT ACT ATG CCA CCT CCT GGC CCA TCA GGA GCT CCA CCT 
A   G   P   T   M   P   P   P   G   P   S   G   A   P   P 
 
766 GGA ATG CCT GGC CAC CCT GCT GGT GCT CCA CCT AAG CCT TGG CCC 
G   M   P   G   H   P   A   G   A   P   P   K   P   W   P 
 
811 GAA GGT CCC ATG GCT AAT GCG GCT GCT CCT GCC ACT GCC CCC CAG 
E   G   P   M   A   N   A   A   A   P   A   T   A   P   Q 
 
856 AAG CTT ATT CCT CCA CAG CCT ACA GGC CGC CCT TCC CCA GCC CCA 
K   L   I   P   P   Q   P   T   G   R   P   S   P   A   P 
 
901 CCT GCT GTG CCA CCC GCA GCT TCC CCG GTG ATG CCC CCA CAG ACT 
P   A   V   P   P   A   A   S   P   V   M   P   P   Q   T 
 
946 CAG TCT CCA GGT CAG CCT TCT CAG CCT CCC CCC ATA GTA CAG TTT 
Q   S   P   G   Q   P   S   Q   P   P   P   I   V   Q   F 
 
991 CAC TCA AAG CTC AAC CGC ATC ACC CCC ATA CAG AAA CCA CGA GGT 
H   S   K   L   N   R   I   T   P   I   Q   K   P   R   G 
 
1036 CTG GAT CCT GTG GAG GTG CTA CAG GAA CGG GAG TAC AGG CTG CAG 
 L   D   P   V   E   V   L   Q   E   R   E   Y   R   L   Q 
 
1081 GCA AGA ATT GCA CAC AGG ATC CAG GAG CTG GAA AAT ATT CCT GGT 
 A   R   I   A   H   R   I   Q   E   L   E   N   I   P   G 
 
1126 TCT TTA CCT GGA GAC CTA AGG ACC AAA GCT ACC ATA GAG CTG AAA 
 S   L   P   G   D   L   R   T   K   A   T   I   E   L   K 
 
1171 GCT TTA AGG CTT CTC AAC TTT CAG AGA CAA CTG CGG CAA GAA GTG 
 A   L   R   L   L   N   F   Q   R   Q   L   R   Q   E   V 
 
1216 GTG GTC TGT ATG CGG AGA GAC ACG GCC CTT GAG ACT GCT CTA AAT 
 V   V   C   M   R   R   D   T   A   L   E   T   A   L   N 
 
1261 GCA AAG GCC TAC AAA CGC AGC AAG CGT CAG TCC CTG CGT GAA GCA 
 A   K   A   Y   K   R   S   K   R   Q   S   L   R   E   A 
 
1306 CGT ATT ACA GAA AAA CTC GAA AAG CAG CAG AGG ATT GAA CAG GAG 
 R   I   T   E   K   L   E   K   Q   Q   R   I   E   Q   E 
 
1351 CGC AAG AGG AGG CAA AAG CAC CAG GAG TAT CTA AAC AGC ATC CTC 
 R   K   R   R   Q   K   H   Q   E   Y   L   N   S   I   L 
 
1396 CAA CAT GCC AAG GAC TCC AAG GAA TTC CAT CGC TCA GTC ACA GGG 
 Q   H   A   K   D   S   K   E   F   H   R   S   V   T   G 
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1441 AAG ATC CAA AAA CTG ACC AAG GCT GTA TCC ACT TAC CAC GCC AAC 
 K   I   Q   K   L   T   K   A   V   S   T   Y   H   A   N 
 
1486 ACA GAA CGA GAG CAG AAG AAG GAG AAT GAA AGA ATT GAG AAG GAG 
 T   E   R   E   Q   K   K   E   N   E   R   I   E   K   E 
 
1531 AGA ATG CGC AGG CTC ATG GCT GAG GAT GAA GAG GGC TAT AGA AAG 
 R   M   R   R   L   M   A   E   D   E   E   G   Y   R   K 
 
1576 CTG ATC GAT CAG AAG AAA GAC AAG CGT CTG GCC TAT CTC CTG CAA 
 L   I   D   Q   K   K   D   K   R   L   A   Y   L   L   Q 
 
1621 CAA ACG GAT GAG TAT GTA GCA AAT CTG ACA GAT TTG GTG CGA CAA 
 Q   T   D   E   Y   V   A   N   L   T   D   L   V   R   Q 
 
1666 CAC AAG GCG GTC CAA GCC CTC AAA GAA AAG AAG AGA AGA AAA AAG 
 H   K   A   V   Q   A   L   K   E   K   K   R   R   K   K 
 
1711 AAA AAG GTG CAA GAG AAC ACA GAA GGA CAA CAG ACT GCA CTT GGG 
 K   K   V   Q   E   N   T   E   G   Q   Q   T   A   L   G 
 
1756 CCA GAT GGA GAG CCA CTG GAT GAG ACC AGC CAG ATG AGT GAC CTC 
 P   D   G   E   P   L   D   E   T   S   Q   M   S   D   L 
 
1801 CCA GTC AAA GTG ATC CAC GTG GAA AGT GGA AAG ATC TTG ATC GGT 
 P   V   K   V   I   H   V   E   S   G   K   I   L   I   G 
 
1846 GCT GAT GCA CCA AAG GCT GGA CAG CTG GAG GCG TGG CTT GAA ATG 
 A   D   A   P   K   A   G   Q   L   E   A   W   L   E   M 
 
1891 AAC CCT GGG TAT GAA GTT GCA CCA CGG TCT GAT AGT GAG GAG AGT 
 N   P   G   Y   E   V   A   P   R   S   D   S   E   E   S 
 
1936 GGA TCA GAG GAG GAA GAA GAG GAA GAA GAG GAA GAA CAA CAG CAG 
 G   S   E   E   E   E   E   E   E   E   E   E   Q   Q   Q 
 
1981 CCT CCA GTC TCT GCC TTG CTG GCT GTG GAT GAG ACC AAA AAA ATC 
 P   P   V   S   A   L   L   A   V   D   E   T   K   K   I 
 
2026 ACT GAC CCA GAC AGC TAT GAT GTG CCT GAG GGT TAT GCC CGG GAA 
 T   D   P   D   S   Y   D   V   P   E   G   Y   A   R   E 
 
2071 TTA ATA GAT AAT GCC CGG CAG GAT GTG GAT GAT GAG TAT GGT ATA 
 L   I   D   N   A   R   Q   D   V   D   D   E   Y   G   I 
 
2116 TCC CAA ATG GAA ATC CGT GGT CTC CAG TCT TAC TAT GCA GTG GCG 
 S   Q   M   E   I   R   G   L   Q   S   Y   Y   A   V   A 
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2161 CAT GCA GTA AGC GAG AAG GTG GAG AAG CAG TCG TCC CTG TTA GTG 
 H   A   V   S   E   K   V   E   K   Q   S   S   L   L   V 
 
2206 AAT GGT ATC CTG AAA CAG TAT CAA ATT AAG GGC CTG GAG TGG CTG 
 N   G   I   L   K   Q   Y   Q   I   K   G   L   E   W   L 
 
2251 GTC TCA CTT TAC AAC AAT AAC CTG AAT GGG ATC CTT GCT GAT GAG 
 V   S   L   Y   N   N   N   L   N   G   I   L   A   D   E 
 
                      G 
2296 ATG GGC CTG GGA AAG ACT ATT CAG ACC ATT GCT CTG ATT ACA TAC 
 M   G   L   G   K   T   I   Q   T   I   A   L   I   T   Y 
                   R 
2341 CTC ATG GAA CAC AAG CGC ATC AAC GGG CCC TTC CTC ATC ATT GTG 
 L   M   E   H   K   R   I   N   G   P   F   L   I   I   V 
 
2386 CCA CTG TCG ACT TTA TCC AAC TGG GTT TAT GAG TTT GAC AAG TGG 
 P   L   S   T   L   S   N   W   V   Y   E   F   D   K   W 
 
2431 GGT CCG TCT GTG GTT AAA GTT TCT TAC AAG GGC TCC CCT GCT GCT 
 G   P   S   V   V   K   V   S   Y   K   G   S   P   A   A 
 
2476 CGA CGT GCT TTT GTT CCC ATG CTT CGC AGC GGG AAA TTC AAC GTC 
 R   R   A   F   V   P   M   L   R   S   G   K   F   N   V 
 
2521 CTC CTC ACT ACA TAC GAG TAT ATT ATT AAA GAT AAG CAA ATA CTA 
 L   L   T   T   Y   E   Y   I   I   K   D   K   Q   I   L 
 
2566 GCC AAG ATC CGC TGG AAA TAC ATG ATT GTG GAT GAA GGC CAC CGA 
 A   K   I   R   W   K   Y   M   I   V   D   E   G   H   R 
 
2611 ATG AAG AAC CAT CAC TGC AAG CTG ACA CAG GTC TTG AAC ACA CAC 
 M   K   N   H   H   C   K   L   T   Q   V   L   N   T   H 
 
2656 TAC GTA GCC CCC CGG CGA CTG CTT CTC ACT GGT ACC CCA CTG CAG 
 Y   V   A   P   R   R   L   L   L   T   G   T   P   L   Q 
 
2701 AAC AAG CTT CCT GAG CTG TGG GCT CTT CTT AAC TTC CTG CTT CCA 
 N   K   L   P   E   L   W   A   L   L   N   F   L   L   P 
 
2746 ACC ATA TTC AAG AGC TGC AGC ACT TTC GAG CAG TGG TTT AAT GCC 
 T   I   F   K   S   C   S   T   F   E   Q   W   F   N   A 
 
2791 CCC TTT GCA ATG ACT GGA GAG AAG GTG GAT CTA AAT GAA GAA GAA 
 P   F   A   M   T   G   E   K   V   D   L   N   E   E   E 
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2836 ACA ATT CTA ATT ATC CGC CGT CTC CAT AAA GTC CTT CGT CCT TTC 
 T   I   L   I   I   R   R   L   H   K   V   L   R   P   F 
 
2881 TTG CTT CGT AGG CTT AAA AAA GAG GTG GAA GCT CAG CTG CCA GAA 
 L   L   R   R   L   K   K   E   V   E   A   Q   L   P   E 
 
2926 AAG GTG GAA TAT GTC ATC AAG TGC GAC ATG TCT GCA TTA CAG CGT 
 K   V   E   Y   V   I   K   C   D   M   S   A   L   Q   R 
 
2971 GTT CTG TAC AGA CAC ATG CAA GGC AAA GGA GTG CTG CTC ACA GAT 
 V   L   Y   R   H   M   Q   G   K   G   V   L   L   T   D 
 
 
3016 GGA TCT GAG AAG GAT AAA AAG GGT AAG GGA GGC ACC AAG ACC CTC 
 G   S   E   K   D   K   K   G   K   G   G   T   K   T   L 
 
3061 ATG AAC ACT ATC ATG CAG CTA AGG AAG ATC AGT AAC CAT CCG TAC 
 M   N   T   I   M   Q   L   R   K   I   S   N   H   P   Y 
 
3106 ATG TTC CAG CAA ATA GAG GAG TCG TTT TCA GAA CAC TTG GGA TTC 
 M   F   Q   Q   I   E   E   S   F   S   E   H   L   G   F 
 
3151 ACA GGA GGA ATT GTA CAG GGG CAG GAT GTC TAC CGG GCA TCT GGG 
 T   G   G   I   V   Q   G   Q   D   V   Y   R   A   S   G 
 
3196 AAG TTC GAG CTC TTG GAT CGG ATT CTG CCC AAG TTG AGA GCC ACC 
 K   F   E   L   L   D   R   I   L   P   K   L   R   A   T 
 
3241 AAT CAC AAG GTC CTG CTC TTT TGC CAG ATG ACC ACA CTG ATG ACG 
 N   H   K   V   L   L   F   C   Q   M   T   T   L   M   T 
 
3286 ATT ATG GAA GAT TAC TTT GCT TAT CGT GGC TTT AAA TAC CTT CGA 
 I   M   E   D   Y   F   A   Y   R   G   F   K   Y   L   R 
 
3331 TTG GAC GGC ACC ACC AAA GCA GAT GAC CGT GGA ATG TTA TTG AAA 
 L   D   G   T   T   K   A   D   D   R   G   M   L   L   K 
 
3376 ACC TTT AAT GAG CCT GGA TCT GAA TAC TTC ATC TTC CTT CTC AGT 
 T   F   N   E   P   G   S   E   Y   F   I   F   L   L   S 
 
3421 ACA CGA GCT GGG GGT CTG GGC TTA AAC CTT CAG TCT GCA GAC ACA 
 T   R   A   G   G   L   G   L   N   L   Q   S   A   D   T 
 
3466 GTT GTT ATA TTT GAT AGT GAC TGG AAT CCA CAT CAG GAT TTG CAG 
 V   V   I   F   D   S   D   W   N   P   H   Q   D   L   Q 
 
3511 GCT CAG GAC CGA GCT CAC AGA ATC GGG CCA CAG AAT GAA GTG CGT 
 A   Q   D   R   A   H   R   I   G   P   Q   N   E   V   R 
                                                                                                                  4 Results 
  68 
  
 
3556 GTA CTA CGC TTA TGC ACC GTG AAC AGC GTG GAA GAA AAG ATC CTG 
 V   L   R   L   C   T   V   N   S   V   E   E   K   I   L 
 
3601 GCA GCA GCA AAG TAT AAG CTA AAT GTC GAT CAG AAA GTT ATC CAG 
 A   A   A   K   Y   K   L   N   V   D   Q   K   V   I   Q 
 
3646 GCC GGA ATG TTT GAC CAG AAA TCC TCC AGC CAT GAG CGC AAG GCC 
 A   G   M   F   D   Q   K   S   S   S   H   E   R   K   A 
 
3691 TTC CTG CAG GCC ATT CTG GAA CAT GAA GAG CAA GAT GAG GAG GAA 
 F   L   Q   A   I   L   E   H   E   E   Q   D   E   E   E 
 
3736 GAT GAG GTG CCG GAT GAC GAA ACT GTG AAC CAG ATG ATT GCA CGT 
 D   E   V   P   D   D   E   T   V   N   Q   M   I   A   R 
 
3781 AAT GAG GAA GAG TTT GAC CTT TTT ATG CGT ATG GAT CTG GAC AGG 
 N   E   E   E   F   D   L   F   M   R   M   D   L   D   R 
 
3826 CGA AGA GAA GAA GCC CGT AAT CCC AAA CGC AAA CCT CGC CTC ATG 
 R   R   E   E   A   R   N   P   K   R   K   P   R   L   M 
 
3871 GAA GAA GAT GAG CTG CCA TCC TGG ATC ATT AAA GAT GAT GCT GAG 
 E   E   D   E   L   P   S   W   I   I   K   D   D   A   E 
 
3916 GTG GAG CGC CTT ACT TGT GAA GAA GAA GAG GAA AAG ATG TTT GGC 
 V   E   R   L   T   C   E   E   E   E   E   K   M   F   G 
 
3961 CGT GGC TCT CGT AGC CGA AAG GAG GTG GAT TAT AGT GAC TCG CTC 
 R   G   S   R   S   R   K   E   V   D   Y   S   D   S   L 
 
4006 ACA GAA AAG CAG TGG CTG AAG GCC ATA GAA GAG GGA ACT CTA GAA 
 T   E   K   Q   W   L   K   A   I   E   E   G   T   L   E 
 
4051 GAG ATT GAG GAG GAA GTG CGC CAG AAG AAA ACC ACT CGC AAG AGG 
 E   I   E   E   E   V   R   Q   K   K   T   T   R   K   R 
 
4096 AAG AGG GAT ATA GAC CCT GGG ATG GTA ACG CCA ACC ACA AGC ACC 
 K   R   D   I   D   P   G   M   V   T   P   T   T   S   T 
 
4141 CGG GGC AGG GAG AGG GAC GAT GAG GGG AAG AAA CAG AAA AAG AGG 
 R   G   R   E   R   D   D   E   G   K   K   Q   K   K   R 
 
4186 GGA CGA CCC CCT GCT GAG AAA CTT TCG CCA AAC CCC CCA AAA CTT 
 G   R   P   P   A   E   K   L   S   P   N   P   P   K   L 
 
4231 ACA AAG AAG ATG AAG AAG ATT GTG GAT GCA GTC ATA AAA TAC AAA 
 T   K   K   M   K   K   I   V   D   A   V   I   K   Y   K 
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4276 GAA AGC TCT GAC GGC CGC CAG CTG AGT GAA GTT TTT ATT CAG TTG 
 E   S   S   D   G   R   Q   L   S   E   V   F   I   Q   L 
 
4321 CCA TCC CGT AAG GAA CTC CCA GAG TAC TAC GAG CTC ATT CGC AAG 
 P   S   R   K   E   L   P   E   Y   Y   E   L   I   R   K 
 
4366 CCA GTG GAC TTT AGA AAG ATC AAG GAG AGG ATC CGA AAT CAT AAG 
 P   V   D   F   R   K   I   K   E   R   I   R   N   H   K 
 
4411 TAC CGA AGC CTG AAC GAT CTG GAG AAA GAT GTC ATG CTG TTG TGT 
 Y   R   S   L   N   D   L   E   K   D   V   M   L   L   C 
 
4456 CAG AAT GCT CAG ACC TTC AAC CTG GAG GGG TCC TTG ATC TAC GAA 
 Q   N   A   Q   T   F   N   L   E   G   S   L   I   Y   E 
 
4501 GAC TCT ATT GTG CTC CAG TCT GTG TTC ACC AGC GTA AGG CAG AAA 
 D   S   I   V   L   Q   S   V   F   T   S   V   R   Q   K 
 
4546 ATA GAG AAG GAA GAA GAG AGC GAA GGA GAT GAG AGC GAG GAA GAG 
 I   E   K   E   E   E   S   E   G   D   E   S   E   E   E 
 
4591 GAG GAA GTG GAA GAA GAA GGC TCA GAG TCA GAG TCA CGC TCT GTG 
 E   E   V   E   E   E   G   S   E   S   E   S   R   S   V 
 
4636 AAG GTC AAG ATT AAG CTG GGT CGC AAG GAG AAA GGT CAG GAA AGG 
 K   V   K   I   K   L   G   R   K   E   K   G   Q   E   R 
 
4681 ATG AAG GGG CGC AGG AGG ACC AGC CGA GGG TGC GGA GCC AAG CCA 
 M   K   G   R   R   R   T   S   R   G   C   G   A   K   P 
 
4726 GTG ATT AGT GAT GAT GAT AGC GAG GAA GAA CAA GAA GAG GCC AAT 
 V   I   S   D   D   D   S   E   E   E   Q   E   E   A   N 
 
4771 GAG CGC TCA GGA AGT GGA AGT GAA GAA GAC TGA 
 E   R   S   G   S   G   S   E   E   D   * 
 
Figure 4.4 Full-length sequence of the xbrg1 open reading frame. The 4803 nucleotides of the 
xbrg1 c-DNA are shown. The amino acid sequence is shown in the single letter amino acid code. 
Letters shown in Green represent SNF2 domain, which spans amino acid residues 742 to 1,037 
while letters shown in blue represent bromodomain, which spans from amino acid residues 1,414 
to 1,504. In the ATPase domain, lysine (K) shown in black at position 770 was mutated to 
arginine (R) to obtain the dominant negative xBRG1. 
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Figure 4.5 (A) Clustlaw alignment of Xenopus BRG1 amino acid sequence with human (AAB40977), 
chicken (CAA62831), Zebrafish (AAP22968) BRG1. The alignment shows the significant homology with 
the BRG1 protein of other vertebrates and shows that the conservation of the amino acid sequence is just 
not in the ATPase domain but is through out the entire length of the protein. 
Touch down PCR was carried out to obtain the predicted full-length gene 
of 5kb length as described in the materials and method section of this report. The 
sequencing revealed an open reading frame of 4803 bp for xbrg1 (Fig4.4.). 
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The nucleotide sequence was translated into amino acid sequence using 
Mac vector 6.5.3 software. The open reading frame translated into a 1600 aa 
long protein. The amino acid sequence was used to search the pfam database to 
determine functional domains in the protein.  
The pfam analysis showed a SNF2 domain extending from aa 742 to aa 
1037 and a bromodomain, the characteristic domain of SWI/SNF family 
members, between aa 1414 to aa 1504 as shown in figure 4.4.  
The xBRG1 protein sequence was aligned with the full-length sequence of 
human BRG1 (AAB40977) (Khavari et al., 1993), Chick BRG1 (CAA62831) 
(Goodwin, 1997), and Zebrafish BRG1 (AAP22968) (Gregg et al., 2003),which 
revealed high sequence identity (Figure4.5.A). The identity was about 87% with 
human BRG1, 88% with Chick BRG1 and 85% with Zebrafish BRG1 (Fig 4.6 H). 
Notably the identity between the ATPase domain of Xenopus BRG1 and Human 
BRG1 was about 97% while the identity between Xenopus and human BRG1 
bromodomain was about 96%. The absence of the poly-glutamine stretch, 
present in hBRM in the N-terminal region of the protein, as well as a C-terminal 
end sequence (EED in BRG1 while DDE in BRM protein) showed that the c-DNA 
obtained corresponds to BRG1 (figure 4.5.B). 
 
Figure 4.5 (B) Clustlaw alignment of C-terminal of BRG1 and BRM proteins of Xenopus and 
Human. Notably, C-terminus end in BRG1 is EED while in BRM, it is DDE. 
 
 
                                                                                                                  4 Results 
  74 
  
4.4 Xbrg1 is maternally expressed and has a tissue-specific 
expression pattern 
 The Northern blot showed that Xbrg1 is expressed as a single transcript of 
about 8 kb and is present both before and after the start of zygotic transcription 
(figure 4.6.I). 
 
Figure 4.6 Normal expression pattern of Xbrg1 at 4-cell, a time before zygotic transcription 
begins, shows that Xbrg1 transcript are provided maternally (A), while at gastrula stage Xbrg1 is 
expressed ubiquitously (B). At Neurula, it starts expressing specifically in prospective neural 
tissues and shows strong expression in eye anlage (C). At st.28 Xbrg1 transcript are present in 
neural tube, eye, otic vesicles, pronephros, branchial arches (D) and at st.35 expression become 
more concentrated to the head region with expression in retina  (E), at st45 its expression is 
detected only in the heart (F). Head section of a st. 35 embryo passing through the eye shows 
expression of Xbrg1 in retina(r) and neural tube (nt) but not in iris (i). (G) Degree of amino acid 
identity between BRG1 homolog of human (AAB40977), chicken (CAA62831), Zebrafish 
(AAP22968) and Xenopus (H). Northern blot analysis of Xbrg1 shows that there is a single 
transcript of approximately 8kb in size (I). 
In order to determine the spatial pattern of Xbrg1 expression in embryonic 
tissues, RNA in-situ hybridization was performed. NF st. 4, NF st. 11, NF st. 14, 
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NF st. 28, NF st. 35 and NF st. 45 of embryonic development were probed with a 
Xbrg1 specific antisense probe. The –36 to +618 fragment was cloned into the 
pCR II-TOPO (Invitrogen Life Technologies) vector to obtain the antisense RNA 
probe as described in materials and methods section of this report. A sense 
strand probe was used as a negative control. Specific in-situ staining was 
observed with the antisense Xbrg1 probe from 2-4 cell stages onwards. At 2-4 
cell stage, only maternal transcript are present since in Xenopus embryos the 
zygotic transcription starts at the mid blastula transition (MBT) (Newport and 
Kirschner, 1982). Up to the gastrula stage, Xbrg1 is expressed ubiquitously in the 
embryo. From neurula stage of embryos, Xbrg1 has a restricted expression 
pattern. As shown in figure 4.6, the expression of Xbrg1 was detected in the 
prospective eye field and prospective neural tube showing a region of high-level 
expression of Xbrg1 at Neurula stage. NF st. 28 embryos show that Xbrg1 is 
expressed strongly in eye, brain tissue and branchial arches, while it has a 
weaker staining in pronephros and in neural tube. Interestingly, its expression 
could not be detected in somites, which express Xbrm (Linder et al., 2004). 
By NF stage 35, expression could be seen in retina, but not in the lens 
tissue, as also seen in embryonic cross-sectioning of head of NF stage 35 
embryos passing through the eyes. The expression of Xbrg1 shows an increase 
in pronephros and in brain tissue while reduces in neural tube as compared to 
NF st. 28 embryos. The expression was also present in the tail region. At NF 
stage 45 expression of Xbrg1 has disappeared in head, eye and neural tissue, 
and was maintained exclusively in heart.  
Thus, Xbrg1 is a maternally expressed gene, and is present ubiquitously 
at gastrula stage and later shows a tissue specific expression pointing towards a 
role of xBRG1 in tissue specific transcription.  
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4.5 Generation and characterization of monoclonal antibodies 
for xBRG1 
In order to carry out future experiments related to chromatin Immunoprecipitation, 
Co-IP and western blotting, monoclonal antibodies specific to BRG1 were raised 
in collaboration with Prof. Elizabeth Kremmer (GSF).  
 
Figure 4.7 Xenopus BRG1 specific monoclonal antibodies were raised. The antibody was raised 
in rat using the GST fusion protein. (A) Amino acid sequence of the xBRG1 protein used to raise 
the antibody. The primary supernatants were tested on in-vitro translated xBRG1 protein (B). All 
the supernatants were found positive for the xBRG1. Further, the supernatants were tested on 
Whole embryo lysate from NF st11 embryos (C). The arrows show the xBRG1 specific band. 
As described in the material and methods section, a specific fragment of 
xbrg1 was cloned into GST vector and the fusion protein obtained was used to 
immunize rats. Several clones were obtained namely XB3F1, XB4D8, XB5B9, 
XB6A1, XB6D8, and XB7G9. These clones were tested first on in-vitro translated 
xBRG1 protein. All antibodies detected xBRG1 specific band on western blot. 
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Further, these supernatants were tested on whole embryo lysate obtained from 
stage11 embryos.  
The western analysis showed that detection of xBRG1 in supernatant by 
XB3F1 was more specific then other supernatants. XB3F1 was able to detect 
endogenous xBRG1 without any nonspecific band except a very low molecular 
weight band, which was present in all supernatants. On the other hand, 
supernatants XB6D and XB7G6 detected xBRG1 along with several non-specific 
bands (figure 4.7.). The XB3F1 clone generated supernatant was used in future 
studies based on these results. The supernatant from the stabilized XB3F1 clone 
showed only the specific xBRG1 band of an expected size of about 200 kDa. 
Since these antibodies will also be used for chromatin 
immunoprecipitation and Co-IP, BRG1 antibody clone XB3F1 was tested for its 
efficiency to immunoprecipitate endogenous BRG1. Immunoprecipitation 
efficiency of antibody clone XB3F1 and XB6D8 was tested first on in-vitro 
translated xBRG1 protein. 
As shown in figure 4.8, both XB3F1 and XB6D8 supernatants were able to 
immunoprecipitate xBRG1. XB3F1 shows specific Immunoprecipitation 
compared to Immunoprecipitation using XB6D8. Further, XB3F1 was tested 
whether it can carry out Immunoprecipitation after cross-linking of DNA and 
protein by formaldehyde treatment used for chromatin Immunoprecipitation. DNA 
and protein were cross-linked by treating the embryos with formaldehyde in three 
conditions varying in temperature and duration. These conditions were following: 
a) 5’ at RT b) 15’ at RT c) 10’ at 37
o
C. The Immunoprecipitation was carried out 
as described in materials and methods. As shown in figure 4.8, XB3F1 was able 
to immunoprecipitate xBRG1 in all cross-linking conditions with approximately 
10% efficiency. 
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Figure 4.8 Supernatant 3F1 and 6D8 were tested for their Immunoprecipitation efficiency. 3F1 
and 6D8 both were able to immunoprecipitate radio labeled in-vitro translated (A) as well as 
endogenous (B) xBRG1 protein. Based on this experiment, 3F1 was preferred over 6D8 for 
Immunoprecipitation as it brings down only specific protein. Further, 3F1 was tested for its 
Immunoprecipitation efficiency of endogenous protein after formaldehyde cross-linking in various 
conditions (C). The blots were probed with 3F1 supernatant. * shows antibody heavy chain band. 
4.6 Optimization of in-vitro transcription for xbrg1  
In order to obtain the in-vitro transcribed mRNA of xbrg1, xbrg1 cDNA was 
cloned in pCS2+ vector. The pCS2+xbrg1 plasmid construct was linearized by 
Not1 restriction digestion.  
                                                                                                                  4 Results 
  79 
  
In-vitro transcription was carried out using SP6 polymerase at 37oC. 
Interestingly, when the transcripts were size fractionated on formaldehyde gels, 
the transcript was about 2 kb shorter then the expected band of 5 kb. In order to 
obtain the full length RNA, two approaches were tried. First, it was checked 
whether another promoter like T3 or T7 gives the full-length transcript. For this, 
xbrg1 in pCR II-TOPO (Invitrogen Life Technologies) vector was used to 
transcribe RNA. pCR II-TOPO vector has  T7 promoter upstream of xbrg1. In-
vitro transcription was done using standard protocol at 37oC, which obtained full-
length transcript of about 5 kb in size. Although the use of T7 promoter obtained  
 
Figure 4.9 Conditions were optimized for in-vitro transcription of xbrg1. The in-vitro transcription 
of pCS2+ wt and dn xbrg1 using Sp6 polymerase gives smaller transcripts then the expected 
transcript of 5 kb in length at 37
o
C(A). The in-vitro transcription of pCR II-TOPO xbrg1 was 
carried out using T7 polymerase (B), which shows full-length transcript. Further, in-vitro 
transcription of pCS2+ wt xbrg1 was carried out using sp6 polymerase at different temperatures 
(C). In-vitro transcription at 20
o
C shows optimal transcription.  
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full-length mRNA but SP6 promoter used in pCS2+ vector, has been shown to 
have higher transcriptional efficiency as well as transcript obtained from SP6 
promoter has highest translational efficiency. Thus, another approach was used 
to obtain the full-length transcript. The in-vitro transcription was carried out at 
various temperatures that is at 10
o
C, 20
o
C, and at 30
o
C. As shown in figure 4.11, 
at 10
o
C the transcript was of full-length but the amount was extremely low, while 
at 30
o
C, the amount was sufficient but transcript were spreaded on the 
formaldehyde gel indicating several short transcripts while at 20
o
C the transcript 
amount was sufficient as well as transcript was also full length (figure 4.9.). Thus, 
in future experiments, in-vitro transcripts for xbrg1 were generated at 20oC using 
SP6 RNA polymerase. 
4.7 Xenopus BRG1 is required for anterior-posterior axis 
formation 
 To carry out in depth analysis of developmental functions of xBRG1, a 
dominant negative construct similar to dn hBRG1 was made. To obtain dominant 
negative version of xBRG1, a lysine at the conserved ATP binding site (GKT), at 
position 770 was point mutated to arginine (K770-R) as has been described for 
hBRG1(Khavari et al., 1993) by a single point mutation using site directed 
mutagenesis.  
The in-vitro synthesized, wild type Xbrg1 and dominant negative Xbrg1 
mRNAs were injected at a dose of 500 pg/embryo in to dorsal marginal zone at 
four-cell stage along with Gfp as lineage tracer. The control embryos were 
injected with in-vitro synthesized Gfp mRNA. The phenotypes were assessed at 
NF stage 35. As shown in figure 4.10, dominant negative Xenopus BRG1 
produced 61% embryos with head defects as seen in case of dominant negative 
hBRG1 overexpression. Overexpression of wild type hBRG1 did not produce 
phenotypes but on contrary, overexpression of wild type xBRG1 resulted in 53% 
embryos with reduced head structures (Table 4.2). Superficially, the head defects 
shown by wild type and dominant negative xBRG1 looked similar, but on closer 
inspection it was found that in case of wild type xBRG1 the cement gland was 
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preferentially reduced, while eyes remained unaffected. In contrast, over- 
expression of dominant negative Xenopus BRG1 affected primarily eye 
formation, while cement glands differentiated normally.  
4.8 Ventral overexpression of wild type xBRG1 produces partial 
secondary axis  
Wild type and dominant negative xBRG1 was overexpressed on ventral 
side of the embryos by injecting 500pg mRNA along with Gfp as a lineage tracer. 
As shown in figure 4.10, overexpression of dominant negative xBRG1 did not 
produce any abnormalities, consistent with dominant negative hBRG1 
overexpression on ventral side of the embryo. In contrast, overexpression of wild 
type Xenopus BRG1 on the ventral side produced partial secondary axis at a 
frequency of about 65% (Table 4.2.). The overexpression of GFP did not produce 
any defect.  
The results obtained from overexpression of xBRG1 on the dorsal side of 
the embryo revealed a possible role of BRG1 in anterior-posterior patterning of 
Xenopus embryo, which are principally consistent with the results obtained by 
hBRG1 overexpression. 
Phenotypes produced by dorsal or ventral overexpression of wild type and 
dominant negative xBRG1 could not be produced by overexpression of wild type 
and dominant negative overexpression of xISWI, another SNF2 domain 
containing protein, either on the dorsal side or on the ventral side of the Xenopus 
embryos. For these experiments, wild type and dominant negative Xiswi in-vitro 
synthesized mRNA were injected into the dorsal marginal zone or into the ventral 
marginal zone. 
Dominant negative xISWI variant was obtained by a single point mutation 
into ATPase domain. The point mutation converted the conserved lysine residue 
at position 204 into arginine. This mutation renders its ATPase domain inactive, 
as reported previously for Drosophila ISWI (Deuring et al., 2000). The mRNA at a 
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dose of 500 pg/embryo was injected along with GFP at 100ng/embryo as a 
lineage tracer at four-cell stage. The phenotypes were scored at NF st.35. The 
embryos injected with wild type (n=24) and dominant negative (n=20) version 
were normal and displayed no abnormalities. 
 
Figure 4.10 Overexpression of wt xBRG1 (B) and dn xBRG1 (C) on dorsal side of the Xenopus 
embryo shows defect in head structure. The overexpression wt xBRG1 shows the defects in 
cement gland development while dn xBRG1 shows defect in eye development as shown in close 
up in left corners of figures. Overexpression of wt xBRG1 on ventral side produces a secondary 
axis (E), dn xBRG1 failed to do so (E). While embryos overexpressing GFP on Dorsal (A) and 
ventral (D) side were normal. Corresponding legend shows GFP expression, used for lineage 
tracing. Nucleotide binding motif comparison of RAD3 helicase with hBRM, hBRG1 and xBRG1. 
The conserved lysine in ATP binding motif is shown in green. This conserved lysine at position 
770 in xBRG1 was converted to arginine to produce dominant negative xBRG1 (G).  
                                                                                                                  4 Results 
  83 
  
Table 4.2 
Dorsal and ventral overexpression of wild type and dominant 
negative xBRG1 
  
4.9 Reduction of endogenous xBRG1 causes severe head and 
axial defect 
 Gain of function phenotypes produced by overexpressing wild type and 
dominant negative versions of xBRG1 illustrated a role played by BRG1 in 
anterior-posterior axis formation. In order to further confirm the role of xBRG1 in 
anterio-posterior axis formation, loss of function studies were performed.  
Xenopus BRG1 protein translation was inhibited using morpholino 
antisense oligo. Xenopus is an allotetraploid vertebrate and thus has two non-
allelic functional copies of each gene. The EST database search gave an EST 
 RNA 
amount 
(pg/emb) 
Total 
Number 
Normal Head 
and Eye 
defect 
(%) 
Secondary 
axes (%) 
Gastrulation 
defect 
Wt 
Xbrg1 
500/DMZ 143 61 77(53) - 5 
Dn 
Xbrg1 
500/DMZ 113 29 69(61) - 15 
Wt 
Xbrg1 
500/VMZ 44 12 - 29(65) 3 
Dn 
Xbrg1 
500/VMZ 18 16 -  2 
Gfp 100/DMZ 16 15   1 
Un-
injected 
 133 127 2 - 4 
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namely BG554361, which includes the N-terminus sequence of the second non-
allelic copy of xbrg1. A morpholino antisense oligo was designed, which targets 
both copies of the gene and thus blocking translation from the transcript of both 
copies. To assess the translational blocking efficiency of xBrg1 antisense 
morpholino oligos, embryos were injected at two-cell stage in to both 
blastomeres of the embryos at a dose of 20 ng/embryo and at 80 ng/embryo of 
xBrg1 specific morpholino oligos. The control morpholino oligos were injected at 
80 ng/embryo. Embryos were collected at gastrula stage and lysed in RIPA 
buffer. For western blot analysis, lysate equivalent to one embryo per lane were 
loaded onto the gel. The blots were probed with xBRG1 specific XB3F1 antibody. 
Western analysis showed a significant reduction in the xBRG1 endogenous 
protein levels by both doses of xBrg1 antisense morpholino oligo. The blots were 
stripped and reprobed with Xenopus ?-CATENIN specific antibody P14L 
(Schneider et al., 1993) as a loading control (Figure 4.11.). 
For phenotypic analysis, xBrg1 antisense morpholino oligos were injected 
at various doses into dorsal marginal zone at 4-cell stage. The phenotypes were 
scored at NF stage 35. The phenotypes obtained were dose dependent and 
showed loss of eyes at lower doses while loss of eyes and reduced anterior-
posterior axes at higher doses of morpholino oligos (Figure 4.11.). Ten 
nanograms of morpholino oligo injections affected 85% embryos while 20 ng of 
morpholino injection produced 89% affected embryos (Table 4.3.). At higher 
doses, the antisense morpholino oligos caused gastrulation defects. On the other 
hand, embryos injected with control morpholino did not show any phenotypes 
even at the dose of 40 ng/ embryo. These embryos were also injected with GFP 
as a lineage tracer. The presence of GFP also shows that the injected cells were 
alive. This result point out a role of xBRG1 in dorso-anterior patterning. On the 
other hand, when antisense morpholino were injected into ventral marginal zone 
of the embryo, embryos showed lesion on ventral side of the embryo at different 
stages of embryo, depending on the amount of antisense morpholino oligos 
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Figure 4.11 xBrg1 MO were designed to target the +1 to +25 of xbrg1 sequence (A). Translational 
inhibition of endogenous brg1 by xBrg1 MO antisense oligos (B). The blots were probed with XB 
3F1, xBRG1 specific antibody. x?-CATENIN was used as a loading control. The xBrg1 MO were 
injected at 2-cell stage to check the efficacy of MO to block the endogenous BRG1 translation. 
The embryos were lysed at NFst.11.The xBrg1 MO produces phenotypes in a dose dependent 
manner. xBrg1 MO were injected at 2.5 pg/emb (C), 5 pg/emb (D), and at 10 pg/emb (E). While 
control morpholino were injected at 40 ng/emb (F).  
 
used. In contrast, injections of xBrg1 antisense morpholino oligos at two-cell 
stage were lethal to the embryo after gastrulation and showed lysed embryos. 
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4.10 Phenotypes produced by xBrg1 antisense morpholino 
oligonucleotides are rescuable  
In order to check whether the phenotypes produced by Brg1 morpholino 
are specific, phenotypes produced by xBrg1 morpholino oligos were rescued by 
overexpression of wild type hBRG1. hbrg1 contains four mismatches in the target 
region of morpholino antisense oligo and, thus, cannot be inhibited by the xBrg1  
antisense morpholino. Wt Hbrg1 mRNA was co-injected with xBrg1 antisense 
morpholino oligos into the dorsal marginal zone at 4-cell stage.  
 
Figure 4.12 The phenotypes produced by xbrg1MO were rescued by overexpressing hBRG1, 
which shows four mismatches in the MO target region (A). The co-injection of Hbrg1 mRNA 
rescues the phenotypes produced by xBrg1 MO and shows partial rescue of eye  (E), partial 
rescue of eye and AP axis (F) and almost complete rescue of eye and AP axis (G) compared to 
xBrg1 MO (D) alone. Control morpholino (B) and Hbrg1 mRNA (C) alone do not produce any 
abnormalities. GFP mRNA was co-injected as a lineage tracer, which has been shown alongside 
of corresponding pictures. 
As shown in figure 4.12, the embryos injected with 10 ng/embryo xBrg1 
antisense morpholino into dorsal marginal zone displayed embryos having loss of 
eyes, reduced head and severely reduced anterior-posterior axes, but when 
xBrg1 morpholino oligos were co-injected with 500 pg mRNA of Hbrg1, embryos 
displayed a range of phenotypes.  
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Table 4.3 
Phenotypes generated by BRG1 depletion can be rescued by 
hBRG1 and x? -CATENIN 
 
The co-injection of Hbrg1 mRNA resulted in only 15% affected embryos 
compared to 85% affected embryos obtained with Brg1 morpholino alone (Table 
4.3.). All of these embryos were showing at least partial recovery of eye 
differentiation while some embryos showed complete recovery of eyes and 
 Total 
Number 
Normal 
/rescued 
Head 
And 
eye 
defect 
(%) 
Gastrulation 
Defect 
Brg1MO 10 ng/emb/DMZ 75 - 64(85) 11 
Brg1MO 20 ng/emb/DMZ 97 - 87(89) 10 
Brg1MO 10 ng/emb+ Wt Hbrg1 
500pg/emb/DMZ 
45 34 7(15) 4 
Brg1MO 10 ng/emb+ Wt Hbrm 
500pg/emb/DMZ 
24 - 22(91) 2 
Brg1MO 10 ng/emb+ Wt Xiswi 
500 pg/emb/DMZ 
38 - 17(44) 21(with head 
and eye 
defect) 
Brg1MO 10 ng/emb+ ?-catenin 
250pg/emb/DMZ 
21 12 8(38) 1 
Wt Hbrg1 
500pg/emb/DMZ 
15 11 2(13) 2 
?-catenin 
250pg/emb/DMZ 
32 26 3(9) 3 
Control Mo 40 ng/emb /DMZ 17 17  - 
Dn Hbrg1 500 pg/emb + ?-
catenin 
250 pg/emb/DMZ 
22 15 7(46) - 
Dn Hbrg1 500pg/emb/DMZ 22 7 15(68) - 
Uninjected 24 24 - - 
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anterior-posterior axes. Interestingly, xISWI and hBRM overexpression failed to 
rescue the phenotypes generated by Brg1 morpholino oligos. 
 These results showed that the phenotypes produced by the xBrg1 
morpholino oligos were specifically produced by interference with xBRG1 protein 
function. 
4.11 BRG1 knock-down affects expression of various 
differentiation markers  
 The BRG1 knock-down experiments displayed severely reduced head 
structures and anterio-posterior axis formation. To find out the effect of BRG1 
knock-down on organogenesis, various tissues were analyzed by in-situ 
hybridization. Xenopus embryos were injected at 4-cell stage into dorsal marginal 
zone with 5 ng per embryo of xBrg1 antisense morpholino oligonucleotides. The 
embryos were fixed at stage 35.  
Embryos were probed with neural specific ?-tubulin in-situ probe 
(Oschwald et al., 1991). In-situ analysis showed that N-? tubulin stains neural 
tissue in head region as well as in neural tube. The expression levels were high 
in head region and lower in neural tube. BRG1 knocked-down embryos displayed 
strongly reduced N-? tubulin staining in head region, while staining was absent in 
neural tube region. These results showed that BRG1 knock-down reduced the 
amount of neural tissue formation (figure 4.13.). 
Next I examined the expression of Nkx2.5, a tinman homologue and a 
known regulator of heart differentiation and morphogenesis (Tonissen et al., 
1994). As shown in figure 4.13, the expression was reduced in xBrg1 MO 
injected embryos, while the expression of Nkx2.5 remained unaltered in control 
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Figure 4.13 The effect of xBRG1 knock-down on various tissues was tested by in-situ 
hybridization. Brg1 morphant embryos shows down regulation of neural specific marker N-?-
tubulin, heart specific marker Nkx2.5, Msr, a marker for blood vessels, and Shh, which is 
expresses in floor plate of notochord and Nasal pits while the expression of ?-globin, a marker for 
ventral blood islands shows significant expansion. The expression of Mlc35 is also reduced by 
xBRG1 knock-down, showing defective muscles in morphant embryos. 
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morpholino injected embryos. These results showed that BRG1 is involved in 
heart formation.  
 To get further insight into vascular system, I analyzed Brg1 morphant 
embryos for the expression of the mesenchyme-assocoiated serpentine receptor 
Msr, whose transcripts are expressed in procardiac tube and forming blood 
vessels, localized in the inner endothelial layer (Devic et al., 1996). As shown in 
figure 4.13, it was found that BRG1 knock-down has affected blood vessel 
formation in morphant embryos while it remains normal in control morpholino 
injected embryos. 
Alpha globin is expressed in ventral blood islands (Banville and Williams, 
1985; Tracey et al., 1998). As shown in figure 4.13, it was found that the 
expression of Alpha globin is increased in Brg1 morphant embryos compared to 
control embryos, which could be due to ventralization of the embryo or due to 
unequal distribution of blood-island due to reduced blood vessel formation. 
Furthermore, I checked the expression levels of sonic hedgehog (Shh), 
which is expressed in the floor plate of notochord and in the nasal pits (Ekker et 
al., 1995). BRG1 knock-down into Xenopus embryos shows down regulation of 
Shh staining, showing defective notochord formation (figure 4.13.). 
It has been reported that BRG1 and BRM are involved in muscle 
differentiation, a study carried out using fibroblast cell lines (de la Serna et a., 
2001). To confirm the role of BRG1 in muscle differentiation, in-vivo muscle 
differentiation was observed in Brg1 morphant embryos. As a muscle marker, 
Mlc35 was used, which stains differentiated muscles in the embryos at late 
stage. The in-situ pattern shows that Mlc 35 staining is reduced (figure 4.13.). In 
addition, chevron pattern of the somatic muscle is perturbed in BRG1 knock-
down embryos. It confirms that the BRG1 is involved in muscle differentiation. 
  These results show that BRG1 knock-down in Xenopus embryos causes 
late defects in multiple tissues. The effects could be due to the direct effect on 
organogenesis or due to defect in early patterning of embryo. To understand the 
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cause of these phenotypes, the genes involved in early patterning of the embryos 
were investigated.  
4.12 BRG1 knock-down causes down regulation of genes 
required for early patterning of the dorsal mesoderm 
 To understand the role of xBRG1 in early patterning, the embryos were 
injected with 20 ng of antisense morpholino oligos at 2-cell stage. The target 
genes were checked by in-situ hybridization at relevant embryonic stages.  
Xenopus nodal related 3 (xnr3) is a direct target gene of WNT/?-CATENIN 
pathway (McKendry et al., 1997). The expression levels of Xnr3 were checked in 
Brg1 morphant embryos. Xnr3 is expressed maximally at NF st.9 and thus 
control morpholino as well as Brg1 morpholino injected embryos were fixed at 
this stage.  As shown in fig 4.14, the expression level of Xnr3 in Brg1 morphant 
embryos is significantly reduced while the size of its expression domain remains 
same compared to control morpholino injected embryos.  
Chordin, a BMP antagonist, is expressed transiently in the BCNE center 
(Blastula Chordin Noggin Expression center) and later in the organizer. The 
expression of Chordin in the BCNE center is under the ?-CATENIN mediated 
WNT signal (Kuroda et al., 2004). To test the expression of Chordin in BCNE 
center, embryos were fixed at blastula stage. As shown in figure 4.14, the 
expression of Chordin was notably reduced by knocking-down BRG1 in the 
embryos compared to control embryos.  
This result not only gives a second read out for Wnt target genes as well 
as explains neural defects seen in whole embryos since the BCNE center later 
gives rise to prospective brain and floor plate. Chordin is expressed at the dorsal 
blastopore lip at the gastrula stage. As shown in legend of figure 4.14, the 
expression of Chordin was reduced in the ectodermal cells while remained 
unaffected in the lip. Next, the expression of Goosecoid, a homeobox gene, 
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Figure 4.14 Whole mount in-situ hybridization of control and Brg1 morphant embryos. Control 
morpholino (40 ng/emb) or Brg1 morpholino (20 ng/emb) were injected at 2-cell stage in both the 
blastomeres. Embryos shown for Xnr3 and chordin were collected at stage 9, while for Goosecoid 
were collected at stage 10 and embryos shown for Chordin (in legend with st. 9 Chordin), Xvent2, 
Xbra, Myf-5, Myod and Xpo were collected at late gastrula stage. Note that upon BRG1 knock-
down, staining for Xnr3, Goosecoid, and Chordin is reduced while staining for Xvent-2 and Xbra 
remains unchanged but staining for Xpo was increased and extends in organizer. Myf-5 and 
Myod, the genes responsible for myogenesis are also down regulated in Brg1 morphant embryos. 
 
which is expressed in the organizer and demarcates the organizer domain (Cho 
et al., 1991), was examined. The embryos were fixed at NF st10.  After BRG1 
knock-down, Goosecoid expression domain was reduced in size but interestingly 
the expression level in the remaining domain was not altered (figure 4.14.). 
These results show the reduced territory of organizer. The goosecoid promoter is 
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known to have two binding sites, one each for WNT signal and NODAL signal. 
Siamois/Twin binding on the promoter relays WNT signal. Therefore, it was 
reasoned that since WNT signal is downregulated as shown by the 
downregulation of Xnr3 and Chordin, I see a reduction in expression domain of 
Goosecoid but probably NODAL signaling remains unaffected and thus maintains 
the intensity of expression. 
Xbra, a Xenopus homologue of the T-box gene brachyury, is expressed in 
the pan-mesoderm (Smith et al., 1991). To find out the effect of BRG1 knock-
down on the mesoderm formation, the expression of Xbra was checked at NF 
st.11. As shown in figure 4.13, the expression level of Xbra remains unchanged 
in the Brg1 morphant embryos compared to control embryos showing that the 
mesoderm formation remains unaffected by BRG1 knock-down.   
Xvent-2, a homeobox gene, has been shown to be required for 
ventralization of mesoderm (Onichtchouk et al., 1996). Xvent-2 is a direct target 
of BMP signaling (Schuler-Metz et al., 2000). To find out the effect of BRG1 
knock-down on ventral mesoderm formation, the expression of Xvent-2 was 
checked. The expression levels of Xvent-2 remain comparable to control 
embryos in Brg1 morphant embryos (figure 4.14). These results show that BRG1 
knock-down does not affect BMP signaling and thus ventral mesoderm formation 
remains unaffected. 
  Xenopus-posterior (Xpo), encodes protein with a ‘CCHC’ finger domain, 
(Sato and Sargent, 1991) and has been proposed to be involved in anterio-
posterior axis organization. Xpo is one of several ventralizing genes, which can 
be induced by xCAD-2 (Pillemer et al., 1998). As shown in figure 4.14, the 
expression of Xpo is limited to the posterior ectoderm and mesoderm in the 
control embryos but is expanded in Brg1 morphant embryos in the organizer 
territory.  
These results shows that knock-down of xBRG1 selectively affect Wnt 
target genes and shows defective organizer formation during gastrulation of 
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Xenopus embryo. BRG1 knock-down affects BCNE center formation as shown 
by the downregulation of Chordin, pointing towards the defective neurogenesis. 
These results although showed that BRG1 is required during early patterning of 
the embryo possibly by the modulation of Wnt target genes expression, but does 
not exclude the possibility of late function of BRG1 in organogenesis. 
4.13 BRG1 knock-down affects the expression levels of Myod 
and Myf-5  
 As shown in figure 4.13, BRG1 knock-down affects Mlc35 expression, and 
thus is involved in frog muscle differentiation. In order to find out the mechanism 
of the loss of muscle differentiation, the expression level of Myod and Myf-5 were 
checked. MyoD and MYF-5 are basic helix loop helix transcription factors and are 
responsible to initiate the muscle development (reviewed in Rupp et al., 2002). 
The embryos were injected with 20 ng of Brg1 morpholino at two-cells stage into 
both blastomeres. The expression level was assessed at NF st. 11.  
BRG1 knock-down from the embryos by antisense morpholino oligos 
clearly caused a reduction of Myf-5 and Myod expression. The expression level 
of Myod was reduced in the ventral mesoderm, while the expression of Myf-5 
was undetectable (figure 4.14.). These results show that BRG1 acts genetically 
upstream of MyoD and Myf-5. 
4.14 Functional interdependence of xBRG1 and ?-CATENIN 
Epistasis experiments were performed in order to further confirm that 
BRG1 acts in Wnt pathway.  
Xenopus ?-CATENIN was used to rescue the phenotypes produced by 
BRG1 knock-down. The mRNA encoding X?-catenin was either co-injected with 
Brg1 morpholino or alone into the dorsal marginal zone at 4-cell stage. Similarly, 
Brg1 morpholino oligos alone were also injected in the same way. The injections 
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were done with Gfp as a lineage tracer. The phenotypes were scored at the 
tadpole stage.  
Injection of Brg1 morpholino alone shows AP axis defect as described 
before. Embryos co-injected with ?-catenin mRNA and Brg1 morpholino oligos 
were significantly rescued, characterized by the presence of eyes, almost normal 
heads and restored length of anterior-posterior axes (figure 4.15.). 
 
 
Figure 4.15 BRG1 and ?-CATENIN are in the same signaling pathway. The phenotypes produced 
by xBrg1 MO injection (A) could be rescued by overexpression of x ?-CATENIN (B) while over- 
expression of x?-CATENIN caused no abnormalities (C). All the embryos were co-injected with 
Gfp mRNA as a lineage tracer and the images are shown in the corresponding legends. 
The rescue shows only 38% percentage affected embryos compared to 
85% affected embryos with Brg1 morpholino alone (Table 4.3.). The embryos 
injected with ?-catenin mRNA alone did not show any significant phenotypes. ?-
CATENIN overexpression also rescued the phenotypes produced by dn hBRG1, 
bringing down the percentage of strongly affected embryos from 68% to 46% 
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(Table 4.3.). The results show that phenotypes induced by functional inhibition of 
BRG1 can be rescued by overexpression of ?-CATENIN. 
It has been shown that overexpression of ??CATENIN on ventral side 
produces a complete secondary axis (Funayama et al., 1995) as also shown in 
figure 4.16. Overexpression of ?-CATENIN on ventral side of the embryo gives 
rise  
 
Figure 4.16 Axis inducing capacity of x?-CATENIN depends on BRG1. x?-catenin produces a 
complete secondary axis on ventral injection (B). BRG1 knock-down on the ventral side of the 
embryo blocks the axis inducing capacity of x?-CATENIN (C) while xBrg1 MO ventral injection 
causes no abnormalities (A). Injected cells can be traced by GFP, which was co-injected. The 
GFP images have been shown in corresponding legends. 
 to secondary organizer by forming dorsal mesoderm at the expense of ventral 
mesoderm. As shown in figure 4.16, when ?-CATENIN was overexpressed in 
Brg1 morphant embryos, it failed to produce secondary axes in the embryos, 
while    ?- CATENIN alone induced a complete secondary axes in about 90% 
embryos. In the same manner, co-injection of dn Hbrg1 with ?-catenin also 
blocked secondary axis formation as only 36% of embryos showed secondary 
axes (Table 4.4.).  
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These results show that both BRG1 and ?-CATENIN are in the same 
pathway and ?-CATENIN genetically interacts with BRG1. 
Table 4.4 
Depletion of BRG1 prevents secondary axes formation by ?-
CATENIN 
 
4.15 Gene - and signal specific role of xBRG1  
The previous results reported here indicated that BRG1 is involved in 
primary patterning of the Xenopus embryos by primarily regulating Wnt signaling 
dependent activation of organizer-specific genes. During embryogenesis, several 
signaling pathways are involved and influence the gene expression of the various 
downstream target genes.  
These signaling pathways are interconnected with each other in a 
complex network, which makes it realistically impossible to do the in-vivo study of 
certain protein on various individual pathways. To overcome this problem, animal 
 Total 
Number 
Normal Head 
And Eye 
defect 
 
Secondary 
Axes 
(%)  
Gastrulation 
Defect 
Brg1Mo 
10ng/emb/vmz 
14 12 - - 2 
??catenin 
250pg/emb/vmz 
42 1 - 38(90) 3 
Brg1Mo 
10ng/emb/vmz+
?-Cat. 
250pg/emb/vmz 
20 18 - 1(5) 1 
dn Hbrg1 
500pg/emb/vmz
+?-cat. 
250pg/emb/vmz 
19 7 - 7(36) 5 
Uninjected 71 71 - - - 
                                                                                                                  4 Results 
  98 
  
 
Figure 4.17 Schematic representation of animal cap assay. The morpholino were injected at 2-
call stage into both blastomeres. The inducer RNA was injected into two blastomeres at 8-cell 
stage into the animal pole. The embryos were cultured until 7hpf and the animal caps were 
excised from blastula stage embryo. The animal caps were further cultured for four hours and 
then lysed to extract total RNA. 
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cap in-vitro induction assay was used. As stated before, animal caps are 
ectodermal cells and their use reduces the complexity of the problem by allowing 
to test the effect of individual signals on the expression of direct target genes. 
The signaling pathways in the animal cap cells are induced by 
overexpression of specific ligand for the specific pathway. Embryos were injected 
with 20 ng of Brg1 morpholino at two-cell stage into both blastomeres. At the 8-
cell stage, uninjected as well as Brg1 morpholino (B-MO) injected embryos were 
injected with inducer mRNA into animal pole. The caps were excised at seven 
hpf and further cultured for 4 hours, before they were lysed to extract total RNA, 
which was used to assess the induction of representative direct target genes of 
different signaling pathways.  
The direct target genes were selected based on previously reported 
cycloheximide insensitive genes or the presence of response element in the 
promoter. Cycloheximide treatment of the cells blocks protein synthesis and thus 
blocking the effect of intermediate proteins in the signaling pathway on the 
outcome of induction of the gene. 
To directly check the role of BRG1 on WNT signaling, the animal caps 
were induced with 50 pg of Wnt8 mRNA. Wnt8 activates WNT signaling pathway 
via interaction with its receptor, which in turns blocks the phosphorylation of ?-
CATENIN and thus preventing its degradation. This stabilized ?-CATENIN is 
transported to the nucleus where it releases the Tcf3 mediated repression and 
thus activating Wnt target genes. In addition to xnr3 (McKendry et al., 1997), 
siamois (Brannon et al., 1997; Brannon and Kimelman, 1996; Lemaire et al., 
1995) is also among other known WNT target genes. The promoter of Siamois 
has been shown to have a Lef/Tcf3 binding sites 
The expression of Siamois was checked by semi-quantitative RT-PCR in 
the un-injected and morpholino treated animal caps along with untreated and 
morpholino treated caps after induction by Wnt8 mRNA. As shown in figure 4.18,  
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Siamois, is not expressed in the uninduced cap, but can be strongly induced by 
Wnt8 mRNA. B-Mo injection alone did not induce expression of Siamois, but 
reduced the induction of siamois about two-three fold. 
 
 
Figure 4.18 Role of BRG1 on various signaling pathways was assessed using animal cap assay. 
The induction of direct target genes for WNT, eFGF and ACTIVIN signaling pathway was 
assessed in the presence and absence of Brg1 MO. The genes tested were Siamois for WNT 
pathway, Xbra and MyoD for eFGF and Xfd-1´ and Goosecoid for ACTIVIN signaling pathway. 
BRG1 shows a gene and signal specific effect. 
 XFD-1’ is a fork head/HNF-3 related transcription factor. Promoter studies 
have revealed the presence of an Activin response element (ARE), which is both 
necessary and sufficient for transcriptional activation of a reporter gene in animal 
cap explants incubated with ACTIVIN A. (Kaufmann et al., 1996). The expression 
of Xfd-1’ in animal caps could be detected after the injection of five pg of Activin 
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mRNA. When BRG1 depleted animal caps were induced by Activin mRNA 
injection, the transcription of xfd-1’ remained unaffected (figure 4.18).  
 The promoter of goosecoid has been shown to have two signaling inputs 
one from the WNT signaling through Siamois/Twin and the other from the 
NODAL signaling. (Germain et al., 2000; Laurent et al., 1997). In order to test the 
effect of BRG1 knock-down on goosecoid transcription under induction by nodal 
signal only, animal caps were induced by 5 pg of Activin mRNA. As shown in 
figure 4.18, Activin could induce goosecoid as reported previously (Green and 
Smith, 1990). In contrast to the effect of BRG1 knock-down seen in whole 
embryos, the induction of goosecoid remained unaffected in the absence of 
BRG1 pointing out that BRG1 is not required for ACTIVIN signaling. 
To find out the role of BRG1 in FGF/MAPK signaling, caps were induced 
by injecting 10 pg of eFGF mRNA at 8-cell stage into animal pole in uninjected 
and Brg1 morpholino injected embryos. The expression of Xbra was assessed, 
which has been shown to be a direct target of eFGF (Smith et al., 1991). As 
shown in figure 4.18, eFGF induces xbra in the animal caps but remains 
unaffected in the absence of BRG1. Similarly, eFGF has also been shown to 
induce myod transcription in the presence of cycloheximide (Fisher et al., 2002), 
as I have also shown in figure 4.18, myod could be induced by eFGF. Unlike 
Xbra, Myod transcripts were undetectable in the absence of BRG1. These results 
pointed out that BRG1 is required for the transcription of myod.  
The in-vitro induction experiments confirmed that BRG1 is predominantly 
involved in WNT signaling pathway. As seen, BRG1 knock-down did not affect 
activin target genes while selective affects eFGF target genes, showing that the 
BRG1 affect is gene and signal specific. 
4.16 Modulation of WNT-dependent gene-activation by xBRG1 
 Xnr3 and Chordin expression was strongly affected in the embryos upon 
BRG1 knock-down (figure 4.14), while Siamois expression was mildly down- 
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regulated in animal cap assay (figure 4.18). Furthermore, ?-CATENIN rescue 
experiments showed that the increased WNT response could compensate for 
reduced BRG1 activity (figure 4.15). Thus, it is possible that effect on siamois 
down regulation was masked by over stimulation of WNT pathway. This was 
investigated by testing the BRG1 knock-down effect on the transcriptional 
readout of weaker WNT signal. 
 
 
Figure 4.19. BRG1 sets up a signaling threshold for the optimal gene expression. The expression 
of Xnr3, Siamois, and Xnr6 was tested for the normal gene expression using two doses of Wnt8 
in the presence and absence of Brg1 MO. The requirement of BRG1 for the normal gene 
expression was further confirmed by co-injection of Xbrg1 mRNA along with sub-optimal dose of 
Wnt8. 
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The animal caps were induced either by 50 pg of Wnt8 mRNA or by 20 pg 
of Wnt8 mRNA providing stronger and weaker WNT responses. The induction of 
xnr3, siamois and xnr6 genes was tested. xnr5 and xnr6 have been shown to be 
direct WNT target genes (Yang et al., 2002).   
 As shown in figure 4.19, both 50 pg and 20 pg of Wnt8 mRNA injection 
could induce xnr3 and siamois while xnr6 could only be induced with 50pg of 
wnt8 mRNA demonstrating that different WNT targets require different amount of 
inducer in order to become induced. When the expression of these genes were 
tested in the absence of BRG1, it was found that BRG1 knock-down causes 
down regulation of Siamois at 20 pg of Wnt8 induction which could be partially 
rescued by induction of caps with 50 pg of Wnt8 mRNA.  
On the other hand, BRG1 knock-down completely inhibited the expression 
of Xnr6 even when the caps were induced by 50 pg of Wnt8 mRNA. On the 
contrary, BRG1 knock-down was unable to affect the expression of Xnr3, even 
when the caps were induced by 20 pg of Wnt8. 
These observations were further confirmed by overexpression of xBRG1 
in animal caps. The caps were induced by 2.5 pg Wnt8 mRNA, a sub-optimal 
dose for the full activation of WNT target genes. As shown in figure 4.19, 2.5 pg 
of Wnt8 mRNA partially induced siamois and xnr3 expression in the animal caps. 
When 2.5 pg of Wnt8 mRNA was co-injected with 500 pg of Xbrg1 mRNA, 
Siamois expression was slightly increased, while Xnr3 expression was strongly 
amplified. Notably, Xbrg1 mRNA alone was not able to induce either of the genes 
in animal caps (figure 4.19.). These results show that BRG1 sensitize the cells 
for WNT signaling by reducing the activation threshold. This means that certain 
WNT target genes can be activated at lower Wnt doses then others under 
reduced BRG1 protein levels. 
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4.17 Cloning of Xenopus ini1 
 INI1 is a component of the BRG1/ BRM complexes. Homozygous deletion 
of ini1 in mouse is lethal and mice die in periimplantation stage (Guidi et al., 
2001), like mice deficient of BRG1. However, it has been shown that some of the 
target genes of BRG1 remain unaffected in the absence of INI1 (Doan et al., 
2004).  
  
  1 ATG ATC ATG GCG TTG AGT AAA ACG TTT GGC CAA AAG CCA GTG AAA 
M   I   M   A   L   S   K   T   F   G   Q   K   P   V   K  
 
 46 TTT CAA TTG GAA GAG GAT GGA GAT TAT TAC ATG ATA GGA TCT GAG 
 F   Q   L   E   E   D   G   D   Y   Y   M   I   G   S   E  
 
 91 GTG GGA AAT TAC TTG CGC ATG TTC AGG GGC TCA TTA TAT AAA CGG 
 V   G   N   Y   L   R   M   F   R   G   S   L   Y   K   R  
 
136 TAT CCT TCC CTT TGG AGA CGG TTG GCA ACA GTA GAA GAG AGG AAG 
 Y   P   S   L   W   R   R   L   A   T   V   E   E   R   K  
 
181 AAA ATA GTA GCG TCT TCT CAT GGC AAG AAA TAT CAT GGC CAT ACC 
K   I   V   A   S   S   H   G   K   K   Y   H   G   H   T  
 
226 ACT CTA GCG ACC AGT GTT ACC CTA TTA AAA GCA TCA GAA GTT GAA 
T   L   A   T   S   V   T   L   L   K   A   S   E   V   E  
 
271 GAG ATC CTT GAT GGC AAT GAT GAG AAA TAT AAA GCA GTC TCC ATT 
E   I   L   D   G   N   D   E   K   Y   K   A   V   S   I  
 
316 AGC ACA GAA CCA CCA ACC TAC CTC AGG GAG CAG AAA GCA AAG AGA 
S   T   E   P   P   T   Y   L   R   E   Q   K   A   K   R  
 
361 AAC AGC CAG TGG GTT CCA ACC CTA CCC AAC AGC TCC CAC CAC CTG 
N   S   Q   W   V   P   T   L   P   N   S   S   H   H   L  
 
406 GAT GCA GTG CCT TGC TCT ACT ACT ATA AAC CGA AAT CGT ATG GGC 
D   A   V   P   C   S   T   T   I   N   R   N   R   M   G  
 
451 CGA GAC AAG AAG AGG ACA TTT CCA CTC TGC TTT GAT GAC CAT GAT 
R   D   K   K   R   T   F   P   L   C   F   D   D   H   D  
 
496 CCA GCA GTC ATT CAT GAA AAT GCT GCT CAG CCA GAA GTA TTG GTT 
P   A   V   I   H   E   N   A   A   Q   P   E   V   L   V  
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541 CCC ATA CGA TTA GAC ATG GAA ATT GAT GGC CAG AAA CTT CGA GAT 
P   I   R   L   D   M   E   I   D   G   Q   K   L   R   D  
 
586 GCC TTC ACG TGG AAT ATG AAT GAG AAG TTG ATG ACT CCA GAA ATG 
A   F   T   W   N   M   N   E   K   L   M   T   P   E   M  
 
631 TTT GCT GAG ATT CTC TGT GAT GAC CTT GAC TTG AAT CCT CTG GCT 
F   A   E   I   L   C   D   D   L   D   L   N   P   L   A  
 
676 TTT GTT CCA GCC ATC GCT TCA GCT ATC CGC CAG CAA ATA GAA TCA 
F   V   P   A   I   A   S   A   I   R   Q   Q   I   E   S  
 
721 TAT CCC ACT GAT AGC ATC CTG GAA GAT CAG TCT GAC CAG AGA GTC 
Y   P   T   D   S   I   L   E   D   Q   S   D   Q   R   V  
 
766 ATC ATC AAG CTC AAT ATC CAT GTT GGA AAC ATT TCA TTG GTA GAC 
I   I   K   L   N   I   H   V   G   N   I   S   L   V   D  
 
811 CAG TTT GAG TGG GAC ATG TCT GAA AAG GAA AAT TCT CCT GAA AAA 
Q   F   E   W   D   M   S   E   K   E   N   S   P   E   K  
 
856 TTT GCT TTA AAG TTA TGC TCG GAG CTT GGA CTT GGT GGG GAG TTT 
F   A   L   K   L   C   S   E   L   G   L   G   G   E   F  
 
901 GTT ACT ACT ATT GCT TAC AGT ATT CGA GGG CAG CTC AGC TGG CAT 
V   T   T   I   A   Y   S   I   R   G   Q   L   S   W   H  
 
946 CAG AAG ACA TAT GCG TTC AGT GAA AAC CCA CTG CCG ACA GTA GAG 
Q   K   T   Y   A   F   S   E   N   P   L   P   T   V   E  
 
991 ATA GCT ATT CGA AAT ACA GGC GAT GCT GAC CAA TGG TGC CCC CTC 
I   A   I   R   N   T   G   D   A   D   Q   W   C   P   L  
 
1036 CTG GAG ACC CTC ACT GAT GCC GAA ATG GAG AAG AAG ATC CGG GAC 
 L   E   T   L   T   D   A   E   M   E   K   K   I   R   D  
 
1081 CAG GAC CGG AAC ACC AGG CGT ATG AGA CGT CTT GCC AAC ACT GCA 
 Q   D   R   N   T   R   R   M   R   R   L   A   N   T   A  
 
1126 CCG GCC TGG TAA 
 P   A   W   *> 
 
Figure 4.20. Full length sequence of xini1 open reading frame. 1137 bp long open reading frame 
has no recognized domains. The corresponding amino acid sequence has been shown in single 
letter code in bold. 
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Thus, in order to further study the role of INI1, I cloned Xenopus ini1 by 
using human INI1 as a query to search the Xenopus laevis EST database. The 
database search gave a highly homologous EST namely, CA973918, which was 
fully sequenced. Xenopus ini1 ORF is of 1037 bp. xINI1 does not contain any 
functionally characterized domain, similar to other vertebrate INI1. The full-length 
sequence of xini1 is shown in figure 4.20. 
 
Figure 4.21 Clustlaw alignment of Xenopus INI1 with mouse and human INI1. Alignment shows 
high conservation spreaded throughout the protein sequence. 
 
 Xenopus INI1 amino acid sequence was aligned with mouse (Q9Z0H3) 
(Bruder et al., 1999) and human (AAA81905) (Kalpana et al., 1994) INI1 using 
Clustlaw software. The alignment shows high homology between the Xenopus, 
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mouse and human INI1. The conservation of the protein is throughout the entire 
length of protein, as shown in figure 4.21. 
4.18 Expression pattern of Xini1 
 The expression pattern of Xenopus ini1 was checked using a dig-labeled 
antisense probe. In-situ hybridization was carried out as described in the 
materials and methods section of this report. It was found that the expression of 
Xenopus ini1 could be detected at 2-cell and 4-cell stage, which represents 
maternal transcript of the gene. 
At neurula stage embryo, Xini1 is expressed in the prospective neural tube 
and in the eye anlage. At NF stage 28, Xini1 is expressed in the head region 
specifically in the eye, pronephros, and branchial arches and in the neural tube. 
By NF stage 40, the expression of Xini1 remains limited to eye, pronephros and 
branchial arches and disappears from the neural tube (figure 4.22).  
 
Figure 4.22 Endogenous expression pattern of Xini1. Xini1 is expressed at two (A) and 4 (B) cell 
stage, a stage when zygotic transcription does not start showing that ini1 is maternally provided 
like Xbrg1. At Neurula, it starts expressing specifically in prospective neural tissues and in eye 
anlage (C). At st.35 Xini1 transcript are present in neural tube, eye, otic vesicles, pronephros and 
branchial arches (D) and at st.40 expression become more concentrated to the head region with 
expression in retina (E).  
 
As shown here, the expression pattern of Xini1 was found to be similar to Xbrg1.  
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5 DISCUSSION 
 ATP dependent BRG1 chromatin remodeling complexes are large 
complexes of about 2 MDa in size. These complexes play a role in opening up 
local chromatin structures by either looping or by disrupting the nucleosomes 
around the promoters of various genes, making these promoters accessible for 
the transcriptional machinery. It has been shown in many previous reports that 
BRG1 containing chromatin remodeling complexes play a role in both repression 
and activation of genes. Most of the studies came from either Yeast or 
Drosophila (reviewed by Becker and Horz, 2002). The role of BRG1 has not been 
studied in vertebrates since knock-out studies in mouse could not reveal the role 
of these complexes in normal development (Bultman et al., 2000). In this study, I 
have shown by gain and loss of function experiments that BRG1 is required for 
the anterio-posterior body axis formation by specifically modulating the cellular 
Wnt signaling response during early patterning of the Xenopus embryo. In 
addition, I have shown that BRG1 modulated transcription is gene and signal 
specific and sets up a signaling threshold for normal Wnt-dependent gene 
induction. 
5.1 Cloning and expression pattern   
 Xenopus brg1 and Xenopus ini1 were cloned by using the human 
homologues as a query to search the database. The members of ATPase family 
show high degree of sequence conservation among the vertebrates as also seen 
in case of Xenopus homologues. In case of Xenopus BRG1, the conservation of 
this protein is not just in the ATPase domain; rather it is extended throughout the 
protein as also shown by Xenopus INI1, which is also conserved throughout the 
whole sequence. This high conservation of sequence identity represents an 
opportunity to use the existing database and provides a method for in-silico 
cloning for other members of the ATPase complexes. 
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 Xenopus BRG1 shows about 85% identity with its human counterpart. 
There were several missing regions in either of the sequences, which could be 
due to different splice variants of protein. The presence of a bromodomain, which 
represents a signature domain of SWI/SNF family members established this 
clone as a member of SWI/SNF family member (Horn and Peterson, 2001). The 
absence of a polyglutamine stretch, which is present in the BRM coding region, 
was one of the distinguishing features of it. Moreover, the sequence motif EED at 
the C-terminus of BRG1 is conserved in all the vertebrate homologues cloned 
until date, while BRM has sequence motif DDE at the C-terminus. Whether these 
differences are of functional importance is not known. These sequence features 
identify this cDNA as the Xenopus homologue of BRG1. Cloning of INI1 was 
undertaken to further understand the function of various subunits of BRG1 
complex using database searches and was found to have significant homology 
with other vertebrate counterparts.  
 Xbrg1 transcript are present in the maternal mRNA pool of the embryo, 
which is consistent with the reported maternal expression of BRG1 protein 
checked by immunobloting of protein extract from various stages of oocyte 
(Gelius et al., 1999).  In the same way, the Zebrafish brg1 has also been 
reported to be expressed maternally (Gregg et al., 2003). The expression of 
Xbrg1 at gastrula stage was ubiquitous, which becomes locally restricted from 
neurula stages onward, which is also one of the conserved features of the Brg1 
expression in Zebrafish. Similarly, mouse Brg1 has also been shown to have 
widespread expression, which later becomes restricted to a number of tissues. In 
mice, highest Brg1 expression is found in the spinal cord, the brain, parts of the 
peripheral nervous system and in retina (Randazzo et al., 1994). This pattern is 
comparable to Zebrafish and Xenopus (Gregg et al., 2003). The Zebrafish retina 
shows expression in differentiating neuroepithelium and at later stage restricted 
to ganglion cells and inner nuclear layers (Gregg et al., 2003). The similar 
expression is also shown by Xbrg1 as seen in cross-sections of st. 35 embryos. 
Interestingly, at stage 45, the expression of Xbrg1 was found only in the heart. In 
a recent report, the expression of Smarcd3, a mouse homologue of BAF60c, a 
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subunit of BRG1/BRM complex, was also found to be restricted to the heart 
region until embryonic stage E9.25 (Lickert et al., 2004). Thus, the expression 
pattern of Xbrg1 is very similar to the previously reported Brg1 expression 
patterns in mice and Zebrafish, which concludes that expression of Brg1 is 
conserved among vertebrates.  
The expression pattern of Xini1 was also found to be similar to that of 
Xbrg1. The expression pattern of Xbaf57 (Domingos et al., 2002) has also been 
reported to be similar to that of Brg1 and Ini1. Thus, xBRG1, xINI1 and xBAF57, 
which are conserved in core SWI/SNF complexes form an synexpression group 
(Niehrs and Pollet, 1999) while specific subunits like BAF60c, which are part of 
tissue specific SWI/SNF remodeling complexes, show a locally restricted 
expression. 
5.2 Role of BRG1 in Dorso-ventral patterning 
5.2.1 Methodological consideration 
In order to study the role of chromatin remodeling molecules in the early 
development of Xenopus laevis, I used both loss and gain of function methods to 
find out the role of BRG1 in normal development. The gain of function studies 
were carried out by microinjection of mRNA at 4-cell stage for either wild type or 
dominant negative versions of BRG1. Microinjection of mRNA at 4-cell stage 
leads to overexpression of the protein in the embryo already prior to the onset of 
zygotic transcription. Overexpression of a core subunit of a protein complex 
might have several consequences. The exogenous protein may compete with its 
endogenous counterpart for incorporation into the complex during assembly. 
Alternatively, if this protein is normally limiting, more complexes may be 
assembled. Increased number of dominant negative BRG1 complexes will be 
competing with the endogenous protein complexes and thus will be inhibiting the 
endogenous function of BRG1. On the other hand increased number of wild type 
BRG1 containing complexes will co-operate with the endogenous function of 
BRG1 and thus potentiate their function. Proteins involved in complexes with 
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BRG1 to obtain full functional capability, are also involved in making complex 
with BRM. Thus during the gain of function studies, it is possible that over-
expressed protein sequesters a subunit of the complex and thus makes it 
unavailable for other complexes which can lead to non-specific effects. This 
possibility of non-specific consequences was ruled out by rescue experiments, in 
which the phenotype of dominant negative BRG1 protein was reverted by 
overexpression of wild type BRG1 protein but not by overexpression of BRM 
protein.  
 Gain of function studies provide useful information about the potential 
function of a protein, however only loss of function studies can reveal essential 
functions of a protein. The methods generally used for loss of function studies in 
Xenopus are maternal knockouts or modified antisense oligonucleotides. siRNA 
procedure has also been used in Xenopus embryos for loss of function studies 
(Anantharam et al., 2003; Nakano et al., 2000; Zhou et al., 2002) but our 
attempts to use siRNA mediated knock-down failed, similar to some other 
Xenopus labs. Maternal knock-out studies (Heasman et al., 1991) are technically 
difficult with limited success and do not distinguishes between zygotic or 
maternal functions of the protein. The most commonly used method of knocking- 
down proteins is by microinjection of modified oligonucleotides in the desired 
region of embryo. Among the modified oligonucleotides, most common ones are 
phosphoorthothioate antisense oligonucleotides and morpholino antisense 
oligonucleotides. Phosphoorthothioate antisense oligonucleotides are 
comparatively cheap, but they are known to produce non-specific effects. 
Moreover, it is often also difficult to choose the correct target site for these 
oligonucleotides. In recent times, morpholino antisense oligonucleotides have 
been used (Heasman et al., 2000), which offer the advantage of high specificity, 
easier selection of target sites, and efficient knock-down of the desired protein. 
Based on these mentioned advantages and disadvantages of various methods 
available, I chose to carry out loss of function studies using morpholino antisense 
oligonucleotides.  
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 In this study, I reported that the full-length transcript of Xbrg1 could only 
be obtained by in-vitro transcription at lower temperature, than the usual 37oC. It 
has been reported previously that the in-vitro transcription using T3, T7 or SP6 at 
37
o
C may result in truncated transcripts and that this problem could be overcome 
by lowering the temperature (Krieg, 1990). Here, the full-length transcript of 
Xbrg1 could be obtained by T7 promoter, but not by SP6 polymerase. Thus, for 
the transcription of xbrg1, the use of SP6 RNA polymerase is problematic. Since 
the pCS2+ vector, which is used to overexpress proteins in Xenopus, contains an 
SP6 promoter upstream of translation start site, it was essential to use SP6 
polymerase. In order to obtain full-length transcripts using SP6 promoter, lower 
temperatures were used for transcription reaction.  As per some available reports 
(Ambion inc), some of the bacteriophage derived RNA polymerase show the 
tendency of falling off and terminating RNA synthesis, leading to prematurely 
terminated transcripts. The underlying reason for this premature termination has 
not been resolved until date.  
5.2.2 Specific role of BRG1 in anterio-posterior axis formation 
I have shown in the report that BRG1 participates in the formation of AP 
axis. These results are shown first, by overexpression of human BRG1, which 
could be rescued and thus representing the specific phenotypes. Later these 
results were also confirmed by overexpression of dominant negative Xenopus 
BRG1. These results show that human BRG1 and Xenopus BRG1 act in a 
similar manner, suggesting functional conservation. On the other hand, wild type 
human BRG1 did show no phenotype on dorsal as well as on ventral 
overexpression, while Xenopus BRG1 produced head defects upon dorsal 
overexpression and induced an incomplete secondary axis upon ventral 
overexpression. These results show that Xenopus BRG1 is more potent than 
human BRG1. This might be due to either higher stability of Xenopus BRG1 or 
due to some sequence divergence, xBRG1 may be capable to form more stable 
complexes due to its compatibility with other endogenous components of BRG1 
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complex. Overall, these results using human and Xenopus BRG1 variants 
confirmed the role of BRG1 in AP axis formation. 
 Apart from these gain of function studies, loss of function studies provided 
further evidence of the importance of BRG1 in head formation and dorsal ventral 
patterning. Notably, the xBrg1 MO induced phenotypes could not be rescued by 
hBRM and xISWI, demonstrating that the function of BRG1 is not redundant and 
could not be taken over by other members of the SNF2 family. Thus, the results 
obtained with gain and loss of function studies unambiguously established the 
role of BRG1 in AP axis formation.  
 Overexpression of wild type and dominant negative human BRM, as well 
as variants of xISWI did not cause any developmental phenotypes. These results 
confirmed that the observed phenotypes with BRG1 are not due to injection 
artifacts or due to toxic effects of RNA. These results obtained from 
overexpression of dominant negative and wild type human BRM are in consent 
with the recent reports showing that BRM knock-out mice do not show any 
phenotypes, probably due to compensation by BRG1 (Reyes et al., 1998). 
Moreover, it is now known that BRG1 is found in BAF and PBAF complexes 
while BRM is found in BAF complexes only. Thus, it is possible that loss of BRM, 
which will affect BAF complexes only, is compensated by BRG1, while the loss of 
BRG1, which affect both BAF and PBAF complexes, can not be fully 
compensated by BRM. Moreover other studies have also pointed out that BRG1 
and BRM have transcriptional specificity (Kadam and Emerson, 2003). 
Furthermore, in a recent report it was shown that the transcription of sox2, a 
gene expressed in early neural cells, is dependent on BRM and not on BRG1 
(Kondo and Raff, 2004) showing the differential requirement of BRM and BRG1.   
The unsuccessful attempts to achieve developmental phenotypes by ISWI 
overexpression may be explained differently. In particular, it is known that xISWI 
is a highly abundant molecule in Xenopus oocytes (Guschin et al., 2000) and, 
thus, I might not be able significantly inhibit its function by overexpression of 
dominant negative protein. These results were also in consent with a recent 
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report showing that mice heterozygous for ISWI were normal, but homozygous 
null mutant mice dies in early embryonic stages (Stopka and Skoultchi, 2003).  
5.3 BRG1 is required for normal expression of WNT target genes  
When the phenotypes obtained from dorsal overexpression of wild type 
and dominant negative xBRG1 were observed closely, the overexpression of 
dominant negative BRG1 was found to cause preferentially loss of eyes, while 
wild type xBRG1, preferentially caused loss of cement glands.  In a recent report, 
it was shown that the local mis-expression of Wnt8 in the head territory under 
control of the cerberus promoter causes preferentially loss of cement glands 
(Silva et al., 2003). A detailed model for head formation has been discussed 
elsewhere (Niehrs, 1999; Niehrs, 2004).  Moreover, overexpression of xBRG1 on 
the ventral side produces a partial secondary axis, which indicates the formation 
of weak organizer on the ventral side. The role of WNT signaling has been 
convincingly shown in organizer formation as the overexpression of ?-CATENIN 
on the ventral side causes secondary axis (Funayama et al., 1995) formation as 
well as inhibition of WNT signaling on dorsal side by UV treatment causes 
ventralization of the embryo (Kao and Elinson, 1988). The role of WNT pathway 
in dorso-ventral patterning has been confirmed by interfering with ?-CATENIN by 
maternal knock-downs as well as by morpholino antisense mediated knock-down 
(Heasman et al., 2000; Wylie et al., 1996). The phenotypes observed in these 
cases were similar to BRG1 knock-down.  Thus, our results strongly support 
dose-sensitive interactions between BRG1-containing remodeling complexes and 
the canonical WNT signaling pathway. 
In-situ hybridization analysis of genes involved in dorsal mesoderm 
formation showed that indeed BRG1 affects WNT target gene expression, as 
evidenced by the downregulation of Xnr3 and Chordin. Reduced expression of 
Goosecoid also supports this conclusion. The goosecoid promoter is known to 
have two signal inputs i.e. WNT signal and NODAL signal. WNT signaling is 
relayed to the gsc promoter by the distinct WNT-targets siamois/twin, while 
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NODAL signaling is mediated by SMAD2/SMAD4 heterodimers (Germain et al., 
2000). Reduced Siamois expression as checked in animal cap assay shows the 
reduced WNT signal input for activation of goosecoid. Importantly, when 
goosecoid was induced by ACTIVIN signaling alone in animal caps, its induction 
was unaffected by BRG1 knock-down, indicating that reduced expression of 
Goosecoid is due to reduced WNT signaling input. Interestingly, a nodal related 
gene xnr6, which has been shown to be transcribed in pre MBT stages under the 
control of WNT signaling pathway (Yang et al., 2002) was found to be 
downregulated in animal cap assay under the reduced protein levels of BRG1.  
      
 
Figure 5.1 BRG1 is involved in the WNT signaling pathway. 
These results suggest that while NODAL signaling remains unaffected, the 
reduced expression of Xnr6 reduces the nodal input on the goosecoid promoter, 
resulting in reduced expression of Goosecoid.  Taken together, four distinct WNT 
target genes were tested and all of them were misregulated by BRG1 over-
/underexpression. I can conclude, therefore that the BRG1-CRC is essential for 
proper transcriptional regulation of WNT /?-CATENIN target genes. 
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5.4 BRG1 containing complexes have gene and signal specific 
functions 
It has been claimed previously that BRG1 acts as a global transcriptional 
activator (Armstrong et al., 2002). The loss of function studies presented here 
point to rather selective functions of BRG1. Reduced levels of BRG1 protein 
results in lower expression of Xnr3, Chordin, Myod and Myf-5, while expression 
of Xbra and Xvent-2 remains unchanged and Xpo expression is increased. 
Although it has been shown that WNT signaling affects Xbra expression (Schohl 
and Fagotto, 2003), I did not find any change in the expression of Xbra. This 
might be explained by a compensation of loss of WNT signaling input by other 
signaling events like FGF signaling, required for Xbra expression (Smith et al., 
1991). Consistent with this assumption, when animal caps were induced by 
eFGF for the induction of Xbra, BRG1 knock-down does not affects the 
transcriptional levels of Xbra. The effect of BRG1 knock-down is not only gene 
specific but also signal specific as seen in animal cap assay. On one hand, 
BRG1 knock-down affects WNT signaling, shown by reduced expression of 
Siamois and Xnr6, ACTIVIN/NODAL related signaling remains unaffected, 
exhibited by Goosecoid and Xfd-1´.  
The effect on FGF/MAPK signal appears also to be highly gene specific, 
given that the Xbra mRNA levels remain normal while expression of Myod was 
strongly reduced. The explanation for reduced transcription of myod came from a 
recent report showing that BRG1 and MyoD interact with each other in the 
presence of activated MAPK (Simone et al., 2004). It has been also shown that 
MyoD promotes its own transcription by autocatalysis (Steinbach et al., 1998; 
Thayer et al., 1989). Thus, it might be possible that BRG1 interacts with MyoD to 
promote the transcription of myod and thus when BRG1 is knocked out, the 
autocatalysis of myod will be blocked, leading to reduced transcription as seen in 
animal cap induction experiments.  
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BRG1 knock-down does not affect BMP signaling as checked by 
expression of Xvent-2, a gene under direct control of BMP signaling. These 
results were unexpected since the weakening of organizer would mean that weak 
organizer would no longer be able to inhibit invasive BMP signaling mediated 
ventral mesoderm formation but it is possible that the remaining activity of 
organizer is still sufficient to prevent the expression of Xvent-2 in the organizer 
territory. Although the expression of Xpo in organizer territory confirms that the 
organizer has been weakened, its increased expression could also be due to the 
repressive function of BRG1 as has been reported previously (Martens and 
Winston, 2003). Taken together, these results pointed out that BRG1 acts in a 
gene and signal specific manner.  
5.5 Effects of BRG1 knock-down on organogenesis  
 The pleiotropic effects of BRG1 knock-down was shown in this report 
(figure 4.13) by reduced expression of several differentiation markers including 
neural n-?-tubulin, heart specific Nkx2.5, muscle specific Mlc35 and blood vessel 
specific Msr. These effects could be explained partly by perturbation of the 
primary embryonic patterning, but it does not exclude a requirement of BRG1 for 
tissue specific transcription factors. The effect on neural tissue development 
observed by neural specific beta-tubulin may be explained partly by the reduced 
expression of Chordin in blastula stage. chordin is a gene that is expressed in the 
BCNE center. The BCNE center gives rise to future neural tissue (De Robertis 
and Kuroda, 2004). A reduction of Chordin expression will impair the BCNE 
center, which will ultimately affect neural tissue development. A recent report has 
also demonstrated a role of Xenopus BRG1 in neurogenesis (Seo et al., 2005) 
although it claims that BRG1 knock-down does not affect neurogenesis during 
early patterning based on the fact that Sox2 expression was unaffected by the 
BRG1 ablation. SOX2 is a member of HMG box transcription factor family, 
involved in early stages of neurogenesis (Bylund et al., 2003). However, a recent 
report has shown that Sox2 expression is controlled by BRM and not by BRG1 
(Kondo and Raff, 2004) in a study carried out in Rats. 
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As I have shown that BRG1 knock-down affects heart formation, a recent 
report supported my observation and provided a mechanism. It was shown that 
BAF60c, which is a component of BRG1 complex is expressed specifically in the 
heart and when knocked-down using siRNA, heart formation is severely affected. 
Furthermore, it was shown that BAF60c is required for transcription of Nkx2.5, 
which is dependent on BRG1. Furthermore, it has been reported that knock-out 
of BAF180, a signature subunit of PBAF complexes, in mice also causes heart 
defects (Wang et al., 2004b). The blood vessel formation is severely inhibited in 
BRG1 MO treated embryos. The process of angiogenesis requires among other 
factors, MMP-2. It has been shown that the transcription of mmp-2 is dependent 
on BRG1 (Ma et al., 2004). This observation points out a possibility that when 
BRG1 is knocked-down, the transcription of mmp-2 might get inhibited and this 
may affect angiogenesis. These observations point out a role for BRG1 
containing chromatin-remodeling complex in tissue specific transcription. In later 
stages of development, the expression of Mlc35 was also reduced, confirming 
the reported role of BRG1 in myogenesis in which authors reported that dominant 
negative BRG1 interferes with the MyoD mediated muscle program shown by the 
down regulation of Myogenin and Mrf-4 (de la Serna et al., 2001). Here in this 
study, I have shown that both Myod and Myf-5 are down regulated upon BRG1 
knock-down and thus showing another level at which myogenesis is affected by 
BRG1. A TCF binding site has been found in the myf-5 promoter, as well as it 
has been shown that myf-5 can be activated immediately after activation of 
animal caps by Wnt stimulation in the presence of cycloheximide (Shi et al., 
2002), suggesting it to be a direct target of Wnt signaling pathway. As shown, 
upon BRG1 knock-down, Myf-5 expression is completely inhibited showing that 
BRG1 is required to activate the transcription of myf-5, possibly by interfering 
with Wnt signaling. Thus, it can be concluded that BRG1 is involved in several 
differentiation programs at key regulatory levels. 
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5.6 Signaling thresholds at the nucleosomal level 
I have shown that xnr6 could be induced by 50 pg of Wnt8 mRNA injection 
while siamois and xnr3 become induced already by 20 pg of Wnt8 mRNA. These 
results imply that different target genes require different doses of Wnt signal to 
obtain their normal level of transcription. The transcription of xnr6 was completely 
inhibited, while siamois transcription was reduced by BRG1 knock-down after the 
induction of Brg1 morphant caps with 50 pg of Wnt8 mRNA. These results show 
that xnr6 requires the highest amount of BRG1 for activation, while siamois could 
be induced in the reduced levels of BRG1. Notably, its Wnt dependent activation 
was not completely rescued even at the highest dose of Wnt8 used in this study. 
On the other hand, the transcription of siamois could be completely inhibited at 
reduced Wnt8 mediated induction.  
 
Figure 5.2 BRG1 acts to set up signaling threshold for normal gene expression. 
These results implied that BRG1 helps to translate signal quantity into 
promoter activity. Unexpectedly, it was found that Xnr3 transcription could not be 
affected by BRG1 knock-down in animal caps unlike in the embryo. Context 
dependency could be one explanation, since animal cap cells are prospective 
ectoderm, while in the embryo Xnr3 is expressed in dorsal mesodermal cells. 
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Another possibility is that the amount of Wnt8 used to induce the xnr3 
transcription is still high enough to counteract the reduced amount of BRG1 in 
the animal cap assay. Thus, xnr3 requires the least amount of BRG1 for 
remodeling of its promoter, and may be fully activated already at very low levels 
of WNT signal.  
This possibility was strengthened by the observation that xBRG1 could 
hyperstimulate the expression of Xnr3 in sub-optimal WNT induction conditions 
much stronger then Siamois induction. Thus, it can be concluded that BRG1 
protein levels set up a threshold for the activation of WNT target genes at a given 
signal strength as presented in the model (figure 5.2). 
5.7 Specific recruitment of BRG1 to target genes 
 From my results, it has become clear that BRG1 modulates the 
transcriptional read out of the canonical Wnt-signaling pathway required for early 
patterning of the Xenopus embryo. In order to do this, BRG1 is expected to bind 
to WNT-target gene promoters. A report showing interaction of BRG1 and ?-
CATENIN, provides a mechanism how BRG1 may become recruited to these 
promoters (Barker et al., 2001). However, this result was disputed since 
interaction of BRG1 and ?-CATENIN could not be reproduced by other labs, 
which tested the interaction of in-vitro translated BRG1 and ?-CATENIN (Kadam 
and Emerson, 2003). However, the epistasis experiments carried out during this 
project showed that ?-CATENIN could rescue the Brg1 morpholino mediated 
phenotypes. Additionally, I could also show that BRG1 is required for the 
induction of secondary axis formation by ?-CATENIN. These results in 
combination confirmed that BRG1 and ?-CATENIN interact genetically. Recently, 
a report could show convincingly that BAF60c enhances the interaction of BRG1 
and ?-CATENIN (Lickert et al., 2004).  This observation suggested that BRG1 is 
specifically recruited to the WNT target genes promoter by the interaction of 
BAF60c and ?-CATENIN. In another case, the recruitment of BRG1 on the myod 
promoter could be explained by the interaction of BRG1 and MyoD in the 
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presence of activated MAPK (Simone et al., 2004). From these observations, it 
was clear that various subunits of BRG1 complex are required for recruitment of 
this complex to a variety of promoters other then having their role in obtaining the 
maximum activity of nucleosomal remodeling by BRG1 complex. 
 
5.8 Conclusions and outlook  
In this study, the role of BRG1 was studied in early development of 
Xenopus. It was shown that BRG1 is required for AP axis formation by affecting 
the early patterning of the embryo. It was also shown that BRG1 affects early 
patterning of Xenopus embryo by modulating WNT signal target genes. 
Furthermore, it was shown that BRG1 affects myogenesis. In this study, I found 
that BRG1 affects specific signaling pathways. BRG1 affected the WNT and 
eFGF-signaling pathway, while the ACTIVIN signaling pathway remained 
unaffected. I could also show that BRG1 sets up a signaling threshold for the 
stimulation of WNT target genes.  
These observations provide an entry point for the analysis of BRG1 
containing remodeling complexes in vivo. It will be interesting to show the 
recruitment of BRG1 on its target promoters using chromatin immunoprecipitation 
(ChIP). Moreover, it will be interesting to investigate, when BRG1 is required – 
i.e. before the assembly of pre initiation complex (PIC) as has been shown for 
some genes (Soutoglou and Talianidis, 2002), or after the assembly of PIC. 
These experiments can further be extended to find out, whether BRG1 stays 
bound to  promoter, or leaves it after initiating the transcription.  
Furthermore, the functions of various other subunits of BRG1 complex 
including INI1 can now be explored using the same strategy, used in this study. 
INI1 is a common component of BRG1 and BRM complex. Therefore, it will be 
interesting to find out if INI1 knock-down affects all BRG1 target genes or other 
genes as well. Furthermore, it can also be tested if some of the BRG1 target 
genes remain unaffected by INI1 knock-down as has been reported. These 
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studies could explore the role of other subunits of BRG1 complex in early 
development. Given the importance of INI1 in rhabdoid tumor development, it 
may also provide further mechanistic explanation of the role of INI1 in this 
disease. Other then INI1, other interesting subunits to study will be BAF180 and 
BAF250 due to their specific presence in PBAF and BAF complexes respectively.  
As it has been shown that BRG1 knock-down affects several tissues, the 
role of BRG1 in organogenesis can also be studied. It has been shown that 
BAF60c and BAF180 are required for heart formation. In Xenopus, animal cap 
system can provide an easy method to study the organogenesis outside the 
organism. Animal caps contain multipotent embryonic stem cells. The animal cap 
tissue can be differentiated into various organs and cell types by specific 
induction protocols, using variable Activin and Retinoic acid concentrations 
(Ariizumi and Asashima, 2001). By this strategy, it is now possible to study the 
specific role of chromatin remodeling complexes in organ development. 
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ABBREVIATIONS 
 
A  Adenine 
Ab   Antibody 
AC   Animal caps 
AP   Alkaline phosphatase 
AP axis Anterior-posterior axis 
APS   Ammonium persulfate 
BCIP   5-Bromo-4-chloro-3-indolyl-phosphate 
BCNE  Blastula Chordin Noggin Expression center 
BMP   Bone morphogenic protein 
bp   base pair 
BSA   Bovine serum albumin 
C   Cytosine 
CNS   Central nervous system 
CS   Chicken serum 
dd H2O  Double distilled water 
DE   Dorsal ectoderm 
Dig   Digoxygenin 
DMZ  Dorsal marginal zone 
Dn  Dominant negative 
DTT   Dithiothreitol 
EDTA  Ethylene diamine tetra acetic acid 
eFGF   Embryonic fibroblast growth factor 
FGF   Fibroblast growth factor 
G   Guanine 
h   Hours 
HCG   Human chorionic gonadotropin 
HEPES  4-(2-Hydroxyethyl)-piperazine-1-ethanesulfonic acid 
HMG   High mobility group 
hpf   Hours post fertilization 
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ICC   Immunocytochemistry 
kb   kilo base pair 
LMZ   lateral marginal zone 
MBS   modified Barth`s saline 
Min  minutes 
MMR   Marc ’s modified Ringer ’s Solution 
T  Thymine 
VMZ  Ventral marginal zone 
Wt  wild type 
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